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Some 3.5 billion years ago, microorganisms were the first to colonize Earth. They have gradually
evolved, within intricate systems of microbial and macroscopic species, to occupy virtually all the
available niches on the planet. Genetic drift and natural selection have molded the phenotypic
expression of a trillion different microbial species [1], shaping their metabolisms and offering ever-more
advantageous abilities to expand, with the production of new metabolites being one key to the fitness
and evolutionary success of new species [2].
The rate of discovery of new natural products of microbial origin has increased significantly since
the 1970s with the advent of modern methods of purification and structural determination, and later,
with holistic approaches to chemical analysis and genetic information-based exploration of natural
chemodiversity [3–6]. With these tools in hand and the exploration of innovative and ecologically
relevant sources of microorganisms, it is possible to rapidly expand the exploration of chemodiversity
on a global scale, and eventually isolate innovative compounds. It should be noted that the enthusiasm
to discover new scaffolds is not necessarily relevant in the context of the search for active or useful
natural products. Structural modifications that do not affect the core scaffold of a metabolite may
provide a significant benefit that can be developed for a therapeutic use. A notable example is in
the immense diversity of terpenes built on a limited number of scaffolds. Terpenes have different
functional roles—and therefore different biological activities—and have largely contributed to the
diversification of higher plants [2,7].
Today, marine microbes can still be regarded as a relatively underappreciated potential source of
active compounds yet to be discovered. Some microorganisms can live freely in the water column,
while many others live in association. For example, sponges host microorganisms that contribute
to their holometabolome, while many coral species host microalgae and symbiotic prokaryotes.
Furthermore, many microorganisms contribute to the construction of interspecific biofilms covering
biotic and abiotic surfaces. While recent advances in natural-product science now provide access to
an unknown dimension of chemodiversity, metabolic engineering will eventually allow the production
of active marine compounds in amounts necessary for pharmaceutical development.
The Special Issue “Marine Microbial Diversity as a Source of Bioactive Natural Products” was
aimed at collecting papers with up-to-date information regarding the characterization of marine
microbes’ metabolic diversity and the evaluation of the therapeutic potential of marine microbes’
metabolites. The interest of the Special Issue was also to show that the exploration of underrated
reservoirs of marine microorganisms can lead to the discovery of valuable secondary metabolites.
In total, 10 articles were accepted and included in the Special Issue.
Most of the articles in this special issue deal with marine fungi, biological and chemical diversity,
and their active metabolites. This may be a sign that marine fungi have been under studied to date,
and are perceived by many researchers as an important source of discovery in this field [8]. Focusing on
marine Arthrinium spp. isolates, Heo et al. conducted a phylogenetic analysis based on internal
transcribed spacers, nuclear large subunit rDNA, β-tubulin, and translation elongation factor region
sequences [9]. The 28 analyzed strains were obtained by cultivation of seaweed tissues (including
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several Sargassum fulvellum individuals) and Arctoscopus japonicus egg masses. It was found that the
28 isolates were in fact 15 species, 11 of which being new to Science. Most of the fungal extracts
exhibited radical-scavenging activity, and some showed antifungal activity, tyrosinase inhibition, and
quorum sensing inhibition. Interestingly, three species were found in both S. fulvellum and A. japonicus
egg masses, perhaps because these fish usually lay eggs on S. fulvellum. The known compound gentisyl
alcohol was found to be responsible for the radical-scavenging activity of two of the Arthrinium extracts.
A fungal diversity analysis was also conducted on decommissioned salterns and neighboring mudflats
in the Yellow Sea of South Korea [10]. Comparative fungal community analysis showed that the salterns
that had been abandoned for more than 35 years had recovered to mudflats. The Yongyudo saltern was
abandoned less than one year before the analysis and had not recovered. Its fungal community was
more diverse and was dominated by Entorrhizomycota, while Chytridiomycota and Mortierellomycota
dominated elsewhere. It has been hypothesized that Entorrhizomycota may include plant pathogenic
fungi and that the dominance of this phylum may originate from the occurrence of their host plants
at the initial stage of ecological succession after the saltern was abandoned. It should be mentioned
that a large number of fungi could not be identified, indicating a lack of DNA-based phylogenetic
information on marine fungi. Eventually, 53 fungal strains were isolated from the different sampling
locations. The cultivable fungi were not necessarily the main taxa from the community analyses.
A total of 18 isolates were possibly new species, and the authors provide the antioxidant, antifungal,
tyrosinase inhibition, and quorum quenching activity of all isolates.
Fungal spores are easily dispersed and are detectable in community analyses. As a result,
not all fungi detected in marine environments by rDNA-based analysis are genuine marine species.
The challenging question of the isolation of marine fungi sensu stricto is key to the future exploration
of the chemical diversity of marine fungi, and possibly the exploitation of their secondary metabolites.
A best-practice guide for the isolation of marine fungi from different matrixes and their conservation
is presented by Overy et al. [11]. Generalist, osmotolerant/halotolerant genera such as Aspergillus
and Penicillium are highly cited in the literature but taxonomic groups composed predominantly of
marine fungi sensu stricto such as Halosphaeriaceae, Torpedosporales, and Lulworthiales have been
little studied for now. It should also be noted that mycologists have been studying marine fungi for
decades, and that currently cryopreserved marine fungi may represent an easily accessible source for
the exploration of their chemical diversity and the isolation of active secondary metabolites.
One of the sources frequently explored in the search for marine fungi are sedimentary deposits.
Examination of the full genome of the marine-derived fungus Penicillium brasilianum HBU-136,
isolated from the Bohai sea in China, highlighted that the strain harbors multiple non-ribosomal
peptide synthetase (NRPS) biosynthetic gene clusters (BGC), including one showing high similarity
to the BGC of fumitremorgins A-C in the fungus Aspergillus fumigatus [12]. The strain was already
known to produce a spirocyclic diketopiperazine alkaloid and cyclotryprostatin B when cultivated
on rice medium. More fermentation conditions were experimented and it was eventually discovered
that three new and unusual indole-diketopiperazines 1–3 were produced by fermentation in a rice
medium supplemented with 1% MgCl2 (Figure 1). The proposed BGC is likely responsible for the
synthesis of these metabolites. Compound 1 was cytotoxic on HL-60 cells (6.0 μM), and compounds
2 and 3 were active on MCF-7 cell line (7.6 and 10.8 μM, respectively). The marine-derived fungus
Aspergillus fumigatus CUGBMF170049 was also isolated from the Bohai sea sediments and was shown to
produce new pseurotin analogs 4 and 5 (Figure 1) [13]. These metabolites were identified by thorough
analysis of spectroscopic data, but unfortunately, were not active in the antimicrobial assays used
in this work. Incidentally, the known compound helvolic acid isolated from the same fungus was
very active on both Staphylococcus aureus and methicillin-resistant S. aureus, with a minimal inhibitory
concentration (MIC) of 0.78 μg/mL. The fungus Geosmithia pallida FS140 was isolated from a sediment
collected at 2403 m depth in the South China Sea [14]. Twelve diketopiperazines, including the three
new thiodiketopiperazines geospallins A-C (6–8), were isolated from this fungus (Figure 1). The three
2
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new compounds exhibited substantial angiotensin-converting enzyme inhibitory activity, with IC50
values of 29–35 μM.
 
Figure 1. Compounds isolated from marine-sediment-derived fungi.
In the sea, many fungal species are associated with macroscopic organisms [9,11,15]. The isolation
of marine fungi from macroorganisms’ tissues may in fact be a fairly straightforward way of isolating
marine fungi sensu stricto. The fungus Aspergillus flocculosus 168ST-16.1 was isolated from the algae
Padina sp., collected at a depth of 10 m in Da Nang, Vietnam [16]. Five new sesterterpene ophiobolins
together with four known ones were isolated from a broth culture of this fungus and identified
by spectroscopic methods. Interestingly, all these compounds were active against six cancer cell
lines with 50% growth inhibition (GI50) values in the range of 0.14 to 2.01 μM. The new compound
14,15-dehydro-6-epi-ophiobolin K (9, Figure 2) was among the most active ones, with a GI50 of
about 0.2 μM on all tested cell lines. The fungal strain Botryosphaeria ramosa L29 was isolated as an
endophyte of the mangrove plant species. Four new isocoumarin derivatives, namely botryospyrones
A, B (10), C, and D (Figure 2) were isolated from this fungus. Interestingly, a fifth compound (11)
was produced only when the culture medium was supplemented with the host plant flavonoid
(2R,3R)-3,5,7-trihydroxyflavanone 3-acetate, which had been found to slightly inhibit the endophyte
growth. Owing to the ease of isomerization of animals by successive ring-opening and ring-closing
steps, it is expected that such compound would eventually generate the more stable stereoisomer, i.e.,
the cis ring junction isomer. Further, the 13C NMR spectrum of compound 11 is similar enough to the one
previously reported in the literature to conclude that the proposed structure was probably erroneous [17].
Compound 11 is in fact likely the (3aR,8aS)-1-acetyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-3a-ol
rather than the (3aS,8aS) stereoisomer. Three coumarins and compound 11 were evaluated in vitro for
antifungal activity toward three phytopathogenic fungi. It is interesting to point out that compound
11, which is only produced by the fungus exposed to a metabolite of the plant, was the most active,
with MIC values in the 28-57 μM range.
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Figure 2. Examples of secondary metabolites isolated from fungi associated to algae and plants.
Finally, describing and understanding the metabolic diversity of marine species will allow
a better understanding of the whole marine ecosystem, a better understanding of the mechanisms that
regulate interspecific interactions in the sea, and possibly, a better understanding of the evolutionary
processes involved. Moreover, the sea is the cauldron of a great diversity of useful and valuable
compounds, whether known or not. As such, many marine microorganisms can become important
sources of compounds useful to humankind. The carotenoid-producing yeast strain Rhodotorula
sp. RY1801 was isolated from the exposed intertidal zone along the South Yellow Sea in Dongtai,
China [18]. The culture conditions were optimized to increase the microbial biomass and the carotenoid
yield of the strain. Eventually, it was possible to reach nearly 1 mg/L carotenoids in the culture,
demonstrating that this fast growing Rhodotorula sp. strain may be used for the commercial production
of carotenoids. The comparison of the phylogenetic and metabolomic profiles of 12 microalgal species
from different lineages provided novel insights into the potential of chemotaxonomy in marine
phytoplankton [19]. The most abundant and diversified metabolites identified over the 12 strains were
polar lipids and pigments. Historically, analysis of pigment composition has been used to assist the
classification of microalgae. Here, it was found that lipid classes and some specific lipids within classes
may serve as phylogenetic markers. For example, within the tested Mamiellales, the Ostreococcus
genus differs by the presence of two monogalactosyldiacylglycerols (MGDG 20:5/16:3 and 16:1/16:1),
and the species O. tauri has six 1,2-diacylglyceryl-3-O-4’-(N,N,N-trimethyl)-homoserines (DGTSs) that
are not found in O. mediterraneus. Overall, a good overlap of phylogenetic and chemotaxonomic
signals was demonstrated, in particular when the analysis focused on the major metabolites of
algae, and evolutionary divergence between species could be inferred in good congruence with the
phylogenies. These results support the hypothesis of a metabolomics equivalent to the “molecular
clock” based on the analysis of sequence data.
As seen from the above synopsis, the papers included in this Special Issue provide an interesting
overview of chemical diversity of marine fungi and algae. New, bioactive, marine-derived fungal
metabolites were isolated and characterized. The articles presented in this Special Issue underline the
central role of the sea as a provider of valuable chemicals for human use.
In conclusion, the Guest Editor thanks all the authors who contributed to this Special Issue,
all the reviewers for evaluating the submitted manuscripts, and the Editorial board of Marine Drugs,
especially, Orazio Taglialatela-Scafati, Editor-in-Chief of the journal, and Estelle Fan, Assistant Editor,
for their kind help in bringing this book into reality.
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Abstract: Despite the rapid development of molecular techniques relevant for natural product
research, culture isolates remain the primary source from which natural products chemists discover
and obtain new molecules from microbial sources. Techniques for obtaining and identifying microbial
isolates (such as filamentous fungi) are thus of crucial importance for a successful natural products’
discovery program. This review is presented as a “best-practices guide” to the collection and isolation
of marine fungi for natural products research. Many of these practices are proven techniques
used by mycologists for the isolation of a broad diversity of fungi, while others, such as the
construction of marine baiting stations and the collection and processing of sea foam using dilution to
extinction plating techniques, are methodological adaptations for specialized use in marine/aquatic
environments. To this day, marine fungi, Sensu stricto, remain one of the few underexplored resources
of natural products. Cultivability is one of the main limitations hindering the discovery of natural
products from marine fungi. Through encouraged collaboration with marine mycologists and the
sharing of historically proven mycological practices for the isolation of marine fungi, our goal is to
provide natural products chemists with the necessary tools to explore this resource in-depth and
discover new and potentially novel natural products.
Keywords: marine fungi; isolation; culturing; identification; natural products; secondary metabolites
1. Introduction
The field of natural product discovery is under transition as genome sequencing and different
‘omics’ techniques gain more prominence within the research field. Techniques such as transcriptomics
and metabolomics, which are used to reveal expressed genes and associated metabolites, are now being
applied as tools in the discovery and expression of natural products. ‘Omics’-based natural product
discovery pipelines are still in their infancy, but have shown their potential in finding new bioactive
molecules without culturing the producing organism [1]. However, the isolation and culturing of
filamentous fungi and other microorganisms will continue to have relevance in the field for many
more years to come and, for many applications, will remain a necessity. For this reason, current and
future generations of natural product chemists should know how to isolate, maintain, and preserve
fungal cultures.
Filamentous fungi are a proven source of structurally diverse natural products. Few opportunities
to explore truly virgin lineages of filamentous fungi for natural products remain; marine fungi in
Mar. Drugs 2019, 17, 42; doi:10.3390/md17010042 www.mdpi.com/journal/marinedrugs6
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the strict sense (Sensu stricto, s.s.) comprise one of these still relatively underexplored areas. Marine
fungi s.s. are those fungi that are exclusively found to occur in the marine environment, many of
which have evolved specialized adaptations that aid in spore dispersal in marine waters. Reports of
chemistry from marine fungi s.s. suggest that they are an excellent source of new chemical entities,
often associated with a variety of different biological activities [2]. For this reason, over the past
few decades, many research groups have focused their attention on the marine environment as a
source of fungi for natural products discovery. As a result, an exponential increase in the publication
of natural products from “marine-derived” fungi has occurred [3,4]. Unfortunately, the majority of
most frequently cited marine-derived taxa belong to well-known osmotolerant/halotolerant generalist
genera associated with ruderal substratum relationships, such as Aspergillus and Penicillium, while the
discovery rate of new natural products from acknowledged marine fungi s.s. has not increased since
the late 1990s [2]. Why the disparity?
Cultivability remains one of the main limitations associated with the discovery of natural products
from marine fungi s.s. [5]. Isolation techniques commonly reported in the literature by marine natural
products groups are dominated by simple plating methods, approaches that favor the isolation of faster
growing generalist, osmotolerant/halotolerant fungal genera. These methods are antiquated and do
not differ significantly from those practiced in the 1940’s and 50’s [2,6]. The implementation of focused
strategies aimed at the isolation of marine fungi s.s. are required to tap into this underexplored resource
and address the goal of discovering new bioactive natural products. The majority of natural products
isolated from marine fungi s.s. have resulted from collaborations between natural products chemists
and mycologists, where specialized strategies for the isolation of marine fungi s.s. were applied.
The motivation of this review is to present a guide of best practices for the marine natural products
community to implement and increase the discovery rate of natural products from exceptional marine
fungi s.s. (summarized in Table 1).
Table 1. Summary of isolation techniques of marine fungi Sensu stricto presented.
Technique/Substrate Substrate References Notes
Isolation from sea foam Seafoam 9,11,43–45
Especially suitable for
arenicolous species, can yield
generalist fungi
Direct plating Any 41,46
Important to employ multiple






Especially suited for the
isolation of slower growing,
unique fungi




Baiting stations Wood 54–55 Encrusting invertebrates canbe problematic
In situ culturing Any 56–60
Novel approach, has the
potential to isolate truly
unique species
2. Sources of Marine Fungi
Filamentous fungi are major decomposers of woody and herbaceous substrata entering marine
ecosystems and propagate by spores, either asexual conidia or by sexual ascospores, basidiospores,
or zygospores. In marine ecosystems, spores are dispersed and passively transported through water,
ultimately landing on a suitable substrate where they germinate and colonize. During colonization,
hyphae (fungal filaments) grow throughout the substrate and, when environmental conditions are
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appropriate, differentiate into specialized structures to reproduce. Observations of fruiting structures,
such as pycnidia or ascomata (typically observed as round “balls” or “tiny dots” emerging from or
forming on the substrate surface) and conidiophores (“branch-like” structures bearing wet or dry
masses of conidia), are sought after by mycologists for isolating and identifying marine fungi (Figure 1).
 
Figure 1. Fruiting structures of marine fungi: (a) Amylocarpus encephaloides is one of the few species of
marine fungi that can be spotted and identified with the naked eye already in the field; (b) these “black
dots” on the receptacle of macroalga Ascophyllum nodosum are fruiting bodies of Stigmidium ascophylli
(syn. Mycosphaerella/Mycophycias ascophylli); (c) apothecial fruiting bodies of Calycina marina on dead
and decaying A. nodosum; (d) conidial mass of the asexual form of the fungus, Lulwoana uniseptata
(=Zalerion maritima), in a borehole made by a Xylophaga bivalve species.
Marine fungi are found on a diverse range of substrates: Submerged wood, estuarine plants (such
as mangroves and salt marsh grasses and rushes), sand grains, sediment, algae, animals (invertebrates
and vertebrates), plankton, and probably even the plastisphere [7,8]. Unlike “marine-derived fungi”,
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many marine fungi s.s. have evolved specialized adaptive strategies to ensure successful spore dispersal
in the marine environment. Ascomata of arenicolous marine fungi lack long central necks (that would
be abraded by the constant movement of the sand grains) and associated ascospores are appendaged
and often found to be trapped in sea foam [7,9]. Submerged wood substrata tend to favor the growth
of members of the Halosphaeriaceae, Torpedosporales, and Lulworthiales (taxonomic groups in the
fungal kingdom composed predominantly of marine fungi), especially in open oceans, where species
are typically characterized by passive ascospore release (deliquescing asci) and appendaged ascospores
that aid in floatation and attachment [10]. When occurring on submerged wood, ascomata are found
partly or completely immersed within the substrata (Figure 2) [9]. Marine Ascomycota are adapted
to life in the intertidal zone, and often release spores through the ostiole during periods of low tide,
which rest upon the ascomata and become washed off into the water column during high tide, and
their ascospores often have gelatinous sheaths (Dothideomycetes), appendages (Sordariomycetes),
or, in some species, both to aid in the attachment of spores to substrata [7]. Many conidia (asexual
spores) of marine fungi are branched or ornamented or extremely long in size to aid in dispersal and
floatation, many of which can be found trapped in seafoam along the shoreline [11].
 
Figure 2. A cross-section micrograph of driftwood-embedded Dyfrolomyces marinospora ascomata
(fruiting bodies) releasing ascospores (scale bar = 100 μm).
Marine fungi abound in intertidal zones, such as mangrove ecosystems, due to the associated and
abundant organic detritus; over 280 species of fungi have been described from submerged mangrove
substrata [7]. Algae dominate marine habitats in temperate regions and approximately 80 fungal
species have been associated with algae either as parasites or symbionts [12]; however, algae as a
source of marine fungal isolates have been grossly neglected and further isolation efforts will likely
yield undiscovered species diversity [7]. Estuarine (or salt) marshes occur in the intertidal zone and
are dominated by the growth of salt-tolerant plants. Few species of salt-tolerant plants have been
surveyed; Juncus roemerianus and Spartina species are an exception (due to their dominance in this
ecosystem) and are associated with a rich diversity of fungal species [13–17].
Although marine fungi in temperate and tropical areas are the most studied, a rich and diverse
mycota exist in polar areas [18–22]. Fungi in these cold environments are associated with similar
substrate relationships as in warmer regions. Sea-ice, however, is a habitat unique to polar marine
regions and supports a diverse community of microorganisms, including fungi. Members of
9
Mar. Drugs 2019, 17, 42
Chytridiomycota and Dikarya (Ascomycota and Basidiomycota) can be found dwelling in high
abundance in sea-ice [18–20]. Studies targeting fungi in macroalgae in Antarctica have revealed
high fungal richness [21]. In the Arctic, 100 species of marine fungi have been morphologically
detected, whereas molecular data indicates the presence of thousands of fungi in the Arctic marine
environment [22].
3. Natural Products from Marine Fungi (Sensu stricto)
The phylogenetic breadth of marine fungi s.s. within the fungal kingdom is extensive, including
marine-specific yeasts, chytrids, and other basal fungal groups; however, fungi in the Dikarya
(ascomycetes and basidiomycetes) and the Zoopagomycotina are richer in the number and diversity of
secondary metabolite gene clusters and therefore are those most likely to yield the greatest diversity
of natural products [23–25]. Filamentous marine fungi (ascomycetes in particular) have proven to be
a plentiful source of new natural products (for a detailed review refer to Overy et al., 2014) [2].
For example, from an isolate of Aigialus parvus (a marine ascomycete occurring on submerged
wood), investigators obtained a total of 11 new natural products representing several different
structural classes (aigialomycins A–G, aigialospirol and associated derivatives, and aigialone) [26–31].
Halorosellinia oceanica (syn. Hypoxylon oceanicum), a marine ascomycete associated with intertidal wood
in mangrove habitats, studied by Wyeth for associated antifungal properties, led to the discovery of
three new lipodepsipeptides (15G256ε, 15G256γ, 15G256δ), five new macrocyclic polyethers (15G256α,
15G256β, 15G256α-1, 15G256ι, and 15G256ω), and five new linear polyesters (15G256α-2, 15G256β-2,
15G256o, 15G256ν, and 15G256π) [32]. New natural products obtained from marine fungi are
associated with a range of biological activities (representative structures are presented in Figure 3).
For example, an isolate of the obligate marine species, Zopfiella marina, isolated from marine mud
(obtained from a depth of 200 m) was found to produce the potent antifungal metabolite, zofimarin, a
sordarin derivative [33,34]. Aigialomycin D demonstrated antiplasmodial activity and cytotoxicity
against human cell lines (where cytotoxicity has been attributed to cyclin-dependent kinase/glycogen
synthase kinase-3 inhibition) [26,35]. The metabolite, pulchellalactam, obtained from a Corollospora
pulchella strain isolated from driftwood exhibited inhibitory activity against CD45 [36], an essential
transmembrane protein tyrosine phosphatase associated with T- and B-cell antigen receptor signaling.
Discovery work involving another marine fungus, Phaeosphaeria spartinae (=Leptosphaeria spartinae),
isolated from the inner tissues of the marine alga, Ceramium sp., resulted in the characterization
of eight new natural products, including spartinoxide and spartinol C, demonstrating inhibition
of the enzyme human leukocyte elastase; a disease target associated with pulmonary emphysema,
rheumatoid arthritis, and cystic fibrosis [37,38]. These examples emphasize that marine fungi s.s. can
be isolated from a range of different substrata and can produce unique and previously undiscovered
natural products. The following text will provide information regarding several methods that are used
by mycologists (and some natural product chemists) to isolate truly unique isolates of marine fungi s.s.
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Figure 3. New natural products of marine fungi s.s.: zofimarin (1), aigialomycin D (2), pulchellalactam
(3), spartinoxide (4) and spartinol C (5).
4. Isolation Techniques
4.1. Sample Collection
To obtain marine fungi, marine environments with limited human disturbance are preferable
collection sites as they support a greater diversity and denser distribution of fungal species [39]. When
obtaining samples, aged materials submerged in seawater with periods of exposure in the air are
preferable, e.g., as evidenced by the presence of other marine decay organisms, such as barnacles [9].
For wood and macroalgae, samples with a roughened and softened surface may indicate the presence
of fungal growth. On rocky shores, wood trapped between crevices of rocks below the tide line support
good fungal growth. For sandy beaches, wood/macroalgae buried deep in the sand or the sand grains
occurring near these organic substrata are ideal. In mangrove/salt marsh environments, intertidal
substrates (i.e., decaying plant parts either attached to the standing plants or those detached and
exposed on the sediment floor during low tide) are often teeming with fruiting bodies of marine fungi.
Different stages of decay support different fungal species; therefore, an effort should also be made
to collect samples from multiple decay stages [40]. Upon collection, samples should immediately
be placed in sterile sealed plastic bags containing paper towel wetted with sterile seawater to avoid
desiccation [41]. When collected by SCUBA (self-contained underwater breathing apparatus) diving,
samples should be placed in sterile sealable plastic tubes or plastic bags while underwater to minimize
handling at the surface (to reduce likelihood of exposure to airborne spores). Samples can then be
placed on ice for transport to the laboratory for microscopic examination and culturing. It should
be noted that slow drying of samples should be avoided prior to processing as the drying process
can cause discharge of fungal ascospores [40]. After returning to the lab, if surface fouling organisms
are present on samples, they can be scraped off to prevent bacterial growth and decay. Samples
should be washed thoroughly in sterile water to remove thick sediment layers and other potentially
contaminating debris. Following rinsing, samples should be drained for approximately one hour to
remove any excess water [40]. Samples can then be directly examined under a dissecting microscope
or placed in an incubation chamber and examined weekly for the presence of fungal reproductive
structures, with weekly spraying with sterile seawater to prevent sample desiccation [42].
Sea foam has been historically used to isolate the highly distinctive appendaged conidia of marine
arenicolous (sand-dwelling) ascomycetes [9,43–45]. During sea foam formation, a large number of
fungal propagules become occluded within the air bubbles formed as the waves break upon the
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shoreline and the bubbles percolate through the shoreline sand [45]. A caveat of using sea foam as
an isolation substrate is that fungal propagules present in sea foam are not limited to marine fungi in
particular; rather, conidia of terrestrial species (saprophytic and plant pathogenic genera) are often
blown in from the shoreline and cosmopolitan generalist fungi naturally growing in the intertidal zone
are also frequently isolated [11,43]. Sea foam can be collected by passing through a fine mesh sieve
(holes approx. 2mm in diam.) using sterile sea water and collected in a sterile container or collected
directly into sterile plastic bottles or centrifuge tubes (Figure 4) [9,11,44]. If the foam has collapsed
and dried (such as deposition at high tide), it can be carefully scraped off and resuspended in sterile
seawater [9]. The addition of an equivalent portion of a double strength preparation of antibiotic
solution (in sterile seawater) prior to direct plating or dilution to extinction culturing is advantageous
to limit the growth of bacteria [11].
 
Figure 4. Seafoam as a source of inoculum: (a,b) Seafoam accumulating onshore during low tide;
(c) collection of seafoam into sterile centrifuge tubes (care should be taken not to collect any additional
sediment or water); (d) upon return to lab, a double strength antibiotic in sterile seawater should
be added and the seafoam allowed to settle for several hours at 4 ◦C. Particles/spores can then be
concentrated by centrifuging for dilution plating. Note: Storage of samples for longer than a day prior
to processing is not recommended, as marine yeasts will continue to grow in the solution, even at
refrigeration temperatures and will hamper the isolation of axenic cultures of filamentous fungi.
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4.2. Direct Plating vs. Particle Filtration and Dilution to Extinction Plating
Direct plating techniques offer a means to capture marine fungi that are embedded in their
respective substrata and may not be apparent upon visual inspection in the lab. This method is
extremely useful for large substrata, such as submerged wood samples, prop roots of mangrove plants,
algae, and the stems/roots of salt marsh plants. Fragments (approximately 0.5 cm2) can be aseptically
cut and placed into petri dishes containing sterile seawater and antibiotics for two to three hours. These
fragments can then be subsequently sliced further (to a size of approximately 3 mm2) and transferred
to agar plates overlaid with sterile seawater and antibiotics for incubation [41].
Alternatively, samples can be collected in the field (which is ideal when sampling from a substrate
that is large and not easily transported to the lab, such as large driftwood samples or logs [46]). In the
field, thin slices of wood are cut-off from the surface wood using EtOH and flame sterilized knife
and forceps (Figure 5). From the spot where the surface wood is removed, a wooden cube is cut-off
and transferred with forceps into sterile plastic bags that are sealed airtight. The sample is kept cool,
transported to the laboratory, and plated on agar plates. The plates are monitored over a period of up
to several months to allow the appearance of the slowest growing fungi. Mycelia growing out of the
wooden cubes are transferred to fresh agar plates and sub-cultured until axenic cultures are obtained.
The incubation conditions should mimic the natural conditions as much as possible to select for marine
fungi s.s. This method has been shown to result in an approximately half of pure culture isolates being
marine fungi, including a significant portion of Sensu stricto species [46].
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Figure 5. Sampling of marine fungi from wooden logs: (a) Flame-sterilization of the sampling knife
sprayed with EtOH using a gas burner; (b) cutting off a thin slice of surface wood to exclude surface
contaminants (using a sharp knife, take as thin a slice as possible to avoid excluding marine fungi
inhabiting the upper cell layers below the wood surface); (c) a sterile spot on the wooden log prepared
for sampling; (d) surface sterilization of the knife and forceps with EtOH and the gas burner; (e) cutting
of a small piece of wood from the wood; (f) picking up the wooden piece with forceps and placing it
into a sterile plastic bag that is sealed airtight.
The combination of substrata particle filtration and dilution-to extinction particle plating is an
improvement upon more traditional isolation approaches and has been proven as being effective
in obtaining marine fungi and thus merits more wide-spread adoption (Figure 6) [2,47]. Substrata
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deconstructed by homogenization are filtered and washed through a series of meshes of decreasing
pore sizes and particles of a given size are harvested and dispensed at high-dilution rates into 48- or
96-well plates [48–50]. This technique increases the rate of capture of fungi originating from vegetative
fragments embedded in the substrata; more importantly, partitioning into 48- or 96- well plates allows
for slower growing fungi (such as obligate marine fungi) actively growing within substrata particles
to be separated and isolated from faster growing taxa. The particle filtration/dilution to extinction
culturing approach is ideal for working with marine sediments. Dilution culturing into 48-well plates
is a proven method for the successful isolation of marine fungi s.s. from seafoam suspensions [11].
 
Figure 6. The use of particle filtration and dilution culturing in 48-well plates for the isolation of marine
fungi (Overy et al. 2014 [2]): (a) Schematic of the particle filtration and dilution plating workflow;
(b) algal particles that were retained on a filter sieve after homogenization and filtration; (c) plating
into 48-well plates allows for the separation of fast and slower growing isolates, increasing the isolation
frequency of slower growing fungi; (d) conidia from a strain of marine fungus, Anguillospora marina
(telemorph = Lindra obtusa), isolated from algal tissue particles (scale bar = 20 μm); (e) conidia and
conidiophores of a strain of the marine fungus, Paradendryphiella arenaria, isolated from algal tissue
particles (scale bar = 20 μm).
4.3. Damp Chambers
The incubation of samples in damp chambers provide a moist (high water activity) environment
to encourage fungal growth and the formation of sexual fruiting structures and conidiophores in a
laboratory setting. Damp chambers consist of a sterilized plastic container (i.e., a Tupperware box,
Petri dish, or plastic bag) lined with a sterile, absorbent material (i.e., filter paper, sand, or vermiculite),
which is moistened with sterile seawater (Figure 7). Sand or vermiculite are preferable as they are poor
growth substrates for bacteria. To prevent bacterial growth, damp chambers should be kept free of
accumulated water (and if filter paper is used, it should be moistened with sterile seawater containing
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antibiotics) [41]. It is important to note that the damp chambering of environmental samples can
lead to problematic infestations from mites and other insects (resulting in cross contamination within
and between samples), but can easily be prevented by including a small container of camphor in the
damp chamber [40]. Damp chambers should be incubated within 5 ◦C of the ambient temperature
at their collection site and sprayed twice weekly with sterile seawater to prevent desiccation [42].
Recommended incubation periods vary between 6–18 months depending on the sample substratum
and its length of decay [51]. Samples should be examined periodically under a dissecting microscope
for mycelial outgrowth and the development of fungal fruiting bodies or sporulating conidiophores.
For example, wood should be examined frequently for 3 months after collection while leaves must
be examined at regular intervals within 2 weeks of collection [41,52]. Due to fungal succession (the
sequence of fungi sporulating on the same substrate over time), it is important to examine a specimen
frequently to maximize the number of species isolated [53].
 
Figure 7. Example of a driftwood damp chamber; note the use of a camphor ball for the prevention
of mites.
4.4. Baiting Stations
Stations can be created using various baits, such as stems of salt marsh plants or wood (i.e. beech,
maple, pine, or balsa wood). Baits should first be sterilized by autoclaving and then strung on a line
(i.e., nylon rope or fishing line), a few inches apart, and submerged approximately 0.5 m from the
bottom. The use of floats and an appropriate anchor will ensure that the bait lines remain vertical in
the water column, do not move their location with the tide, and provide a visual guide to identify
their location (Figure 8). The length of submersion time will affect the fungal biodiversity that can be
isolated (fungal succession). Over time, baits can also become encrusted with invertebrates, such as
barnacles and encrusting tunicates, or become consumed by shipworm, which will hinder the isolation
of fungi. One advantage of this technique is that the selection of substrata can be controlled, as hard
wood and soft wood can lead to the isolation different species of marine fungi. To harvest, baits are
removed from the line and placed into a sterile bag or suitable sterile container for transportation to
the lab. In a sterile environment, the bait surface should be scraped with a sterile spatula to remove
surface debris and invertebrates (as these organisms will rot and promote significant bacterial growth
in the damp chamber) and rinsed several times in sterile seawater. Overnight incubation in plastic bags
containing an antibiotic preparation in sterile seawater is effective in reducing the number of viable
bacterial cells prior to placing the bait into damp chambers. If using sterile filter paper in the damp
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chamber, the filter paper should also be saturated with seawater containing antibiotics to prevent the
growth of bacteria. Baits should be examined at regular intervals and provided the damp chambers
remain humid, be kept for up to a year to monitor for the emergence of different marine fungi [54].
Ideally, damp chambers should be incubated at temperatures proximal to the average temperature
range of sea water in which the baiting station was placed [55].
 
Figure 8. The use of baiting stations for the isolation of marine fungi (Overy et al., 2014 [2]): (a) Sterilized
wooden boards are suspended in the water column; (b) harvested wooden board after 6 months in a
damp chamber, ascomata are apparent on the surface; (c,d) ascomata of Corollospora maritima in situ
(scale bar = 250 μm); (e) squash mount of C. maritima ascomata obtained from board (scale bar = 30 μm);
(f,g) ascospores of C. maritima with characteristic polar and equatorial appendages (scale bar = 10 μm).
5. In Situ Culturing
Direct culturing vs culture independent biodiversity studies predict that only approximately
1% of prokaryotes can be cultured using conventional techniques [56]. Although there are no
total estimates for the cultivability of marine fungi, from similar culture vs. culture independent
data sets, a low culture recovery (5–7%) has also been observed (Rämä unpublished). Culturing
conditions in the laboratory are gross simplifications of natural systems. Many microbes require
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environmental interactions to grow. Therefore, to access a more bio-diverse range of marine fungi,
new and innovative isolation methodologies need to take these factors into consideration. In situ
culturing techniques attempt to address these issues and, for bacteriology, have resulted in the
successful isolation of previously undescribed organisms [57,58]. Here, suspensions of environmental
samples are held between semipermeable membranes and placed back into their native environment.
The semipermeable membranes permit the diffusion of growth factors to encourage microbial growth
while retaining/preventing the movement or exchange of microbial cells to the environment. It has
been shown that microbial cells maintained in in situ culturing devices can, to a significant extent,
be domesticated and subsequently subcultured in vitro [57]. There are several existing applications
for isolating and cultivating previously uncultivated microorganisms, such as diffusion chambers, its
high-throughput version, the Ichip, and the commercially available MicroDish Biochamber [57].
Whereas the previous applications are based on inoculating cells inside each device that will then
be taken out to culture in situ, microbial traps operate according to another principle [59]. An empty
device, with growth medium sandwiched between membranes allowing movement of growth factors
and/or cells, is taken out to a desired environment. During incubation, filamentous organisms
grow into the device through the membrane pores and can later be domesticated in pure cultures
in vitro. Using a membrane with a pore size of 0.4–0.6 μm will select for fungi and other filamentous
organisms [60]. The selection of a small enough pore size blocks all cell movement and can be used
to protect the growth medium inside the device against, e.g., airborne contaminants when trapping
sediment fungi. Microbial traps are not available commercially, but they are simple in structure and
can be easily built (Figure 9). The construction should take place in a sterile environment to avoid
getting contaminants inside the trap.
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Figure 9. Microbial traps for isolating fungi constructed from stainless steel washer (e.g., 50 × 3 mm
in dimensions and with a through whole of 17 mm in diameter) and polycarbonate membranes (e.g.,
Whatman™ Nuclepore™): (a) Steel washers with three drill holes (for securing to solid surfaces, such
as driftwood or sea ice), each ready for the construction of a microbial trap under laminar flow; (b)
using an appropriate adhesive (e.g., aquarium silicon), bottom membranes of the traps with a sufficient
pore size to allow fungal filaments to grow into the trap are glued in place (next steps (not pictured)
include filling the inside of the washer with agar and, after cooling down of the agar, gluing the bottom
membrane of the trap in place); (c) using screws, the microbial trap is secured in situ on sea-ice (the
figure displays the top of the trap with a small-pored membrane that does not allow movement of the
cells from surrounding air into the trap containing agar medium); (d) trapping deep-sea sediment fungi
using in vitro incubation on sediment sample (again, the top membrane does not allow contaminants
to enter the agar medium inside the trap - for a comprehensive description of the construction, see
Epstein et al. (2010) [60]).
6. Isolation and Examination of Samples
Fruiting bodies of marine ascomycetes occur superficially, partially, or fully immersed on/in
their respective substrates and when viewed under a stereo microscope, can be isolated directly from
substrata. The contents of fruiting bodies or conidia/conidiophores can be aseptically transferred
using sterilized fine-tipped forceps or a pin to an appropriate culture medium. Fruiting bodies that are
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completely immersed within a substratum can be exposed using a sterile razor blade or scalpel. Once
exposed, the fruiting body centrum can be transferred to an isolation medium or slide for microscopic
examination. For single-spore isolations, centrum material should be first aseptically dispersed in
drops of sterile seawater on a sterile glass microscope slide. This spore suspension is then transferred to
an appropriate culture medium (i.e., seawater or cornmeal agar containing antibiotics) and monitored
daily for the germination of spores using a stereomicroscope. Once observed, individual germinated
spores can be transferred by a flame sterilized needle onto a new culture medium and repeatedly
sub-cultured to produce axenic cultures [40]. The best time to subculture is while colonies are distinct
and autonomous, from areas of newest growth. Mycelial colonies from single spore isolations are
preferred to ensure reproducibility in liquid fermentation or solid substrate culturing when screening
natural products. For asexual marine fungi with conidia observed from conidiophores appearing on
the surface of substrates, individual spores can be picked and inoculated directly onto cornmeal agar
plates with antibiotics; alternatively, the single spore isolation method described above can be applied.
The few described marine Basidiomycota generally produce reduced size basidiomata, which can be
crushed to release spores for identification and isolated as described above.
Various media formulations can be employed for the isolation of marine fungi s.s.; however,
the choice of isolation medium will have a direct impact on the diversity of fungi obtained [61].
Media that are rich in simple sugars may restrict the growth and sporulation of lignicolous fungi;
rather, such rich media often promote the growth of more generalist, cosmopolitan genera, such as
Pencillium and Aspergillus. Lignicolous marine fungi prefer a minimal medium, such as 0.1% glucose,
0.01% yeast extract, 1.8% agar in aged seawater, or adding sterilized birch or balsa wood on top of
sea water agar [62]. Seawater or cornmeal seawater agar are commonly used alternatives for the
isolation of wood-inhabiting fungi as most species germinate on these media. Agar containing mono-
or disaccharides should be avoided if yeast growth is a problem. Specialized carbon sources, such as
cornmeal seawater agar or V8 seawater agar, can be used to prevent yeast growth [42,52,63]. Including
antibiotics to the isolation media prevents bacterial growth; the addition of cyclohexamide will retard
faster, growing generalist, cosmopolitan fungi. Penicillin G (300 mg/L) and streptomycin sulfate
(500 mg/L) are effective when used together, added to cooled agar immediately before pouring plates;
whereas chloramphenicol can be added to the medium prior to autoclaving. Ideally, inoculated agar
plates should be incubated at temperatures close to that of the collection site until sporulation is
observed [41]. Once stable cultures are obtained, they can then be transferred to more nutrient rich or
specialized media designed for natural product production.
Microscopic examination is an essential step in identifying or confirming the taxonomy of the
isolated fungus and is strongly encouraged at the point of initial inoculation, as many fungi produce
sterile colonies in culture. Fruiting bodies and conidiophores are placed on a glass microscope
slide in a drop of appropriate mounting solution (i.e., lactic acid, lactophenol, cotton blue, sterile
sea water, etc.) and covered with a glass cover slip for viewing under a compound microscope.
In the case of fruiting structures, such as pycnidia or ascomata, gently pressing on the cover slip
will cause the fruiting body to rupture and release its spores, creating a ‘squash-mount’ [9]. As well,
centrum contents can be removed directly to a mounting medium for viewing under the microscope.
Compound microscopes with a magnification of at least 400 × (ideally 600 × 1000 ×) are best suited for
observation of micromorphology as many spores (ie., conidia, ascospores, basidiospores, zygospores,
etc.) are less than 20 μm in diameter or length, and information, such as ornamentation, are critical
identification characteristics and cannot be resolved at lower magnifications. When using transmitted
light microscopy, the use of stains, such as lactophenol cotton blue, aqueous nigrosine, and India
ink, can improve contrast. Phase contrast and differential interference contrast microscopy are also
useful optical techniques for increasing contrast when viewing specimens. Ascospore appendages and
sheaths are often diagnostic for particular species and will only unwind after a period of submersion
in water [41]. Dichotomous and pictorial keys based on these fungal reproductive structures are useful
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identification resources [9,64–66]. Semi-permanent microscope slide mounts can be made following
the method of Volkmann-Kohlmeyer and Kohlmeyer [67].
In addition to micromorphology, identification by DNA sequencing is encouraged. The internal
transcribed spacer region of ribosomal DNA is the acknowledged species-level DNA barcode region for
fungi and should be sequenced and compared with the reference DNA database, NCBI GenBank, using
the BLAST tool [68]. For certain groups of fungi, additional genes may be informative for species-level
identifications, e.g., β-tubulin or elongation factor 1-α; for marine yeasts, the 28S ribosomal large
subunit region; and for basal fungal lineages, the 18S ribosomal subunit region [69]. Obtained DNA
sequences should be deposited in GenBank and associated with vouchered specimen material (dried
specimen and/or preserved cultures), as our fungal identifications are only as precise as our reference
databases [46].
7. Preservation
Cryopreservation is preferred for long-term storage of fungal cultures. Agar discs cut from living
cultures are placed into sterilized cryoplastic microtubes containing 1 mL of sterile 10% w/v glycerol
as a cryoprotectant [62]. Four to five agar discs should be transferred in a laminar flow cabinet from
the growing margin of a fungal culture using a sterilized transfer stick or needle. Microtubes should
be stored at 15 ◦C for 15 min before freezing them at a rate of 1 cm per minute from 15 to −40 ◦C
and 2 cm from −40 to −80 ◦C. Tubes can then be moved to a storage vessel and preserved in liquid
nitrogen at −180 ◦C. Alternative cryoprotectants include 10% dimethylsulfoxide (DMSO) or 10%
glycerol 5% trehalose, which vary in effectiveness depending on the fungal species. For shorter-term
storage, agar discs obtained from cultures as above can be stored in sterile distilled water at 4 ◦C with
annual replacement.
Subcultures can also be maintained for storage on agar slants. Slants are made in test tubes with
0.1% agar overlaid with sterile seawater or mineral oil [40,62]. Spores or small colonies are transferred
to the surface of the slant using aseptic techniques. The test tube is then capped and stored at 15–20 ◦C
for up to 8 weeks [40]. Alternatively, subcultures can be transferred from agar plates onto potato
dextrose or corn meal agar test tube slants and stored at 4 ◦C permanently (with annual replacement).
Cultures can also be preserved using lyophilization (freeze-drying). This method of preservation,
however, is only suitable for fungi that sporulate abundantly. As a result, it is not ideal for most
marine fungi [62]. To avoid loss of activity through continuous subculturing, multiple first-generation
cryostocks should be prepared.
8. Concluding Remarks
It can be argued that “marine-derived” fungi are a proven source of new natural products; this
is not in dispute as over a thousand new compounds or new derivatives of known molecules have
been discovered over the past few decades. However, recent evidence has demonstrated that the
new chemistry is a result of saline stress, where terrestrial counterparts of the same species produce
the same chemistry as discovered from marine-derived strains when grown on media containing
seawater [70]. Simply mining the terrestrial isolates of osmotolerant species on media containing
seawater will achieve the same ends. However, in such a scenario, marine fungi (Sensu stricto) will
remain an underexplored resource. To address this, attention currently focused on marine derived
fungi must shift focus to the isolation of marine fungi (Sensu stricto). In addition, new culturing
techniques should be adopted and developed for accessing a greater diversity of marine fungi that has
been shown to exist using environmental sequencing.
Assessment of whether marine fungi have evolved to produce secondary metabolites that are
distinct from their terrestrial relatives is awaiting completion of genomic sequences. These data will
lead to hypotheses about how isolation in the marine habitat may have influenced the evolution of
secondary metabolite gene clusters in terms of divergence from ancestral pathways or loss or expansion
of pathways for individual structural classes. The principal ascomycete lineages of marine fungi
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derive primarily from the Sordariomycetidae, Dothideomycetidae, and the Eurotiomycetidae [71–75].
Sequencing of several hundred fungal genomes of representative terrestrial species revealed that the
main subclasses of these subphyla often have very rich secondary metabolomes, therefore, it is logical
to assume that the marine lineages derived from within these ascomycete subclasses would also have
an active and complex secondary metabolism. The few reports of chemistry from acknowledged
marine fungi suggest that they will be an excellent source of new chemical entities, often associated
with a variety of different biological activities [2].
There are several examples in the literature where collaborations between marine mycologists and
natural product chemists have resulted in new chemistry discovered from marine fungi [27,32,76–79].
Hence, we encourage chemists to collaborate with marine mycologists, many of which have personal
collections of marine fungi that can be provided for chemical investigation or to acquire marine fungi
from recognized culture collections. Through active cooperation and adoption of classical isolation
methodologies with modern adaptations, the field of natural products discovery from marine fungi
(Sensu stricto) will facilitate a deeper exploration of this truly unique and underexplored group of fungi.
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Abstract: In our previous study, all Arthrinium isolates from Sargassum sp. showed high bioactivities,
but studies on marine Arthrinium spp. are insufficient. In this study, a phylogenetic analysis of
28 Arthrinium isolates from seaweeds and egg masses of Arctoscopus japonicus was conducted using
internal transcribed spacers, nuclear large subunit rDNA, β-tubulin, and translation elongation factor
region sequences, and their bioactivities were investigated. They were analyzed as 15 species, and 11
of them were found to be new species. Most of the extracts exhibited radical-scavenging activity,
and some showed antifungal activities, tyrosinase inhibition, and quorum sensing inhibition. It was
implied that marine algicolous Arthrinium spp. support the regulation of reactive oxygen species
in symbiotic algae and protect against pathogens and bacterial biofilm formation. The antioxidant
from Arthrinium sp. 10 KUC21332 was separated by bioassay-guided isolation and identified to be
gentisyl alcohol, and the antioxidant of Arthrinium saccharicola KUC21221 was identical. These results
demonstrate that many unexploited Arthrinium species still exist in marine environments and that
they are a great source of bioactive compounds.
Keywords: antioxidant; biological control; ecological role; gentisyl alcohol; multi-gene phylogeny;
tyrosinase inhibition
1. Introduction
Among a number of marine fungi isolated from a brown alga Sargassum sp., Arthrinium spp.
showed high levels of cellulolytic enzyme productivity, radical-scavenging, or antifungal activities [1].
To date, however, studies on marine Arthrinium spp. are insufficient in terms of reliable phylogenetic
analysis, physiological activity, bioactive secondary metabolites, and ecology.
The genus Arthrinium Kunze (sexual morph Apiospora; Ellis 1971 [2], Apiosporaceae) was reported
as an endophyte in plant and ecologically-diverse species occurring in various habitats in both
terrestrial and marine environments [3,4]. The genus Arthrinium has numerous broad synonyms [5].
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Cordella is a potential synonym for Arthrinium and distinguished primarily by the existence of setae.
Pteroconium, with the uncertain status of its generic name, has been regarded as an individual
genus separate from Arthrinium, although Apiospora is the sexual morph of both Pteroconium and
Arthrinium [2,5,6]. Currently, 80 Arthrinium species are reported in Index Fungorum (2018), but
most Arthrinium taxa do not have enough sequence data and lack a detailed description of their
morphological characteristics. Recently, the genus Arthrinium was re-examined by phylogenetic
analysis of 16 species, which suggested that it is necessary to use β-tubulin (TUB) and translation
elongation factor (TEF) regions to resolve species complexes [4]. Recently, Wang et al. (2018) published
eight new Arthrinium spp. using three combined loci and multi-gene phylogenetic analysis with high
bootstrap supports [7].
Marine-derived fungi have been suggested as a novel source of bioactive secondary metabolites,
which can be applied in the pharmaceutical and cosmetic industry [8]. This suggestion was due to
cephalosporin C production by Acremonium chrysogenum being reported in 1961 as the first bioactive
metabolite from marine fungi, but novel natural compounds from marine fungi were less explored
in comparison with compounds from terrestrial fungi [9]. Marine natural compounds have provided
sufficient interest to the pharmaceutical industry due to their unique chemical properties [10]. In particular,
marine fungal endophytes have been recognized as potential producers for bio-based commercial
products [11]. Marine Arthrinium spp. have been reported as an endo-symbiont of marine algae,
especially brown algae. They have been discovered to produce natural compounds such as arthrinone,
arthrichitin, terpestacin, (1R,2S,3aS,8aR)-3a,6-dimethyl-1-(propan-2-yl)-1,2,3,3a,4,7,8,8a-octahydroazulene-1,
2-diol (CAF-603), norlichexanthone, myrocins, libertellenones, spiroarthrinols, and griseofulvin
derivatives [12–15]. However, a limited number of bioactive compounds were reported: arthpyrones
F–I and apiosporamide (antibacterial) [16]; arthrinins A–D (antitumoral and antiproliferative) [13];
decarboxyhydroxycitrinone, myrocin A, libertellenone C, and cytochalasin E (antiangiogenic);
arthone C and 2,3,4,6,8-pentahydroxy-1-methylxanthone (antioxidant) [17]; and cytochalasin K and
10-phenyl-[12]-cytochalasin Z16 (cytotoxic) [18]. In this regard, it was suggested that marine Arthrinium spp.
have great potential to produce various bioactive compounds that can be the ingredients of a wide range
of bioagents, many of which have not been discovered yet. In this study, the biological activities of marine
Arthrinium spp. extracts were investigated to evaluate the value of marine Arthrinium spp. as a source of
bioactive compounds and to infer their ecological role in symbiotic relationships with marine algae.
The aims of this study were (1) to identify and phylogenetically analyze marine-derived
Arthrinium spp., (2) to evaluate the pharmaceutical value of marine Arthrinium spp. as a source
of bioactive compounds, (3) to evaluate the ecological role in symbiosis with brown algae, and (4) to
isolate and structurally identify a bioactive compound from marine Arthrinium species.
2. Results and Discussion
2.1. Identification and Multi-Gene Phylogeny
A total of 28 marine-derived Arthrinium strains were isolated from an unknown seaweed, Sargassum
sp., Agarum cribrosum, and egg masses of Arctoscopus japonicus (Table 1). For the phylogenetic analysis, we
constructed a phylogenetic tree using combined datasets from internal transcribed spacers (ITS), partial
nuclear large subunit rDNA (LSU), TUB, and TEF 1-alpha (EF-1α) region sequences containing 45 taxa
and 680, 559, 590, and 534 nucleotide characters, respectively (Figure 1). As the results of the MrModeltest
with the Akaike information criterion (AIC), a general time reversible (GTR) + proportion of invariable
sites (I) + gamma distribution (G) model was chosen for LSU and TUB, and the symmetrical model
(SYM) + I + G model and Hasegawa-Kishino-Yano (HKY) + I + G model were chosen for ITS and EF-1α,
respectively. The form of the tree demonstrated that all the species were clustered with high posterior
probabilities (95–100%). As a result, the 28 Arthrinium strains were divided into 15 species, including
11 novel species candidates. All new species will be reported in the near future.
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Figure 1. The phylogenetic tree of the Arthrinium species based on the combined ITS, LSU, TUB,
and EF-1α sequence alignment from Bayesian analysis using MrBayes v. 3.2.1. The dataset was created
from 45 taxa and 2363 characters. The fungal cultures examined in this study are boldfaced. The number
above the branch indicates the posterior probability values ≥70. The scale bar indicates nucleotide
substitutions per position.
2.2. Marine Habitat of Arthrinium
Most of the Arthrinium species isolated from each substrate were identified to be different (Table 1).
Seven different Arthrinium species were isolated from the egg masses of A. japonicus. The two known
species were Arthrinium saccharicola and A. sacchari, and the other five strains were considered novel
Arthrinium candidates. Interestingly, A. saccharicola, A. arundinis, and Arthrinium sp. 1 were found
in both Sargassum fulvellum and the egg masses of A. japonicus [19]. A. japonicus spawns the largest
number of eggs on Sargassum fulvellum, one of the major endophytic hosts of Arthrinium spp. [20].
It was strongly speculated that the separation of the same Arthrinium species from both substrates
was based on this fact. The conidia of the algicolous Arthrinium spp. can easily be transferred to the
egg masses of A. japonicus. In another study, the fungal diversity of the A. japonicus egg masses were
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investigated, and eight Arthrinium species were founded: A. saccharicola, A. sacchari, A. phaeospermum,
A. arundinis, and A. rasikravindri, as well as three unknown Arthrinium species [19]. According to
Park et al. (2018), Arthrinium accounts for a small portion of the strains isolated from egg masses of
A. japonicus. Nonetheless, the fact that there were many new species candidates suggests that various
unexplored Arthrinium species are present in the marine environment.
A. saccharicola, known as a plant pathogenic fungus, has been isolated from living and dead culms
of Phragmites australis and even from the air in the Netherlands and France and from seawater in
mangrove habitats in Hong Kong [4,21]. This suggested that A. saccharicola has low host specificity.
Additionally, A. arundinis, A. marii, and A. sacchari have been isolated from more than one substrate
in another study [7]. A. arundinis has been isolated from the leaf of Hordeum vulgare and living
leaves of Fagus sylvatica in Iran and Switzerland [4]. Additionally, in a recent study, 19 strains of
A. arundinis were isolated from nine different hosts in China [7]. Taxonomical work on Arthrinium
species isolated from marine ecosystems has been relatively lacking compared to work on those
isolated from terrestrial ecosystems. Thus, more taxonomic and systematic analyses of marine-derived
Arthrinium spp. are needed.
2.3. Biological Activities of Marine Arthrinium spp.
2.3.1. Antioxidant Activity
Since Arthrinium spp. showed high antioxidant activity, other marine-derived Arthrinium species
were also expected to do so [1]. The results showed that almost every Arthrinium strain showed high
radical-scavenging activity on the assay using 2.2′-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid
(ABTS) radicals as a substrate (Table 1). In particular, the crude extract of Arthrinium sp. 3 KUC21327
exhibited even higher ABTS radical-scavenging activity than ascorbic acid. Reactive oxygen species
(ROS) are responsible for many kinds of diseases and aging because they damage biomolecules, such as
DNA and protein, through oxidative chain reactions [22]. This suggests that the symbiotic relationship
between Arthrinium spp. and their major host, seaweeds, may be based on the regulation of the
ROS-defense system. Many seaweeds have been used as functional food and cosmetic ingredients
because of their great antioxidant ability [23,24]. It was speculated that these algicolous fungi might
contribute to the antioxidant ability of seaweeds.
Researchers have discovered many kinds of antioxidants, which can scavenge free-radicals
generated from ROS, and filamentous fungi were one of the main natural sources of antioxidants.
Filamentous fungi produce a wide range of secondary metabolites, and many polyphenolic compounds
have been reported to exhibit high radical-scavenging abilities against ROS and free radicals [25].
In the case of marine Arthrinium spp., arthone C and 2,3,4,6,8-pentahydroxy-1-methylxanthone were
reported as antioxidants [17]. Our ABTS assay results imply that marine-derived Arthrinium spp.
commonly produce certain kinds of antioxidant compounds. Among them, A. sacchari KUC21340,
A. saccharicola KUC21221, A. saccharicola KUC21343, and Arthrinium sp. 10 KUC21332 exhibited high
radical-scavenging activity against the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical. Because the
reaction media of ABTS and DPPH assays differ (PBS buffer and 80% MeOH, respectively), the
measured activity is affected by the solubility of potential antioxidant compounds for each solvent [26].
These four strains produce antioxidant compounds that are less hydrophilic than those of the other
strains and remain active in MeOH. In particular, the IC50 values of A. saccharicola KUC21221 and
Arthrinium sp. 10 KUC21332 were significantly lower than those of the other species, implying that
these species have high antioxidative capacities. The high radical-scavenging activity of A. saccharicola
KUC21221 extract was already reported [1]. Among the two candidates, Arthrinium sp. 10 was selected
in consideration of the novelty of this fungal species, its antioxidant compound was separated, and the
chemical structure was identified.
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2.3.2. Antifungal Activity
In our previous study, all six Arthrinium sp. isolated from Sargassum sp., a brown alga, exhibited
high antifungal activities against terrestrial plant pathogens [1]. As Arthrinium spp. are one of the
key endophytes of seaweed, some Arthrinium species were expected to have symbiotic relationships
in immune mechanisms by producing antibiotics against other marine microorganisms harmful to
the algae. As a result, the extracts of three A. saccharicola (KUC21221, KUC21341, and KUC21343)
and Arthrinium sp. 2 KUC21220 showed inhibitory effects against mycelial growth of the test fungus
Asteromyces cruciatus, an alginate-degrading fungus (Table S2). Alginate is a major constituent of
brown algae and plays an important role in brown algae by forming the structure of the algal biomass
and physically protecting algae from pathogens [27]. Some marine fungi have been reported to
be able to degrade alginate: Asteromyces cruciatus, Corollospora intermedia, Dendryphiella arenaria,
and D. salina [28]. In particular, A. cruciatus is one of the major marine colonizers ubiquitous in
the marine environment [29]. This fungus can be regarded as a potentially harmful microorganism to
brown algae, as it can colonize the entire algal biomass and breakdown alginate enzymatically when
the defense system of algae is weakened. Decomposition of the biomaterial leads to the collapse of the
defense system.
In particular, the two A. saccharicola (KUC21341 and KUC21342) extracts had the highest antifungal
activities as they could inhibit the growth of A. cruciatus at a concentration of 100 μg/mL. Since they
were identified as the same species, the antifungal secondary metabolites are highly likely to be
identical. This result implied that the two Arthrinium species, especially A. saccharicola, may have a
symbiotic relationship with brown algae that assists its defense system against other marine fungi.
Furthermore, it was strongly speculated that their antifungal metabolites can affect other pathogenic
fungi, considering that six marine-derived Arthrinium strains (A. arundinis KUC21229 and KUC21261,
A. saccharicola KUC21221, Arthrinium sp. 1 KUC21228 and KUC21232, and Arthrinium sp. 2 KUC21220)
showed antifungal activity against several terrestrial plant pathogenic fungi [1]. Considering that
most antimicrobials have low specificity, it was thought that they might have evolved to synthesize
antifungal compounds not only for themselves, but also for their symbiotic partner, marine algae.
Plants are protected by cocktails of moderately-active compounds, such as essential oils, and synergy
with antimicrobials lowers the minimum effective concentration of individual antimicrobial compound
to prevent the emergence of resistant pathogens [30]. Similarly, it was suggested that the broad
spectrum antifungal potential of these marine algicolous Arthrinium spp. may contribute to improving
the fitness of the algal hosts by providing a broad spectrum of defense that does not trigger the
emergence of resistant pathogens. It is necessary to study the interaction between antimicrobials of
Arthrinium spp. and secondary metabolites of the algal hosts.
2.3.3. Tyrosinase Inhibition Activity
A total of eight Arthrinium extracts exhibited inhibitory activity against tyrosinase, and A. sacchari
KUC21340, Arthrinium sp. 2 KUC21279, and Arthrinium sp. 7 KUC21329 were the best producers
of tyrosinase inhibitors (Table S2). Tyrosinase catalyzes the oxidation of not only tyrosine, but
also L-3,4-dihydroxyphenylalanine (L-DOPA), a reactive intermediate compound of melanin, to
dopaquinone, which eventually converts it to pheomelanin [31]. Tyrosinase inhibitors suppress the
formation of melanin in human skin and prevent the darkening of the skin tone, and researchers
have discovered several inhibitors of fungal origin, such as protocatechualdehyde from Phellinus
linteus, 6-n-pentyl-α-pyrone from Myrothecium sp., and kojic acid, the most widely-studied tyrosinase
inhibitor, from various fungi, especially Aspergillus oryzae [32–34]. These tyrosinase inhibitors have
various mechanisms, and many antioxidant compounds have been reported to exhibit tyrosinase
inhibition activity by suppressing melanin biosynthesis by scavenging reactive quinone products [31].
The extracts of A. sacchari KUC21340, Arthrinium sp. 2 KUC21279, and Arthrinium sp. 7 KUC21329
exhibited both tyrosinase inhibitory and radical-scavenging activity, and it can be interpreted that
the tyrosinase inhibitors can be identical to their antioxidant compounds. This result indicates that
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the three Arthrinium species can produce tyrosinase inhibitors with antioxidant activity that regulates
melanin biosynthesis by scavenging reactive quinone products.
2.3.4. Quorum Sensing Inhibition Activity
The extracts of Arthrinium sp. 1 KUC21228 and KUC21232 and Arthrinium sp. 6
KUC21321 inhibited the production of violacein by C. violaceum CV026 in the presence of
N-(3-oxo-hexanoyl)-L-homoserine lactone (3-oxo-C6-HSL), an N-acyl homoserine lactone (AHL),
which is one of the most widely-studied quorum sensing (QS) molecules (Figure 2). In particular,
Arthrinium sp. 1 KUC21228 extract showed a high inhibitory activity even comparable to that of
the positive control, which is a pure compound (Figure 2A). QS is responsible for the formation of
bacterial biofilms and the expression of virulence genes, and bacterial biofilms have been reported to
be approximately 1000-times more resistant to antibiotics than their planktonic counterparts [35]. Some
fungi produce quorum-quenching compounds such as patulin and penicillic acid from Penicillium
spp., which can suppress bacterial biofilm formation [36]. All four Arthrinium strains that showed
QS inhibition activity were isolated from seaweeds that are well known to produce various quorum
sensing inhibitors (QSIs), namely bromoperoxidase from a brown alga Laminaria digitate and floridoside,
bentonicine, and isoethionic acid from a Korean red alga Ahnfeltiopsis flabelliformis [37,38].
 
Figure 2. Quorum sensing inhibitory activity of extracts from four marine algicolous Arthrinium strains.
(A) Arthrinium sp. 1 KUC21228; (B) Arthrinium sp. 1 KUC21232; (C) Arthrinium sp. 5 KUC21289;
(D) Arthrinium sp. 6 KUC21321; (+) positive control (piericidin A); (−) negative control (DMSO).
In fact, many filamentous fungi associated with the plant rhizosphere have been reported to
degrade 3-oxo-C6-HSL enzymatically [39]. Therefore, it was suggested that these seaweed-endophytic
Arthrinium species can produce QSIs that are expected to be lactonase or other kinds of AHL-degrading
enzymes, which degrade 3-oxo-C6-HSL and assist in resistance to bacterial biofilms in seaweeds.
Otherwise, it could be norlichexanthone, a known metabolite of Arthrinium sp., reported to inhibit
the QS mechanism in Staphylococcus aureus, a human pathogen [40]. Considering that arthpyrones
F-I and apiosporamide were reported as antibacterial compounds from marine Arthrinium sp., some
marine Arthrinium species may directly inhibit seaweed-pathogenic bacteria [16]. The three new
seaweed-endophytic Arthrinium strains were revealed to be potential QSI producers, which makes
them valuable as a source of biological compounds that inhibit the bacterial biofilm, which causes huge
economic losses in many areas, such as food, aquaculture, wastewater treatment, and the shipping
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industry [41,42]. The selected fungi will be subjected to an in vitro experiment as a subsequent
screening by quantifying their activity.
2.4. Antioxidant Compound from Arthrinium sp. 10
The extract of Arthrinium sp. 10 KUC21332, a new species candidate with the highest
radical-scavenging activity, was selected to identify the active compound. A bioassay-guided isolation
of this extract afforded gentisyl alcohol (1) (Figure 3). The chemical structure was identified using
spectroscopic data and a comparison with literature data [43]. The 1H and 13C NMR spectra, LC
chromatogram, UV spectrum, and MS spectra of Compound 1 are shown in the Supplementary
Materials (Figures S1–S4). In addition, the results of comparative analysis of A. saccharicola KUC21221
extract, Arthrinium sp. 10 KUC21332 extract, and gentisyl alcohol using ultra-performance liquid
chromatography (UPLC) with a photodiode array (PDA) detector confirmed that the antioxidant
compound of A. saccharicola KUC21221 is the same as that of Arthrinium sp. 10 KUC21332, that is
gentisyl alcohol (Figure S5).
 
Figure 3. Structure of Compound 1.
The radical-scavenging activity of Compound 1 was evaluated using the ABTS and DPPH
assays. As described in Table 2, it exhibited higher activities than the positive control (ascorbic
acid), which corresponds to the result of a previous report [44]. Gentisyl alcohol has also been
reported to have proangiogenic, caspase inhibition, histone deacetylases inhibition, antibacterial
(against methicillin-resistant Staphylococcus aureus), antifungal (against Colletotrichum gloeosporioides),
antileishmanial (against Leishmania donovani), and cytotoxic (against human breast and colon cancer cell
lines, MCF-7 and HT-29, respectively, and against sea urchin Strongylocentrotus intermedius) activity [45–53].
This is the first report of the production of gentisyl alcohol from the genus Arthrinium.
Table 2. ABTS and DPPH radical-scavenging activity of Compound 1 isolated from Arthrinium sp.
10 KUC21332.
Compound
Antioxidant Activity (IC50, μM)
ABTS a DPPH b
Gentisyl alcohol (1) 26.43 28.74
Ascorbic acid * 77.79 38.61
a ABTS, 2.2′-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid; b DPPH, 2,2-diphenyl-1-picrylhydrazyl; * positive control.
3. Materials and Methods
3.1. Microorganisms
3.1.1. Fungal Resources
Marine-derived Arthrinium spp. used in this study were obtained from the Korea University
Culture (KUC) collection and Marine Fungal Resource Bank (MFRB) at Seoul National University as
a marine bioresource bank of Korea by the Ministry of Oceans and Fisheries. Asteromyces cruciatus
SFC20161110-M19 was obtained from MFRB to use as a target fungus of the antifungal assay.
The algicolous fungi were isolated according to the following procedure [1,19]. Marine algae
and the egg masses of A. japonicus were washed with sterile 3.44% artificial sea water (ASW) and cut
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into 5-mm2 squares. The pieces were placed on each of three culture plates: dichloran rose bengal
chloramphenicol agar (Difco, Sparks, MD, USA), glucose yeast extract agar (1 g/L glucose, 0.1 g/L
yeast extract, 0.5 g/L peptone, and 15 g/L agar), and Sabouraud dextrose agar (Difco, Sparks, MD,
USA) supplemented with 3.44% ASW, 0.01% streptomycin, and 0.01% ampicillin to prevent bacterial
growth. The plates were incubated at 25 ◦C for 7–15 days, and the grown fungi were transferred to a
potato dextrose agar (PDA, Difco, Sparks, MD, USA) plate with 3.44% ASW periodically.
3.1.2. DNA Extraction, PCR, and Identification
Genomic DNA extraction was performed using fungal culture grown on malt extract agar by the
AccuPrep Genomic DNA Extraction kit (Bioneer, Seoul, Korea). The DNA sequences of KUC21221,
KUC21229, KUC21261, KUC21228, KUC21232, and KUC21220 were obtained from our previous
research [1]. PCR reactions were performed with three different primer regions using the AccuPower
PCR Premix Kit (Bioneer, Seoul, Korea). ITS (forward: ITS1F (5′-CTTGGTCATTTAGAGGAAGTAA-3′)
and reverse: LR3 (5′-CCGTGTTTCAAGACGGG-3′)) [54,55], LSU (forward: LR0R
(5′-ACCCGCTGAACTTAAGC-3′) and reverse: LR5 (5′-TCCTGAGGGAAACTTCG-3′) or LR7
(5′-TACTACCACCAAGATCT-3′)) [56], TUB (forward: T10 (5′-CATCGAGAAGTTCGAGAAGG-3′)
or Bt2a (5′-GGTAACCAAATCGGTGCTGCTTTC-3′) and reverse: T2 (5′-TAGTGACCCTTGGCCCA
GTTG-3′) or Bt2b (5′-ACCCTCAGTGTAGTGACCCTTGGC-3′)) [57,58], and EF-1α (forward: EF1-728F
(5′-GGA(G/A)GTACCAGT(G/C)ATCATGTT-3′) and reverse: EF2 (5′-GGA(G/A)GTACCAGT(G/C)
ATCATGTT-3′)) [59,60] were amplified under the temperature cycling parameters as follows. For ITS
and LSU, 95 ◦C for 4 min, followed by 30 cycles of 95 ◦C for 30 s, 55 ◦C for 30 s, and 72 ◦C for 30 s; an
elongation step of 72 ◦C for 5 min was performed at the end. For TUB, 95 ◦C for 5 min, followed by
30 cycles of 95 ◦C for 35 s, 55 or 56 ◦C for 50 s, and 72 ◦C for 2 min; an elongation step was performed
at 72 ◦C for 7 min. For EF-1α, 94 ◦C for 2 min, followed by 29 cycles of 93 ◦C for 30 s, 55 or 56 ◦C for
30 s, and 72 ◦C for 1 minute; an elongation step was performed at 72 ◦C for 10 min. DNA sequencing
was executed by Macrogen (Seoul, Korea) using the Sanger method with a 3730xl DNA Analyzer
(Life technology, Carlsbad, CA, USA). The obtained DNA sequences were submitted to the GenBank,
and the accession numbers are presented in Table 1.
3.1.3. Phylogenetic Analysis
The obtained DNA sequences with reference sequences (Table S1) obtained from GenBank using
a BLAST search were proofread, aligned using MAFFT 7.397, and modified manually using MacClade
v4.08 (http://macclade.org) [61,62]. They were tested by MrModeltest v2.3 (https://www.softpedia.
com/get/Science-CAD/MrModeltest.shtml) with default options using the AIC [63]. Bayesian analysis
was performed by MrBayes v3.2.1 (http://nbisweden.github.io/MrBayes) [64]. Two operations were
performed and contained 1,000,000 generations. For each operation, the result of every 100th generation
was sampled. Among them, the first 25% of the trees was removed, and the last 75% was selected.
A phylogenetic tree was constructed according to the 50% majority-rule, and tree reliability was
confirmed by the posterior probability.
3.2. Preparation of Fungal Extracts
All of the fungal species were precultured on 20-mL Petri dishes containing PDA at 25 ◦C until
mycelia covered the dishes. After the preculture period, three agar plugs with mycelia were transferred
to Petri dishes (150 × 20 mm) containing 50 mL of PDA and incubated at 25 ◦C for seven days in
darkness. The fungal cultures were incubated in triplicate. To obtain fungal extracts, the solid media
with mycelia were extracted with 200 mL of methanol for 24 h, followed by filtration with Whatman
No.1 filter paper. Filtrates were dried at 37 ◦C under a vacuum and cooled at 4 ◦C during circulation.
The dried residues were redissolved in a half and half percentage of water-ethyl acetate solution. After
six hours, the portion of ethyl acetate was collected and evaporated under the same temperature
condition mentioned above. The dried extracts were maintained in the 20-mL scintillation vials at 4 ◦C
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until use. To obtain a large amount of crude extracts for separating the bioactive compound, a culture




ABTS (Sigma-Aldrich, Inc., St. Louis, MO, USA) was dissolved in phosphate-buffered saline (PBS,
pH 7.4) to 7 mM. Then, the ABTS solution was mixed with potassium persulfate solution that was
dissolved in PBS to 2.45 mM. The mixture was stored in the dark at room temperature for 24 h. After
the ABTS•+ radical was formed, the ABTS solution was diluted with PBS to an absorbance of 0.70
(±0.02) at a wavelength of 734 nm. Then, 990 μL of ABTS radical solution and 10 μL of fungal extract
(10 mg/mL in DMSO) were reacted in a cuvette. The absorbance was measured at 734 nm after 6 min
using a spectrophotometer (SunriseTM, Tecan, Männedorf, Switzerland).
DPPH Radical-Scavenging Assay
DPPH (Sigma-Aldrich Inc., St. Louis, MO, USA) was dissolved in 80% methanol at 150 μM.
The 200 μL of DPPH solution and 22 μL of the fungal extracts (10 mg/mL) was mixed in each well
in a 96-well plate. The plate was allowed to reach a steady state for 30 min at room temperature.
The absorbance was measured at 540 nm.
3.3.2. Antifungal Assay
Antifungal activity was determined in a 96-well plate using the microtiter broth dilution
method [65]. Twenty-five microliters of spore suspensions (4 × 105 conidia/mL) of Asteromyces
cruciatus SFC20161110-M19 were added to each well containing 25 μL of 4× potato dextrose broth
and 49 μL of D.W. Finally, the fungal extracts were added to a final concentration of 100 μg/mL.
The inoculated 96-well plates were incubated at 25 ◦C, for three days. To determine the minimum
inhibitory concentration (MIC), the extracts with lower concentrations (50, 25, 12.5, 6.5 μg/mL)
were tested.
3.3.3. Tyrosinase Inhibition Assay
A tyrosinase inhibition assay was conducted based on the method described by Lai et al.
(2009) [66]. Forty microliters of fungal extract (2.5 mg/mL in 50% DMSO), 70 μL of 0.1 M potassium
phosphate buffer (pH 6.8), and 30 μL of tyrosinase from mushroom (0.02 mg/mL in the buffer; Sigma
Aldrich, St. Louis, MO, USA) were mixed in a 96-well plate. The mixture was heated to 30 ◦C for
five minute, and 100 μL of 2.5 mM L-DOPA (Sigma Aldrich, St. Louis, MO, USA) was added to the
well. After 30 min, the reaction was terminated by putting the plate in ice, and the absorbance was
measured at 492 nm. Kojic acid (Sigma Aldrich, St. Louis, MO, USA) was used as a positive control,
and a mixture without L-DOPA was regarded as a blank.
3.3.4. Quorum Sensing Inhibition Assay
QSI screening was performed based on the inhibition of violacein production by Chromobacterium
violaceum CV026 strains under culture conditions supplemented with an exogenous QS molecule,
3-oxo-C6-HSL [67]. The C. violaceum CV026 cultured overnight was diluted with LB medium (5 g of
yeast extract, 10 g of tryptone, and 5 g of NaCl in a liter of D.W.) to an OD600nm of 0.1, and 97 μL of
the diluted culture were added to each well of a 96-well plate. One microliter of 3-oxo-C6-HSL (final
concentration of 10 μM; Sigma-Aldrich, St. Louis, MO, USA) and two microliters of fungal extract
(diluted to 10 mg/mL in DMSO) was added to each well. As a negative control and positive control,
DMSO and 100 nM (Z)-4-bromo-5-(bromomethylene)-2(5H)-furanone (Furanone C-30; Sigma-Aldrich,
35
Mar. Drugs 2018, 16, 508
St. Louis, MO, USA) were used, respectively. After 16 h at 28 ◦C, 100 μL of DMSO was added to each
well and vigorously shaken for an hour at room temperature to determine the production of violacein.
The selected extracts were further examined using a paper disc method. Fifteen microliters of the
diluted culture of C. violaceum CV026 was spread on an LB agar plate, and a paper disc (diameter 8 mm;
Advantec, Tokyo, Japan) impregnated with 40 μL of extract and 1 μL of 1 mM 3-oxo-C6-HSL was
placed in the center of the plate. DMSO was used as a negative control, and piericidin A isolated from
Streptomyces xanthocidicus KPP01532 was used as a positive control [67]. The plates were incubated
overnight at 28 ◦C.
3.4. Isolation and Identification of the Bioactive Compound
3.4.1. Experimental Procedures
Column chromatography was performed by silica gel (200–300 mesh, Merck, Darmstadt,
Germany), and prep-HPLC was performed by a Waters system consisting of a 515 pump and 2996 PDA
detector (Milford, MA, USA). NMR spectra were recorded on a Varian 500-MHz NMR spectrometer
(Palo Alto, CA, USA), and ESIMS spectra were recorded on an LCQ Fleet Ion Trap MS spectrometer
(Thermo Scientific, Madison, WI, USA). UPLC was performed using Waters ACQUITY UPLCTM.
3.4.2. Bioassay-Guided Isolation
The crude extract (826.2 mg) was fractionated on a column (3 × 30 cm) packed with a silica
gel using elution with n-hexane-EtOAc gradient ratios (1:0 to 0:1) to provide seven fractions (F1–F7).
Among the seven fractions, F5 exhibited 100% DPPH radical-scavenging activity at a concentration
of 500 μg/mL and was separated into five peak fractions (F5-P1–F5-P5) by prep-HPLC (5–30% ACN,
8 mL/min). The first subfraction (F5-P1) exhibited 100% DPPH radical-scavenging activity at a
concentration of 10 μg/mL and was further purified by silica gel column chromatography (1 × 20 cm)
using elution with CHCl3-MeOH in gradient ratios (50:1–20:1) to provide target Compound 1 (F5-P1-2,
61.9 mg).
Gentisyl alcohol (1) 1H NMR (DMSO-d6, 500 MHz) δH 8.58 (2H, br s, overlap, OH-2 and OH-5),
6.75 (1H, d, J = 3.0 Hz, H-6), 6.55 (1H, d, J = 8.5 Hz, H-3), 6.43 (1H, d, J = 8.5, 3.1 Hz, H-4), 4.92 (1H, br
s, OH-7), 4.41 (2H, br s, H-7); 13C NMR (DMSO-d6, 125 MHz) δC 150.2 (C-5), 146.8 (C-2), 129.8 (C-1),
115.5 (C-3), 114.4 (C-6), 113.7 (C-4), 58.7 (C-7); ESIMS (m/z) 139.2 [M − H]−, 185.1 [M + COOH]−.
4. Conclusions
The multi-gene phylogenetic analysis revealed that 28 Arthrinium strains isolated from various
marine environments consisted of four known species and 11 new species candidates. Most of
them exhibited strong antioxidant activity, and some showed antifungal, quorum sensing inhibition,
and tyrosinase inhibition activity. It was demonstrated that marine algicolous Arthrinium spp. can
support the regulation of reactive oxygen species in symbiotic algae and protect against pathogens and
bacterial biofilm formation. They can form a symbiotic relationship in a way that increases the viability
and environmental competitiveness of symbiotic algae in exchange for nutrients such as mannitol,
which is the main photosynthetic product of brown algae [68]. A strong antioxidant compound was
isolated from a new species, Arthrinium sp. 10 KUC21332, and identified to be gentisyl alcohol (1),
and the antioxidant compound of A. saccharicola KUC21221 was identical. These results suggest that
many Arthrinium spp. remain unexploited in the marine environment, and marine Arthrinium spp.
are a great source of bioactive compounds. Other bioactive compounds from marine Arthrinium spp.,
including antifungal compounds, tyrosinase inhibitors, and QSIs, will be isolated and identified in the
near future.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/16/12/508/
s1: Figure S1: 1H NMR spectrum of Compound 1, Figure S2: 13C NMR spectrum of Compound 1, Figure S3: LC
chromatogram and UV spectrum of Compound 1, Figure S4: MS spectra of Compound 1, Figure S5: UPLC peaks
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and UV spectrum of A. saccharicola KUC21221 extract, Arthrinium sp. 10 KUC21332 extract, and Compound 1.
The arrows indicate gentisyl alcohol, Table S1: GenBank accession numbers of the reference sequences used in
the phylogenetic analysis in this study, Table S2: Marine algicolous Arthrinium spp. exhibiting antifungal and
tyrosinase inhibition activity.
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Abstract: Intertidal zones are unique environments that are known to be ecological hot spots. In this
study, sediments were collected from mudflats and decommissioned salterns on three islands in the
Yellow Sea of South Korea. The diversity analysis targeted both isolates and unculturable fungi via
Illumina sequencing, and the natural recovery of the abandoned salterns was assessed. The phylogeny
and bioactivities of the fungal isolates were investigated. The community analysis showed that the
abandoned saltern in Yongyudo has not recovered to a mudflat, while the other salterns have almost
recovered. The results suggested that a period of more than 35 years may be required to return
abandoned salterns to mudflats via natural restoration. Gigasporales sp. and Umbelopsis sp. were
selected as the indicators of mudflats. Among the 53 isolates, 18 appeared to be candidate novel
species, and 28 exhibited bioactivity. Phoma sp., Cladosporium sphaerospermum, Penicillium sp. and
Pseudeurotium bakeri, and Aspergillus urmiensis showed antioxidant, tyrosinase inhibition, antifungal,
and quorum-sensing inhibition activities, respectively, which has not been reported previously.
This study provides reliable fungal diversity information for mudflats and abandoned salterns and
shows that they are highly valuable for bioprospecting not only for novel microorganisms but also
for novel bioactive compounds.
Keywords: fungal community; marine fungi; phylogenetic analysis; saltwork; tidal flat
1. Introduction
As interest in marine living resources worldwide has increased, research on marine fungi has
progressed considerably over the past two decades, including the discovery of new species and novel
natural compounds [1]. It is still insufficient compared to the research on terrestrial fungi, but the
study of marine fungi has been extended to intertidal zones such as mangrove forests and coastal
wetlands [2,3]. In addition, there are other unique intertidal environments such as mudflats and
abandoned salterns.
There are different types of tidal flats, and mudflats are differentiated from sandy tidal flats.
Mudflats are a kind of coastal salt marsh made of clay deposited by waves and rivers and are a unique
environment as they are exposed to the atmosphere twice a day depending on the tide. In the Yellow
Mar. Drugs 2019, 17, 601; doi:10.3390/md17110601 www.mdpi.com/journal/marinedrugs41
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Sea of South Korea, mudflats are distributed widely along the coastline. The Ministry of Oceans
and Fisheries (MOF, South Korean government) reported that the total area of mudflats in 2013 was
2487.2 km2, which is approximately 2.5% of the national territory [4]. Although the area has decreased
by 22.4% since 1987 due to the mudflat reclamation project for the expansion of agriculture land,
recent efforts have been made to preserve and restore mudflat areas. For example, the MOF expanded
the protected mudflat area from 79.62 km2 to approximately 1265.46 km2 in 2018 [5]. The coast of
the Yellow Sea has topographical conditions that are suitable for solar salt production, as the coastal
slope is very low. A large number of solar salterns have been constructed and operated on the coast
throughout history. A broad area of the intertidal mudflat had even been reclaimed for this purpose.
However, in the 1980s, people were informed that mudflats have great ecological and economic
value, so citizens and environmental scientists insisted on restoring the mudflats. Mudflats are
an ecological hot spot that performs numerous ecological functions, such as providing habitat for
shellfish, water birds, and migratory birds. According to the Korea Marine Environment Management
Corporation (KOEM, South Korean government), the economic value of the Korean mudflats was
estimated at approximately 15 billion dollars per year in 2017, including value from food production,
waste treatment, recreation, habitat/refugia, disturbance regulation, and conservation [6]. In addition,
people were concerned about consuming solar salt, as global concerns about marine pollution and
its negative effects on human health were raised. In this context, most of the salterns were closed
because of the government’s policy as well as the decrease in market demand, and the embankments
of the closed salterns were withdrawn to allow the natural recovery of the mudflats [5]. As a result,
these abandoned salterns have become a unique environment where the tides have returned to the
salterns installed in the dry and windy areas of the intertidal zone.
Because of strong selective pressure, environments that are unique or disadvantageous for
survival are likely to have novel microorganisms as well as novel secondary metabolites [7,8].
Therefore, microorganisms living in these unusual environments, especially fungi, which have been
considered a treasure trove of bioactive secondary metabolites, are highly valuable to investigate.
Many studies have been reported on saltern extremophiles and microorganisms in the mangrove
forest, another intertidal environment [9–12]. Until now, however, studies of the diversity, physiology,
and bioactivity of fungi in intertidal mudflats and abandoned salterns have rarely been reported in
the overall field. To the best of our knowledge, there are only two studies on the fungal diversity
of these environments: one on the diversity of Aspergillus in a mudflat and one on the diversity of
mycorrhizal fungi in an abandoned saltern [13,14]. Therefore, it is necessary to investigate the microbial
communities of these environments. Through community analysis, a recovery assessment of the
decommissioned salterns is also possible; there has been no study on the recovery of the microbial
community in this environment to date [15]. Even in other similar sites around the world, few
studies on macrofauna/flora have been reported, and there has been no study of the microorganisms,
which are the cornerstone of the ecosystem. In fact, it has been proven by many researchers in recent
decades that microbial community analysis is a useful tool for ecosystem assessment. Most such
studies have used bacterial communities because of the large bacterial DNA database that is available.
However, a large amount of fungal DNA data has now been stored as well. It is also necessary to
evaluate these environments as biological resources. Studies on the fungi isolated from mudflats and
their bioactive secondary metabolites are also rare. To date, Chaetomium cristatum, Fusarium oxysporum,
Aspergillus niger, Thielavia hyalocarpa, Thielavia sp., and Paecilomyces formosus have been reported
and are known to produce cristazine (cytotoxic and antioxidant), oxysporizoline (antibacterial),
6,9-dibromoflavasperone (antioxidant), 1-O-(α-d-mannopyranosyl)geraniol (a biotransformation
product of geraniol), thielaviazoline (antibacterial and antioxidant), and formoxazine (antibacterial
and antioxidant), respectively [16–21]. The lack of studies is likely primarily due to the limited global
distribution of mudflats and salterns. Another possible reason is that it is difficult to isolate a large
number of fungi due to the extreme environmental conditions; the environment dramatically changes
42
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between aerobic and anaerobic conditions twice a day, and dry stress occurs at the ebb of the tide due
to the weather conditions described above.
The aims of this study were 1) to analyze the fungal community and diversity in the intertidal
mudflats and the abandoned solar salterns of the Yellow Sea in South Korea; 2) to assess the natural
recovery of the abandoned salterns to mudflats and determine the indicator taxa; and 3) to evaluate
these environments for the bioprospecting of novel species and bioactive compounds.
2. Results and Discussion
2.1. The Fungal Community in Intertidal Mudflats and Abandoned Salterns
Intertidal sediments were sampled from mudflats and abandoned salterns in Yongyudo, Gopado,
and Yubudo located on the coast of the Yellow Sea in South Korea (Figure 1).
 
Figure 1. (A) Locations of the three sampling sites and an illustration of abandoned salterns and
mudflats in the west coast of South Korea. (B) Illustration of abandoned salterns and tidal flats in the
west coast of South Korea. The circles indicate the sampling points.
2.1.1. Fungal Diversity and Recovery Assessment
The fungal communities and diversity in these intertidal environments were investigated by
high-throughput sequencing of the sediment samples. Through the community analysis, the natural
recovery of the decommissioned salterns was also assessed.
At the phylum level of the fungal community composition, Ascomycota and Basidiomycota, the two
major phyla of the kingdom Fungi, were the dominant phyla (Figure 2A). Meanwhile, the community
composition of the abandoned saltern in Yongyudo was clearly different. It was highly dominated by
Entorrhizomycota, while Chytridiomycota and Mortierellomycota dominated the other abandoned
salterns and mudflats. Considering that the phylum Entorrhizomycota is composed of plant pathogenic
fungi, the difference may be due to the introduction of their host plants at the initial stage of ecological
succession after the saltern was abandoned. Meanwhile, a large number of fungi could not be identified,
indicating a lack of DNA-based phylogenetic information on fungi in these intertidal environments.
As the community compositions of the other salterns and mudflats were similar to each other except for
that of the saltern in Yongyudo, a nonmetric multidimensional scaling (NMDS) plot was constructed
using the database of fungal operational taxonomical units (OTUs) and their abundance to determine the
distance between the fungal communities. According to the NMDS results, it appeared that the distance
between the abandoned saltern and the mudflats in Yongyudo was much longer than the distance
between the two environments on the other islands (Figure 2B). This indicates that the abandoned
salterns in Yongyudo that were abandoned less than a year ago were the least recovered to mudflat. Since
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the salterns of Yubudo and Gopado were abandoned 20 and 35 years ago, respectively, it was expected
that natural recovery would have occurred. This was supported by the short distance between the
communities of the two salterns and those of nearby mudflats on the NMDS plot. Thus, we clustered the
samples by the expected recovery status, consisting of recovered saltern (RS), nonrecovered saltern (NS),
and mudflat. In fact, the NMDS plot showed that the fungal communities of the two environment types
in Yubudo and Gopado were almost similar but were not completely clustered, especially in Gopado.
This indicated that the fungal communities of the abandoned salterns were not fully recovered even
after 35 years. Similarly, Bernhard and his colleague reported that salt marshes that were impounded
and subsequently restored took more than 30 years to recover and become similar to the neighboring
tidal flats [22]. They suggested that the regular inflow of tidal water increases the stability of the
ecosystem. The abandoned salterns require a great deal of time to return to their original state due to
the disturbance of human activity blocking the tidal water for a long time, resulting in a significant
decrease in stability of microbial communities. Thus, with natural restoration alone, an artificially
isolated environment requires an extremely long time to construct a microbial ecosystem similar to that
of the adjacent environment, and it may require more than 35 years in the case of the abandoned salterns.
Figure 2. (A) Fungal community composition of intertidal mudflats and abandoned salterns in
Yongyudo, Yubudo, and Gopado at the phylum level. Mean values of the abundance are used.
(B) Nonmetric multidimensional scaling plot of the fungal community in intertidal mudflats and
abandoned salterns in Yongyudo, Yubudo, and Gopado.
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To verify the differences between the fungal communities, Shannon-Wiener and Gini-Simpson
indices of each community were calculated. These two indices have been commonly used to calculate
α-diversity, and the value of Shannon-Wiener and Gini-Simpson indices are more affected by species
richness and evenness, respectively. The α-diversity indices of the NS were significantly lower in both
the indices compared to those of the other environments, as expected (Table 1). This indicates that
artificially blocking tidal inflow and conducting solar salt production reduce the species richness and
evenness of the microbial community in the saltern, and the reduced diversity does not recover in a
short period of time.
Table 1. The α-diversity indices of the fungal community in abandoned salterns and intertidal mudflats.
Sample Shannon-Wiener Index (H') Gini-Simpson Index (DS, 1-λ)
Gopado
Abandoned saltern (RS) 4.177 0.928
Mudflat 3.607 0.885
Yubudo
Abandoned saltern (RS) 4.433 0.954
Mudflat 3.901 0.806
Yongyudo
Abandoned saltern (NS) 1.471* 0.477*
Mudflat 3.497 0.859
Mean values are presented. NS, non-recovered saltern; RS, recovered saltern. * statistical significance of p < 0.05.
We tested the significance of the difference by the clustered group using the Kruskal-Wallis rank
sum test. There was no significant difference between the α-diversity indices of RSs and mudflats,
while those of the NS were significantly lower than those of the others. The abandoned saltern in
Yongyudo was an environment continuously interrupted by humans until recently. Thus, the ecosystem
of the NS could be easily dominated by a small number of species that could survive or adapt under
this harsh condition, resulting in significantly lower microbial diversity. In fact, the diversity indices of
RSs and mudflats were high when compared to those of fungal communities in other environments,
such as livestock manure, compost, and soil [23–26]. This implies that diverse fungi exist in these
unique environments, thus making them valuable for bioprospecting.
2.1.2. Determination of Indicator Taxa
We tried to determine the major differences among the fungal communities. Various analytical
methods were used to find indicator taxa that are responsible for the differences, including linear
discriminant analysis effect size (LEfSe), indicator species analysis (ISA), RandomForest, and mvabund.
First, we visualized the result of the Kruskal-Wallis rank sum test with a LEfSe cladogram (Figure 3
and Figure S1). It was obvious that the abundance of Ascomycota differs significantly between NS and
the other environmental groups, tending to be lower in NS (Figure S2). RS and mudflat both tended
to be abundant in Chytridiomycota and Basidiomycota, but many of the taxa overlapped each other.
This finding supports that there is no significant difference between RSs and mudflat, and the RSs were
in the process of recovery to mudflats.
For the next step, we investigated the taxa specific to each group via ISA. ISA results in an “IndVal
score” calculated by multiplying the relative abundance by the relative frequency of a taxon in each
group. Microbial community data are known to be zero-rich and to have many rare species. In this
case, OTUs with low mean abundance tend to have low mean variance; this can lead to statistical
misinterpretations if some rare species are highly specific to a certain environment. Therefore, the results
with low frequency have low fidelity, and taxa with frequencies less than 5 were screened out. As a
result, several lineages of taxa were selected to be specific to each environment (Table 2).
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Figure 3. Linear discriminant analysis effect size (LEfSe) cladogram of fungal composition in abandoned
salterns and mudflats (logarithmic linear discriminant analysis (LDA) score > 2, p < 0.05). Red, green,
and blue nodes/shades indicate taxa that are significantly higher in relative abundance. The diameter
of each node is proportional to the taxon’s abundance. NS and RS mean non-recovered saltern and
recovered saltern, respectively.
Table 2. Indicator taxa results from the indicator species analysis (IndVal score > 0.9, p < 0.05, and
Frequency ≥ 5).
Taxa Group IndVal Score p Value Frequency
Ascomycota
Stemphylium NS 1.0000 0.005 8
Lecanoromycetes NS 0.9012 0.007 17
Pertusariales NS 0.9266 0.005 16
Basidiomycota
Chionosphaeraceae RS 0.9137 0.005 15
Ballistosporomyces sasicola RS 0.9137 0.006 13
Tremellales NS 0.9238 0.005 12
Tremellaceae NS 0.9362 0.004 12
Tremella NS 0.9359 0.005 9
Chytridiomycota
Zygorhizidium planktonicum RS 0.9322 0.003 8
Entorrhizomycota NS 0.9995 0.004 16
Entorrhizomycetes NS 0.9995 0.003 16
Mucoromycota
Umbelopsidomycetes Mudflat 0.9553 0.001 5
Umbelopsis sp. Mudflat 0.9632 0.001 5
NS, non-recovered saltern; RS, recovered saltern.
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RandomForest analysis was carried out to determine whether there is a hierarchy-based
relationship in the fungal community that can distinguish the sample groups. The results are
shown as the mean decrease in accuracy and Gini impurity, which indicates the importance of the taxa
in the generated decision tree. At the class to species level, two lineages of taxa, Gigasporales sp. and
Umbelopsis sp., were repeatedly ranked at the top (Figure 4).
 
Figure 4. RandomForest importance plot analyzed using fungal abundance data at the species level.
Finally, mvabund was used to determine which taxon abundances differed significantly by group.
Recently, it was proved that model-based analysis of multivariate abundance data combined with
negative binomial regression is excellent for detecting multivariate effects that otherwise would lead
to statistical misinterpretation and is powerful when selecting indicator species using multivariate
abundance data [27]. Several lineages of taxa, including the order Gigasporales and the family
Umbelopsidaceae, appeared to differ significantly among the groups (Table 3).
Various analyses were conducted to determine indicator taxa, but the results of these analyses
were not identical. Therefore, the indicator species supported by multiple analyses were selected.
Gigasporales sp. was supported by every analysis except for ISA, and Umbelopsis sp. was selected in
every analysis except for LEfSe. Thus, these two fungal lineages can be regarded as definite indicator
taxa for mudflats. In fact, the order Gigasporales belongs to the Glomeromycetes (Glomeromycota),
the arbuscular mycorrhizal fungi. It was speculated that the abundance of Gigasporales sp. increases
as it forms a symbiotic network with the indigenous halophytes of mudflats and as the abandoned
saltern is restored to a mudflat [28]. Meanwhile, Entorrhizomycetes was selected by both ISA and
mvabund as well as by a simple visual assessment of the fungal community composition (Figure 2A).
However, it was difficult to determine the indicator taxa for the NS because only one sampling site,
the abandoned saltern in Yongyudo, represented the NS environment. In other words, this plant
pathogenic fungus may be dominant there because of the existence of its unique host plants. Therefore,
it can be regarded as an indicator taxon of the NS in Yongyudo but not of all the NSs in the Yellow Sea.
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Table 3. Indicator taxon results from the mvabund analysis (p < 0.05).



















2.1.3. Diversity of Culturable Fungi
The community analysis implied that these intertidal environments are valuable for bioprospecting.
Thus, the culturable fungi were isolated from the sediments to evaluate their diversity and to compare the
results of metagenome analysis.
A total of 53 fungal strains was isolated from the sediments of the intertidal mudflats and
the abandoned salterns (Table 4). It was obvious that the number of fungal isolates was much
higher in Yongyudo than in the other two regions. It was suspected that this could be due to the
sediment properties, such as the texture and grain size, since there was no significant difference in the
environmental factors among sampling locations (Figure S1). The genera Talaromyces and Trichoderma
were mostly isolated from the mudflat samples, and most Penicillium spp. were found in the NS.
Meanwhile, the diversity and the number of fungal isolates in the NS were much higher than those of
the other salterns, which was completely opposite to the result of the metagenome analysis, where the
diversity of the NS was the lowest (Table 1, Table 4 and Table S1). In addition, all of the isolates except
for Phanerochaete chrysosporium KUC10791 belong to Ascomycota. These results support that the actual
diversity of environmental microorganisms must be investigated by eDNA-based metabarcoding
approaches, unless all possible culture conditions and isolation methods are employed [29].
All 53 strains were grouped into 43 groups by morphological analysis and ITS sequences.
The best-fit model of ITS sequences is a general time reversible (GTR) + proportion of invariable sites
(I) + gamma distribution (G) by MrModeltest and contains 121 taxa and 844 nucleotide characters.
In the phylogenetic analysis, 53 strains were classified into 2 phyla, 5 classes, 11 orders, 20 families,
22 genera, and 43 species, based on current taxonomic concepts. The dominant genera of the ITS tree
were Penicillium (number of strains = 9), followed by Talaromyces (number of strains = 7), Aspergillus
(number of strains = 6), Trichoderma (number of strains = 6), and Cladosporium (number of strains
= 2) (Figure 5). Talaromyces and Trichoderma were the most complex clades and had low resolution.
Thus, to precisely perform phylogenetic analysis of Trichoderma and Talaromyces, EF1-α for Trichoderma
species and benA for Talaromyces species were amplified, and phylogenetic trees were constructed
(Figure S3 and S4). The best-fit model of EF1-α for Trichoderma is Hasegawa-Kishino-Yano (HKY)
+ I + G and contains 41 taxa and 794 nucleotide characters. Multiple sequence alignments of two
loci (ITS & benA) were analyzed for Talaromyces. Both loci were assigned GTR + I + G as the best fit
model, and concatenated datasets contained 64 taxa and 1,155 nucleotide characters (ITS, nchar = 598;
benA, nchar = 557). Through the EF1-α phylogenetic analysis of Trichoderma, KUC21406, KUC21404,
KUC21401, KUC21411, and KUC21394 are confidently classified as T. afroharzianum and T. harzianum in
the EF1-α tree. Talaromyces sp. 2 KUC21413 was closely related to T. viridulus in the ITS tree. In the
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concatenated tree (ITS & benA), however, the position changed to be near T. galapagensis with low
posterior probability. Therefore, Talaromyces sp. 2 KUC21413 was assigned as a novel species candidate.
Talaromyces sp. 1 KUC21276 appeared to be closely related to T. angelicus (99.81% sequence similarity
in ITS; 93.22% in benA). Talaromyces sp. 3 KUC21415 and Talaromyces sp. 3 KUC21421 appeared to
be closely related to T. helices (99.81% sequence similarity in ITS; 96.7% in benA). Talaromyces sp. 4
KUC21408 appeared to be closely related to T. boninensis (97.97% sequence similarity in ITS; 93.72% in
benA). Thus, they are suggested to be candidate novel species.
Table 4. General information on the 53 fungal isolates from sediments of abandoned salterns and
intertidal mudflats.
Fungal Name KUC ID
Isolation Source GenBank Accession Number





Aspergillus urmiensis 21379 MN518380 N.D. N.D.
A. urmiensis 21392 MN518381 N.D. N.D.
A. urmiensis 21396 MN518382 N.D. N.D.
Cladosporium sphaerospermum 21388 MN518383 N.D. N.D.
Emericellopsis microspora 21381 MN518384 N.D. N.D.
Gibellulopsis nigrescens 21385 MN518385 N.D. N.D.
Humicola alopallonella 21393 MN518386 N.D. N.D.
Lulwoana sp. 21398 MN518387 N.D. N.D.
Nectriaceae sp. 21383 MN518388 N.D. N.D.
Neocamarosporium betae 21428 MN518389 N.D. N.D.
Penicillium chrysogenum 21395 MN518390 N.D. N.D.
Penicillium citrinum 21390 MN518391 N.D. N.D.
Penicillium sumatrense 21382 MN518392 N.D. N.D.
Penicillium sp. 1 21380 MN518393 N.D. N.D.
Penicillium sp. 1 21386 MN518394 N.D. N.D.
Penicillium sp. 1 21387 MN518395 N.D. N.D.
Penicillium sp. 1 21389 MN518396 N.D. N.D.
Penicillium sp. 1 21399 MN518397 N.D. N.D.
Phanerochaete chrysosporium 10791 MN518398 N.D. N.D.
Simplicillium aogashimaense 21397 MN518399 N.D. N.D.
Sporormiaceae sp. 21391 MN518400 N.D. N.D.




Amorphotheca resinae 21414 MN518403 N.D. N.D.
Aspergillus floccosus 21405 MN518404 N.D. N.D.
Helotiaceae sp. 21409 MN518405 N.D. N.D.
Penicillium sp. 2 21400 MN518406 N.D. N.D.
Pseudogymnoascus pannorum 21417 MN518407 N.D. N.D.
Sporothrix mexicana 21410 MN518408 N.D. N.D.
Talaromyces liani 21412 MN518409 MN531288 N.D.
Talaromyces stipitatus 21402 MN518410 MN531294 N.D.
Talaromyces sp. 2 21413 MN518411 MN531292 N.D.
Talaromyces sp. 3 21415 MN518412 MN531289 N.D.
Talaromyces sp. 4 21408 MN518413 MN531293 N.D.
Trichoderma koningiopsis 21403 MN518414 N.D. MN580171
Trichoderma afroharzianum 21401 MN518415 N.D. MN580166
T. afroharzianum 21404 MN518416 N.D. MN580167
T. afroharzianum 20406 MN518417 N.D. MN580168
Trichoderma harzianum 21411 MN518418 N.D. MN580169
Westerdykella capitulum 21407 MN518419 N.D. N.D.
Cladosporium sp. 21418
Gopado
Abandoned saltern (RS) MN518420 N.D. N.D.









Aspergillus japonicus 21425 MN518425 N.D. N.D.
Aspergillus tritici 21427 MN518426 N.D. N.D.
Paracamarosporium sp. 21423 MN518427 N.D. N.D.
Phoma sp. 21426 MN518428 N.D. N.D.
Pseudeurotium bakeri 21422 MN518429 N.D. N.D.
Talaromyces sp. 1 21276 MN518430 MN531291 N.D.
Monascus sp. 21277 Mudflat MN518431 N.D. N.D.
KUC ID, Korea University Culture collection ID; ITS, internal transcribed spacer; benA, β-tubulin; EF1-α, translation
elongation factor 1-α; NS, non-recovered saltern; RS, recovered saltern; N.D., no data.
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Figure 5. The Bayesian analysis tree based on ITS. Bayesian posterior probabilities (PP) at the nodes
are presented if > 75. Type strains are indicated as *. The fungi isolated from this study are in bold. The
scale bar indicates the number of nucleotide substitutions per position. NS and RS mean non-recovered
saltern and recovered saltern, respectively.
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The dominant taxa of the intertidal sediments were Penicillium species (number of strains = 8) and
Talaromyces species (number of strains = 6). A number of fungal isolates belonged to Eurotiomycetes,
followed by Sordariomycetes. A total of 18 candidate novel fungal species was isolated from this study.
This result demonstrates that many novel fungal candidates remain unexploited in abandoned salterns
or intertidal mudflat sediments.
2.2. Biological Activities of Fungi from Intertidal Mudflats and Abandoned Salterns
To evaluate the potential value of the intertidal environments for bioprospecting, a variety of
biological activities of the fungal extracts were investigated.
2.2.1. Antioxidant Activity
It is well known that reactive oxygen species (ROS) and excessive free radicals cause oxidative
chain reactions that damage biomolecules such as proteins and DNA and are responsible for a
wide variety of diseases and aging [30,31]. Many antioxidants scavenging free radicals have been
discovered, and fungi are one of the major sources of these compounds. However, only four
antioxidants were discovered from mudflat-derived fungi: cristazine, 6,9-dibromoflavasperone,
thielaviazoline, and formoxazine from Chaetomium cristatum, Aspergillus niger, Thielavia sp., and
Paecilomyces formosus, respectively [16,18,20,21]. In this study, the extracts of 68 fungi isolated from
intertidal mudflats and abandoned salterns were screened for their antioxidant capacity. Among the
fungal extracts, three Aspergillus spp. (A. floccosus KUC21405, A. japonicas KUC21425, and A. urmiensis
KUC21396), four Penicillium spp. (P. chrysogenum KUC21395 and Penicillium sp. 1 KUC21386,
KUC21387, and KUC21389), Phoma sp. KUC21426, and Talaromyces liani KUC21421 exhibited high
radical-scavenging activity in both assays using 2.2’-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid
(ABTS) radicals and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals as substrates, respectively (Table 5).
Several antioxidants have been reported from the genus Aspergillus, for example,
3,3“-dihydroxyterphenyllin, 3-hydroxyterphenyllin, candidusin B, and dihydroxymethyl pyranone from
A. candidus [32,33]; 1,8-dihydroxynaphthalene melanin from A. bridgeri [34]; methyl 4-(3,4-dihydroxybenz
amido)butanoate, 5-O-methylsulochine, methyl 2-(2,6-dimethoxy-4-methylbenzoyl)-3,5-dihydroxybenz
oate, methyl-2-(2,6-dihydroxyl-4-methylbenzoyl)-3-hydroxy-5-methoxybenzoate, physcion, 4-(3,4-dihy
droxybenzamido)butanoic acid, and (E)-N-(2-hydroxy-2-(4-hydroxyphenyl)ethyl)-3-(3-hydroxy-4-
methoxyphenyl)acrylamide from A. wentii [35]. However, there is no report of antioxidants from A.
floccosus, A. japonicus, or A. urmiensis that showed the strong radical-scavenging activity seen in our
results. The genus Penicillium has been reported to produce antioxidants, for example, atrovenetin
from P. atrovenetum, P. herquei, and P. simplicissimum (previously known as P. paraherquei) [36–38];
2,3,4-trimethyl-5,7-dihydroxy-2,3-dihydrobenzofuran and gentisic acid from P. citrinum [39]; and
2,3-dihydroxy benzoic acid from P. roquefortii [40]. An ethanol extract of P. chrysogenum showing
moderate radical-scavenging activity in our results showed high activity in a previous study [41].
Because bisvertinolone has been reported in this species and many bisorbicillinoids are known
to be antioxidants, the antioxidant of this species is likely to be bisvertinolone [42]. In the
case of the genus Phoma, there is only one report of antioxidant compounds, for example,
bromochlorogentisylquinones A and B, chlorogentisyl alcohol, and gentisyl alcohol from P. herbarum [43].
Some antioxidants have been reported from the genus Talaromyces, for example, 8-hydroxyconiothyrinone
B, 8,11-dihydroxyconiothyrinone B, 4R,8-dihydroxyconiothyrinone B, 4S,8-dihydroxyconiothyrinone
B, and 4S,8-dihydroxy-10-O-methyldendryol E from T. islandicus [44]; pentalsamonin from
T. purpureogenus [45]; N-(4-hydroxy-2-methoxyphenyl) acetamide from T. funiculosus [46]; and
6-methylbiphenyl-3,3′,4,5′-tetraol and desmethylaltenusin [47].
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A. japonicas KUC21396, Penicillium sp. 1 KUC21386 and KUC21389, and Phoma sp. KUC21426
extracts exhibited even higher ABTS radical-scavenging activity than the positive control, ascorbic
acid. In particular, the IC50 values of both ABTS and DPPH radical-scavenging activity of Phoma
sp. KUC21426 extract were significantly lower than the values of other extracts, implying its high
antioxidative capacity. To the best of our knowledge, this is the second report of radical-scavenging
activity of the genus Phoma, which contains a number of plant pathogen species.
2.2.2. Tyrosinase Inhibitory Activity
A total of five fungal extracts (Cladosporium sphaerospermum KUC21388, Lulwoana sp.
KUC21398, P. citrinum KUC21390, Trichoderma afroharzianum KUC21411, and Westerdykella
capitulum KUC21407) showed tyrosinase inhibitory activity (Table 5). Tyrosinase is able to
oxidize l-3,4-dihydroxyphenylalanine (l-DOPA) to dopaquinone, which is eventually converted
to pheomelanin [48]. As melanin biosynthesis is responsible for darkening of the skin tone, researchers
have tried to discover tyrosinase inhibitors. Tyrosinase inhibitors can suppress melanin formation in
the skin, so they can be developed as whitening agents. In particular, kojic acid, the most widely used
tyrosinase inhibitor, was discovered through the screening of 600 marine fungi [49].
There is no report of tyrosinase inhibitors from the genera Cladosporium, Lulwoana, and Westerdykella.
It has been discovered that various Penicillium spp. can produce kojic acid, but there has been no
report of any tyrosinase inhibitor from P. citrinum. On the other hand, several tyrosinase inhibitors
have been reported from the genus Trichoderma, for example, homothallin II from T. viride [50] and
1-(1,2,5-trihydroxy-3-isocyanopent-3-enyl)-ethanol, 1-(3-chloro-1,2-dihydroxy-4-isocyano-4-cyclopenten-
1-yl)ethanol, and 1-(1,2,3-trihydroxy-3-isocyano-4-cyclopenten-1-yl)ethanol from T. harzianum [51,52].
Some antioxidants have been reported to be able to inhibit tyrosinase by scavenging reactive quinone
products [48]. Since none of the five fungal extracts exhibited remarkable radical-scavenging activity,
it is obvious that their tyrosinase inhibitors use inhibiting mechanisms other than scavenging reactive
quinone products.
Considering that all the activities were measured using crude extracts, the tyrosinase inhibitory
activity of C. sphaerospermum KUC21388, P. citrinum KUC21390, and Trichoderma harzianum KUC21411
extracts were notable. In particular, the IC50 value of C. sphaerospermum KUC21388 extract was even
comparable to that of the positive control, kojic acid. This is the first report of tyrosinase inhibition
activity in the genus Cladosporium, which is generally known to produce melanin.
2.2.3. Antifungal Activity
Antifungal experiments on Asteromyces cruciatus and Lindra thalassiae were conducted using the
extracts of fungi isolated from intertidal mudflats and abandoned salterns. The two target fungi were
selected considering that our fungal isolates were derived from the marine environment. A. cruciatus is
a potentially harmful fungus to brown algae because it degrades alginate, a major constituent of brown
algae. Alginate plays an important role in brown algae by forming the structure of the algal biomass
and physically protecting algae from pathogens. L. thalassiae is a pathogenic fungus of sea plants and
brown algae that causes raisin disease [53–55]. The results showed that the extracts of 17 fungal strains
showed inhibitory effects against mycelial growth in A. cruciatus or L. thalassiae (Table 5).
All the extracts of the four Penicillium sp. 1 strains had potential antifungal activities, as they
could inhibit the growth of A. cruciatus at a minimum concentration of 50 μg/mL and could inhibit
the growth of L. thalassiae as well. Since they were identified as the same species from the same
isolation source, the potential antifungal secondary metabolites are highly likely to be identical.
There are a number of antifungal compounds reported from the genus Penicillium, for example,
brefeldin A from P. brefeldianum; griseofulvin from P. griseofulvum; atpenins A4, A5, and B from
P. atramentosum [56]; xanthocillin X and penicisteroid A from P. chrysogenum [56,57]; calbistrins from P.
restrictum [58]; canadensolide from P. canadense [59]; macrocyclic polylactones from P. verruculosum [60];
patulin from P. carneum , citrinin from P. melinii (previously known as P. damascenum), palitantin
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and arthrographol from P. implicatum [61]; and compactin from P. brevicompactum [62]. There is no
report of antifungal compounds or activity from the genus Pseudeurotium. In the case of the genus
Talaromyces, some antifungal compounds have been reported, for example, talaroconvolutins from
T. convolutus [63], talaron from T. flavus [64], 3-O-methylfunicone from T. pinophilus, wortmannin
from T. wortmannii, macrophorin A from T. purpurogenus, and botryodiplodin from T. stipitatus [56].
In particular, Penicillium sp. 1 KUC21389 and Pseudeurotium bakeri KUC21422 exhibited significantly
lower MIC values than the other strains. To the best of our knowledge, this is the first report of
the antifungal activity of the genus Pseudeurotium. It is strongly speculated that these antifungal
metabolites can affect other pathogenic fungi, so they could be developed as biocontrol agents.
2.2.4. Quorum Sensing Inhibitory Activity
Since only a few fungal quorum-sensing inhibitors (QSIs) have been found to date, it is worth
investigating fungi from extreme environments such as intertidal mudflats and abandoned salterns.
The two-step screening process showed that the extracts of A. urmiensis KUC21392 moderately inhibited
the production of violacein by C. violaceum CV026 in the presence of N-(3-oxo-hexanoyl)-l-homoserine
lactone (3-oxo-C6-HSL), an N-acyl homoserine lactone (AHL), which is one of the most widely studied
quorum sensing (QS) molecules (Figure 6). Bacterial biofilms cause huge economic losses in many
areas, such as the food industry, aquaculture, wastewater treatment, and the shipping industry [65,66].
QS is responsible for biofilm formation and the expression of virulence genes, and bacterial biofilms
have been reported to be approximately 1,000 times more resistant to antibiotics than their planktonic
counterparts [67]. Some fungi produce quorum-quenching compounds such as patulin and penicillic
acid from Penicillium spp., which can suppress bacterial biofilm formation [68]. Other studies reported
that the extracts of Fusarium graminearum, Lasidiplodia sp., Phellinus igniarius, and fruiting bodies of
Auricularia auricular, Tremella fuciformis, and Ganoderma lucidum have QS inhibitory activity [69–74].
Fungal QSIs were reported in the genera Penicillium and Trichoderma: polyhydroxyanthraquinones,
penicillic acid, and patulin from P. restrictum, P. radicicola, and P. coprobium, respectively [68,75]; and
carot-4-en-9,10-diol from T. virens [76]. Penicillium spp. are a good source of QSIs, considering that 33
out of 100 Penicillium extracts were screened as potential QSI producers in a previous study. In addition,
Penicillium atramentosum was reported to produce QSIs other than penicillic acid or patulin [77].
A. urmiensis KUC21392 was identified as a potential QSI producer and is valuable as a source of natural
compounds that regulate bacterial biofilms and related diseases. This is the first report on the QS
inhibitory activity of the genus Aspergillus.
 
Figure 6. Quorum-sensing inhibitory activity of fungal extracts. (A) Aspergillus urmiensis KUC21392;
(B) Penicillium sp. 2 KUC21400; (C) Talaromyces stipitatus KUC21402; (D) Trichoderma afroharzianum
KUC21401; (E) Trichoderma afroharzianum KUC21404; (+) positive control (piericidin A); (−) negative
control (DMSO).
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Interestingly, four fungal extracts (Penicillium sp. 2 KUC21400, T. stipitatus KUC21402, T.
afroharzianum KUC21401 and KUC21404) inhibited the growth of C. violaceum, resulting in a
distinct hollow circle around the paper disc (Figure 5). Based on their antibacterial activity
against C. violaceum, these four fungal strains were found to be producers of antimicrobial
compounds that inhibit gram-negative bacteria. A number of antibacterial compounds have been
discovered from the genus Penicillium, including rugulotrosin A and B, secalonic acid B and D,
penicillixanthone A, citrinin, viridicatumtoxin B, penialidin B and C, penicyclones A–E [78–83]. P.
rubens is the producer of penicillin, the first antibiotic that triggered the discovery of antibiotics [84].
Norlichexanthone, 3,1′-didehydro-3[2”(3′”,3′”-dimethyl-prop-2-enyl)-3”-indolylmethylene]-6-methyl
pipera-zine-2,5-dione, gladiolic acid, and talaroderxines A and B were also produced by Penicillium
solitum, P. chrysogenum, Penicillium gladioli, and Penicillium derxii, respectively [85–88]. The genus
Talaromyces, which was formerly regarded as the teleomorphic state of Penicillium, has also been
reported to produce various antibacterial compounds: fumitremorgin C, pseurotin A1 and A2,
3-dehydroxymethylbisdethio-3,10a-bis(methylthio)gliotoxin, bisdethiobis(methylthio)gliotoxin,
didehydrobisdethiobis(methylthio)gliotoxin, 7-hydroxy-deoxytalaroflavone, deoxytalaroflavone,
7-epiaustdiol, 8-O-methylepiaustdiol, stemphyperylenol, skyrin, secalonic acid A, emodin,
norlichexanthone, and talaromycesone A [89–93]; (−)luteoskyrin, cyclochlorotine, (+)rugulosin,
rubroskyrin, lumiluteoskyrin, simotoxin, pibasterol, and skyrin produced from T. islandicus and
Talaromyces rugulosus [94]; wortmannin, flavomannins A-D, and talaromannins A and B from T.
wortmannii [95,96]; (−)-8-hydroxy-3-(4-hydroxypentyl)-3,4-dihydroisocoumarin, pentalsamonin,
5-hydroxy-7-methoxy-2-methylbenzofuran-3-carboxylic acid and 1-(5-hydroxy-7-methoxybenzofuran
-3-yl)ethan-1-one, bacillosporin A, and talaromycolides A–C from Talaromyces verruculosus,
T. purpureogenus, Talaromyces amestolkiae, Talaromyces bacillisporus, and T. pinophilus
respectively [45,97–100]; talaraculone B, (-)mitorubrin, and bacillisporin A and B from Talaromyces
aculeatus [101,102]; and 2,2′,3,5′-tetrahydroxy-3′-methylbenzophenone, 1,4,7-trihydroxy-6-methylxa
nthone, and 1,4,5-trihydroxy-2-methylxanthone from T. islandicus [103]. In the case of T. stipitatus,
talaromyone was reported as an antibacterial compound [104]. Therefore, the potential antibacterial
compound produced by T. stipitatus KUC21402 is likely to be talaromyone. The genus Trichoderma is
well known for producing various antibacterial compounds: 3-(3-oxocyclopent-1-enyl) propanoic
acid, trichodermaol, alternariol 1′-hydroxy-9-methyl ether [105–107]; pseudokonin KL III and
IV produced from T. pseudokoningii [108]; suzukacillin, viridian, lignoren, and gliotoxin from
T. viride [109–112]; 6-n-pentyl-α-pyrone from T. harzianum and T. longibrachiatum [113]; shikimic
acid from T. ovalisporum [114]; and coniothranthraquinone 1 and emodin from T. aureoviride [115].
Therefore, the potential antibacterial compounds of T. afroharzianum KUC21401 and KUC21404 are
unlikely to be novel, but this is the first report on the antibacterial activity of this species.
3. Materials and Methods
3.1. Microorganisms and Diversity Analyses
3.1.1. Sediment Sampling and Fungal Isolation
Intertidal sediments 10 cm deep from the surface were sampled into sterile polyethylene jars
using a sterile knife. The sediment samples were sieved using 2-mm sieves and stored at −80 ◦C for
further use. To isolate fungi from the sediment samples, 1 gram of wet sediment was mixed with
10 mL of sterilized D.W. and vortexed. Preliminary tests with a variety of different intertidal sediment
samples showed that the optimal concentration for isolating fungi from intertidal sediments was
5–10 times higher than those typically used when using forest sediments. The reason may be that the
amount of organic matter in the sediment is relatively small, so that the amount of microbial biomass
is small. The sediment suspension was serially diluted to a ratio of 1 g : 1000 mL, and 3 mL of the
diluted suspension was added to 47 mL of the culture medium composed of 2% malt extract, 3.59%
artificial sea salt (Instant Ocean, Aquarium Systems, Mentor, OH, USA), and 0.01% streptomycin
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sulfate (Sigma-Aldrich, St. Louis, MO, USA) for inhibiting the growth of bacteria. After that, 150 μL of
the inoculated medium was distributed into each well of four sterilized 96-well plates. The plates were
incubated at room temperature for 2–4 weeks until the fungal mycelia were visible to the naked eye.
Each fungal colony was transferred to an individual 2% malt extract agar plate with 0.01% streptomycin
sulfate. The plates were incubated at room temperature for a week and subcultured to isolate single
strains. The isolated fungal strains were stored in 10% glycerol solution at 4 ◦C for further use and
deposited in the Korea University Culture (KUC) collection.
3.1.2. DNA Extraction, PCR, and Identification
Genomic DNA was extracted from fungal culture using the AccuPrep® Genomic DNA Extraction
Kit (Bioneer, Seoul, Republic of Korea), of which lysis buffer was replaced with fungal lysis buffer
(12 mL of 0.5 M EDTA pH 8.0, 40 mL of 1 M Tris-HCL pH 8.0, 1 g of SDS, 0.8766 g of NaCl, and
D.W. to a final volume of 100 mL). PCR amplification of ITS regions were carried out with ITS1F-LR3
primer [ITS1F (5′-CTT GGT CAT TTA GAG GAA GTA A-3′) and LR3 (5′- CCG TGT TTC AAG ACG
GG-3′) [116,117] using the AccuPower® PCR Premix (Bioneer, Seoul, Republic of Korea). benA for
Talaromyces species was amplified using the Bt2a-Bt2b primer [Bt2a (5′-GGT AAC CAA ATC GGT GCT
GCT TTC-3′) and Bt2b (5′-ACC CTC AGT GTA GTG ACC CTT GGC-3′)] [118]. EF1-α for Trichoderma
species was amplified using EF1-EF2 primer [EF1 (5’-ATG GGT AAG GAR GAC AAG AC-3’) and EF2
(5’-GGA RGT ACC AGT SAT CAT GTT-3’)] [119]. ITS regions were amplified under the conditions:
95 ◦C for 4 min, followed by 35 cycles of 95 ◦C for 30 s, 54 ◦C or 55 ◦C for 30 s, and 72 ◦C for 30 s.
An elongation step of 72 ◦C for 5 min was performed at the end. For benA, the conditions were as
follows: 95 ◦C for 5 min, followed by 38 cycles of 95 ◦C for 35 s, 55 ◦C or 56 ◦C for 50 s, and 72 ◦C for
2 min; an elongation step was performed at 72 ◦C for 7 min. For EF1-α, the conditions were as follows:
94 ◦C for 2 min, followed by 34 cycles of 93 ◦C for 30 s, 56 ◦C for 30 s, and 72 ◦C for 1 minute; and
an elongation step was performed at 72 ◦C for 10 min. Through electrophoresis with 1% agarose gel,
PCR products were conformed. PCR products were purified with the AccuPrep® PCR Purification
Kit (Bioneer, Seoul, Republic of Korea) according to the user guide. DNA sequencing was performed
using an 3730xl DNA Analyzer (Life technology, Carlsbad, CA, USA) with indicated PCR primers
by Macrogen (Seoul, Republic of Korea). All the sequences were submitted to the GenBank and are
presented in Table 1.
3.1.3. Phylogenetic Analysis
All the obtained sequences were assembled, proofread and edited using MEGA v. 7.0 [120].
Edited sequences were aligned using MAFFT 7.130 [121] and ambiguously aligned positions
manually modified using MacClade 4.08 [122]. Through MrModeltest 2.3 using Akaike information
criterion criteria, the best-fit models were calculated for the Bayesian phylogenetic analysis [123].
The Bayesian phylogenetic analyses were performed for 10 million generations using MrBayes
3.2.1 [124]. Phylogenetic trees were sampled every 100th generation. After sampling, the last 75% of
the trees were selected. The constructed phylogenetic tree followed the 50% majority-rule and the tree
reliability was presented by posterior probability.
3.1.4. DNA library Preparation and Amplicon Sequencing
Total DNA was extracted from 0.3 g of frozen sediment using a PowerSoil DNA isolation kit
(MoBio, Carlsbad, CA, USA) following the manufacturer's protocol. DNA libraries were constructed
using the Illumina MiSeq platform with the fungal ITS rDNA gene. An approximate 300–350 bp
region of the ITS2 region was amplified with forward primer fITS7 [125] and reverse primer ITS4 [116].
Primer fITS7 contained a unique 12-nt barcode at the 5′ end for MiSeq sequencing detection. Paired-end
read sequences were generated by high-throughput sequencing technology.
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3.1.5. Bioinformatics Analyses
The sequences obtained in this study were processed using QIIME v1.9.1 [126]. The primer, key,
and barcode sequences were trimmed from both ends. Sequences composed of homopolymers (n > 6)
and chimeras were removed, and the remaining sequences were analyzed. The sequences were then
clustered as operational taxonomic units (OTUs) based on a ≥ 97% similarity threshold and the average
linkage method using Vsearch [127]. The representative sequence that was most abundant from each
OTU was taxonomically assigned using the UNITE [128] reference database.
Nonmetric multidimensional scaling (NMDS) analysis applying the Bray–Curtis similarity index
was performed to plot the similarity of the fungal communities in a way such that distances could
be represented in two dimensions, using the vegan package in R statistical software, version 3.5.3.
Alpha diversity indices were calculated using QIIME, and differences among the sediments from the
abandoned salterns and mudflats were compared. After taxonomic profiling, we also investigated
which fungal taxa differed in relative abundance among the intertidal environments. The relative
abundances of the fungal communities were compared using linear discriminant analysis effect size
(LefSe) analysis [129] with a LDA score threshold of 2.0 at the phylum, class, order, and family levels.
Indicator species analysis was performed using the labdsv package in R to determine the key fungal
taxa that best represent the Yellow Sea intertidal environments. Indicator species values are based on
how specific and widespread the taxa are within a particular group and are independent of the relative
abundance of other fungi [130]. RandomForest analysis was performed to identify key predictors of
the environments among the fungal taxa. The accuracy importance measure was calculated for each
tree and averaged over the forest (10,000 trees). This analysis was performed using the randomForest
package in R. To determine which fungal taxa differed among the environments, the multivariate
statistical package mvabund [131] was used in R; this approach is reported to have much greater power
than distance-based approaches. In the generalized linear model, the relative abundance of each fungal
taxon was modeled on the negative binomial distribution.
3.2. Preparation of Fungal Extracts
All the fungal isolates were precultured on 90-mm Petri dishes (10090, SPL Life Sciences Co.,
Pocheon, Republic of Korea) containing 20 mL of potato dextrose agar (PDA) at 25 ◦C for a week.
After that, three agar plugs with actively-growing mycelia were inoculated to 150-mm Petri dishes
(10150, SPL Life Sciences Co., Pocheon, Republic of Korea) containing 50 mL of PDA and incubated
at 25 ◦C for 7 days in the dark. The cultures were extracted with 200 mL of MeOH and filtered with
Whatman No.1 filter paper. The filtrates were dried at 35 ◦C using a rotary evaporator, and the dried
extracts were dissolved in 15 mL of D.W. and 15 mL of EtOAc. After 6 hours, the EtOAc layers were
transferred to 20-mL scintillation vials and dried using the rotary evaporator, and the dried extracts
were stored at 4 ◦C until use. All the extracts were prepared in triplicate.
3.3. Biological Assays
The biological assays were performed with methods that were the same as or slightly modified
from the methods used in our previous study [132].
3.3.1. Antioxidant Assay
ABTS Radical-Scavenging Assay
The 7-mM ABTS (Sigma-Aldrich, St. Louis, MO, USA) solution in phosphate-buffered saline
(PBS, pH 7.4) was mixed with potassium persulfate solution that dissolved in PBS to 2.45 mM.
The mixture was stored in the dark at room temperature for 24 h to form the ABTS•+. The solution
was diluted with PBS to an absorbance of 0.70 (±0.02) at a wavelength of 734 nm. Then, 198 μL of
ABTS radical solution was mixed with 2 μL of the fungal extract (10 mg/mL DMSO) in a 96-well plate.
The absorbance was measured at 734 nm after 6 min using a spectrophotometer (SunriseTM, Tecan
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Group Ltd., Port Melbourne, VIC, Australia). Ascorbic acid (Sigma Aldrich, St. Louis, MO, USA) was
used as a positive control.
DPPH Radical-Scavenging Assay
The 200 μL of 150 μM DPPH (Sigma-Aldrich, St. Louis, MO, USA) solution in 80% methanol was
mixed with 22 μL of the fungal extract (10 mg/mL DMSO) in a 96-well plate. The plate was stored in
the dark at room temperature, and the absorbance was measured at 540 nm after 30 min using the
spectrophotometer. Ascorbic acid was used as a positive control.
3.3.2. Tyrosinase Inhibition Assay
Tyrosinase inhibitory activity was measured based on the method of Lai et al. (2009) [133].
Briefly, 70 μL of 0.1 M potassium phosphate buffer (pH 6.8), 40 μL of fungal extract (2.5 mg/mL 50%
DMSO), and 30 μL of tyrosinase from mushroom (0.02 mg/mL buffer; Sigma Aldrich, St. Louis, MO,
USA) were added into each well of the 96-well plate. The plates were floated on water in a waterbath
at 30 ◦C for 5 minutes, and 100 μL of 2.5 mM l-DOPA (Sigma Aldrich, St. Louis, MO, USA) was added.
After 30 min, the plates were placed in ice to terminate the reaction, and the absorbance was measured
at 492 nm. Kojic acid (Sigma Aldrich, St. Louis, MO, USA) was used as a positive control.
3.3.3. Antifungal Assay
Asteromyces cruciatus SFC20161110-M19 was obtained from Marine Fungal Resource Bank (MFRB)
at Seoul National University as a marine bioresource bank of Korea by the Ministry of Oceans and
Fisheries, and Lindra thalassiae NBRC106646 was purchased from Biological Resource Center under
National Institute of Technology and Evaluation. Antifungal activity was determined in a 96-well
plate using the microtiter broth dilution method [134]. Twenty-five microliters of spore suspensions
(4 × 105 conidia/mL) of the target fungi were added to each well containing 25 μL of 4X potato dextrose
broth and 49 μL of D.W. The fungal extracts were added to a final concentration of 100 μg/mL.
The inoculated plates were incubated at 25 ◦C for 3 days. The extracts with lower concentrations
(50, 25, 12.5, 6.5 μg/mL) were tested to determine MIC, the minimum concentration of an antimicrobial
agent that causes microbial death.
3.3.4. Quorum Sensing Inhibition Assay
QSI screening was performed based on the inhibition of violacein production by Chromobacterium
violaceum CV026 strains under culture conditions supplemented with an exogenous QS molecule,
3-oxo-C6-HSL [135]. The C. violaceum CV026 cultured overnight was diluted with LB medium (5 g
of yeast extract, 10 g of tryptone, and 5 g of NaCl in a liter of D.W.) to an OD600 nm of 0.1, and 97 μL
of the diluted culture was added to each well of a 96-well plate. One microliter of 3-oxo-C6-HSL
(final concentration of 10 μM; Sigma–Aldrich, St. Louis, MO, USA) and 2 microliters of fungal extract
(10 mg/mL DMSO) were added to each well. As a negative and positive control, two microliters of
DMSO and two microliters of 100 nM (Z)-4-bromo-5-(bromomethylene)-2(5H)-furanone (Furanone
C-30; Sigma-Aldrich, St. Louis, MO, USA) were used, respectively. After 16 h at 28 ◦C, 100 μL of
DMSO was added to each well and vigorously shaken for an hour at room temperature to determine
the production of violacein.
The selected extracts were further examined using a paper disc method. Fifteen microliters of the
diluted culture of C. violaceum CV026 was spread on an LB agar plate, and a paper disc (diameter 8 mm;
Advantec, Tokyo, Japan) impregnated with 40 μL of extract and 1 μL of 1 mM 3-oxo-C6-HSL was
placed in the center of the plate. DMSO was used as a negative control, and piericidin A isolated from
Streptomyces xanthocidicus KPP01532 was used as a positive control [135]. The plates were incubated
overnight at 28 ◦C.
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3.4. Statistical Analyses
The half maximal inhibitory concentration (IC50) values were calculated by nonlinear regression
analysis using SigmaPlot 12.0 (Systat Software Inc., San Jose, CA, USA).
4. Conclusions
The results of the fungal community analysis showed that only the abandoned saltern in Yongyudo
was significantly different from the other abandoned salterns or mudflats. The fungal communities in
the abandoned salterns in Yubudo and Gopado had been restored to a similar status as those in the
mudflats, but that was not the case of the saltern in Yongyudo, which was abandoned less than a year
ago. The results also implied that it takes more than 35 years to restore abandoned salterns to mudflats
via natural restoration. The α-diversity of the fungal community in the NS was significantly lower
than that of the RSs and mudflats. The diversity indices were high in general, which implies that these
unique environments are valuable for bioprospecting.
Through various statistical analyses, the lineages of Gigasporales sp. and Umbelopsis sp. were
selected as indicator taxa of mudflats in the Yellow Sea in South Korea. We demonstrate that the
ecological recovery of the abandoned salterns can be assessed by using the two indicator taxa to indicate
not only the recovery state but also the recovery direction, i.e., whether the recovery process is moving
in the right direction. In this study, several analytical methods were applied to investigate indicator
taxa. However, the results were not identical, even though we only used methods that use the absolute
abundance data rather than processed data such as ecological distances that could lead to statistical
misinterpretation [27]. Therefore, indicator taxa must be selected by carefully comparing the results
of various types of analysis. We also proved that the fungal community is highly suitable for use in
ecosystem assessment, as it has a sufficient level of identification with good resolution. The limitation
was that the number of samples, especially for the NS and RS environments, was insufficient. A larger
sample size is recommended for more accurate statistical analysis with high fidelity.
To evaluate the fungal diversity and compare it with the results from the metagenome analysis,
the culturable fungi were isolated from the sediment samples. A total of 53 fungal strains was isolated,
and the number of fungal isolates differed by sampling location rather than by environment type.
Based on the phylogenetic analysis, Talaromyces was the most diverse genus, consisting of seven
different species. The genera Talaromyces and Trichoderma were mostly isolated from the mudflat
sediments, and most Penicillium spp. were found in the NS. The diversity and the number of isolates
in the NS were higher than those in the other salterns, which is inconsistent with the results of
metagenomics, and every isolate except P. chrysosporium belongs to the Ascomycota. This result
showed that metagenomics must be applied when examining the microbial diversity within an actual
environment, as has been suggested over the past decades [29]. Interestingly, a total of 18 fungal
isolates was identified as candidate novel species.
To evaluate the potential value of the intertidal environments for bioprospecting, a variety
of biological activities of the fungal extracts were investigated. Regardless of the actual diversity,
the isolates from both intertidal environments exhibited a variety of biological activities. Over half of
the culturable fungal isolates (29 strains) exhibited biological activities, and Penicillium spp. exhibited
the most varied activities. The antioxidant compound of Phoma sp. KUC21426, the tyrosinase inhibitors
of C. sphaerospermum KUC21388, the antifungal compounds of Penicillium sp. 1 KUC21389 and P. bakeri
KUC21422, and the quorum-sensing inhibitor of A. urmiensis KUC21392 will be separated and identified
in the near future. Since bioactive compounds with these activities have never been reported from
these species, the likelihood of discovering novel compounds is high.
In this study, we presented the fungal community and diversity of the abandoned solar salterns
and the intertidal mudflats on three different islands located in the Yellow Sea of South Korea, and we
identified indicator taxa for the assessment of the restoration of abandoned salterns to mudflats.
Additionally, we provided reliable DNA information for the 53 fungal isolates from the intertidal
sediments and their exploitable biological activities. We demonstrated that these unique environments
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are highly valuable in bioprospecting not only for novel microorganisms but also for novel bioactive
compounds. Restoring the reduced biodiversity of abandoned salterns is important in terms of
environmental protection and conservation. However, many novel fungal species were found from the
abandoned salterns, and interestingly, all fungal strains selected for high bioactivity were isolated from
NS or RS. Therefore, active measures to recover abandoned salterns to mudflats should be carefully
determined and planned, taking into account their value as a source of biological resources.
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Abstract: Identification and analysis of the whole genome of the marine-derived fungus
Penicillium brasilianum HBU-136 revealed the presence of an interesting biosynthetic gene cluster
(BGC) for non-ribosomal peptide synthetases (NRPS), highly homologous to the BGCs of
indole-diketopiperazine derivatives. With the aid of genomic analysis, eight indole-diketopiperazines
(1−8), including three new compounds, spirotryprostatin G (1), and cyclotryprostatins F and G
(2 and 3), were obtained by large-scale cultivation of the fungal strain HBU-136 using rice medium
with 1.0% MgCl2. The absolute configurations of 1−3 were determined by comparison of their
experimental electronic circular dichroism (ECD) with calculated ECD spectra. Selective cytotoxicities
were observed for compounds 1 and 4 against HL-60 cell line with the IC50 values of 6.0 and 7.9 μM,
respectively, whereas 2, 3, and 5 against MCF-7 cell line with the IC50 values of 7.6, 10.8, and
5.1 μM, respectively.
Keywords: biosynthetic gene cluster (BGC); indole-diketopiperazine; Penicillium brasilianum;
cytotoxicities
1. Introduction
In the past decades, marine-derived fungi have attracted more and more attention to medicinal
chemists because of their ability to produce biologically active compounds with diverse structures for
drug discovery [1]. Especially, one fungus species could generate structurally versatile natural products
because it consists of a large number of biosynthetic gene clusters (BGCs) associated with its secondary
metabolism [2,3]. For example, several bioactive compounds have been generated by the same fungus
from different sources, including antifungal diketopiperazine-type alkaloids [4], antibacterial dimeric
diketopiperazines [5], cytotoxic prenyl asteltoxin derivatives [6], and anti-virus highly oxygenated
cyclopiazonic acid-derived alkaloids [7]. However, it has been proven that most of the genes encoding
secondary metabolites in fungi are cryptic under certain culture conditions [8]. In recent years, due to
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the advances in genome sequencing and bioinformatics-based predictions of encoded natural products
in BGCs, it has been enabled to obtain structurally-unique secondary metabolites from fungi with the
assistance of genomic information [8–10].
During our investigation focused on discovering bioactive natural products from marine-derived
fungi [11–14], two known cytotoxic diketopiperazine alkaloids, spirocyclic diketopiperazine
alkaloid (4) [15] and cyclotryprostatin B (5) [16], were discovered from the marine-derived fungus
Penicillium brasilianum HBU-136 by using rice medium in the first large-scaled fermentation. After
gaining these two known diketopiperazine alkaloid derivatives, we tried to locate their BGC in the
genome of the fungus HBU-136. A search of the genome sequence using antiSMASH 4.2 found
that the strain harbors multiple BGCs for non-ribosomal peptide synthetases (NRPS), one of which
shows high similarity to the BGC of fumitremorgins A-C in the fungus Aspergillus fumigatus [17–19].
By gene-to-gene comparisons, it is disclosed that the main difference between the BGC in HBU-136
(ctp) against in Aspergillus fumigatus (ftm) lies at the tailoring genes (Table S2 and Figure S45), which
suggested that the BGC in HBU-136 may having the ability to produce new derivatives. Based on this
information, we tried more fermentation conditions with LC-MS analysis, and finally found three
new indole-diketopiperazines (1−3) from the rice medium with 1.0% MgCl2 fermentation. Herein, we
report the isolation, structural characterization, putative biosynthetic relation and biological activities
of these compounds.
2. Results and Discussion
2.1. Identification and Analysis of the Indole-Diketopiperazine BGC
The whole genome sequence of Penicillium brasilianum HBU-136 was sequenced within HiSeq X10
platform (Illumina, CA, USA) (150 fold) and further assembled into 937 contigs (35.5 Mb) with de novo
assembly software ABySS and SPAdes. For further accurate BGCs mining and comparison, all the
genes were predicted by gene finding software GeneMarks ES/ET and Augustus with self-training.
Then, 50 secondary metabolite gene clusters were proposed by using antiSMASH 4.2 as a gene cluster
mining tool (Table S1). Thereinto, 12 out of the 50 BGCs were described as NRPS, including a BGC
highly homologous to the fumitremorgin BGC (8 out of 9 genes show similarity Table S2) [17–19].
This highly similar gene cluster involved an NRPS gene (ctpNRPS), three cytochrome P450 genes
(ctpP450-1/2/3), one oxmethyltransferase gene (ctpOMT), two prenyltransferase genes (ctpPT-1/2), and
one putative oxidase gene (ctpOx) (Table S2).
By gene-to-gene comparison, it suggested that the proposed gene clusters were consistent well with
the assembly of the dipeptide skeleton for indole-diketopiperazines (Figure 1). The key biosynthetic
step of dipeptide skeleton started from two successive amidation reactions catalyzed by the ctpNRPS
gene and led to the formation of brevianamide F [20,21]. Then ctpPT-1 gene mediated the isopentane
addition and delivered the product directly to ctpP450-2 gene, who catalyzed the tetrahydropyridine
ring formation, or to ctpOMT gene to get the methoxyl first before the ring-formation step [20,21]. The
formed cyclotryprostatin skeleton could be further transformed into spirotryprostatin-type by ctpP450-3
gene via a radical formation and migration eliciting semipinacol-type rearrangement mechanism [22].
P450s, the most versatile biocatalysts in nature, have been proved to catalyze such uncommon reactions
during skeleton constructing processes in many cases [23]. After the core skeletons constructed, the
structural diversity of both spirotryprostatins and cyclotryprostatins mainly come from the tailoring
reactions of ctpP450-3 gene to complete hydroxylation reactions, ctpP450-1 gene to catalyze the benzene
hydroxylation, and ctpOMT gene to mediate the methylation reaction.
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Figure 1. (A) The biosynthetic gene cluster of cyclotryprostatin from Penicillium brasilianum (ctp).
(B) Proposed biosynthetic pathway of the isolated indole-diketopiperazines.
More intriguingly, the gene ctpP450-3, whose corresponding gene in ftm is the multi-functional
gene ftmG, was also inferred to encode a muti-functional P450 according to their sequence identity,
suggesting that new polyhydroxylated indole-diketopiperazines could be generated by the fungal
strain HBU-136. At this point, we tried eight different media conditions (C1–C8) with LC-MS screening
to mine more biosynthetic products for ctp. Guided by HPLC-MS, it was found that three previously
unrecognized compounds exhibiting the typical indole UV spectrum were produced by the strain
HBU-136 when 1.0% MgCl2 was added to rice medium (C-8). According to previous literature, the
addition of MgCl2 into the medium was reported to impact the secondary metabolism [13,24], which
was confirmed once again by our research. Finally, eight indole-diketopiperazines (1–8), including three
new compounds, spirotryprostatin L (1) and cyclotryprostatins F–G (2–3), and five known analogs,
spirocyclic diketopiperazine alkaloid (4) [15], cyclotryprostatin B (5) [16], 20-hydroxycyclotryprostatin
B (6) [25], 12β-hydroxy-13α-ethoxyverruculogen TR-2 (7) [26], and an unnamed compound (8) [27],
were then obtained (Figure 2).
Figure 2. Chemical structures of compounds 1–8.
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2.2. Structure Elucidation
Spirotryprostatin L (1), a yellow amorphous powder, was obtained with the molecular formula
C22H25N3O7 (12 degrees of unsaturation) by positive HRESIMS. The IR absorption bands at 3447 cm−1
and 1647 cm−1 indicated the presences of hydroxyl and carbonyl groups. The characteristic UV
absorption maxima at 220, 249, 287, 387 nm suggested a spirotryprostatin skeleton for 1 [15,16].
The NMR signals in 1 (Tables 1 and 2) were representative of one keto carbonyl (C-3), two amide
carbonyls (C-11 and C-17), one 1,3,4-trisubstituted aromatic unit (C-3a, C-4, C-5, C-6, C-7, and C-7a),
and three methyls (one oxygenated) (6-OCH3, C-22, and C-21). These structural features suggested a
prenylated indole-diketopiperazine nucleus of 1, structurally similar to the known compound 4 which
was previously obtained from the fungus Aspergillus fumigatus [15]. A detailed analysis for HMBC
correlations of 1 (from 12-OH to C-12 and C-13) (Figure 3) indicated that an additional hydroxyl group
[δH 5.14 (1H, brs, 12-OH) and δC 90.2 (C-12)] was attached to C-12. Based on the systematic 2D NMR
data analyses, the plane structure of 1 was determined.
Table 1. 1H NMR Data (δ) of 1–3 (500 MHz, CDCl3, J in Hz).
No. 1 2 3
1 7.86, s 7.97, s
4 7.50, d (8.7) 7.48, d (8.4) 7.58, d (7.6)
5 6.45, dd (8.7, 2.0) 6.80, dd (8.4, 2.0) 7.17, dtd (8.0, 7.6, 0.9)
6 7.17, dtd (8.0, 7.6, 0.9)
7 6.27, d (2.0) 6.86, d (2.0) 7.37, d (7.6)
8 4.70, s 5.02, s 4.79, s
12 4.38, dd (10.7, 6.3)
13 2.35, m 2.40, m 2.50, m
2.27, m 1.98, m 2.01, m
14 2.15, m 2.10, s 2.12, m
2.00, m 1.98, m 2.01, m
15 3.74, m 3.80, m 3.76, m
3.54, m 3.70, m 3.71, m
18 4.83, d (9.5) 6.36, d (9.6) 6.68, d (9.7)
19 4.79, d (9.5) 5.33, d (9.6) 5.57, d (9.7)
21 1.56, s 2.04, s 1.80, s
22 1.79, s 1.77, s 2.07, s
8-OH 4.96, brs
12-OH 5.14, brs
6-OCH3 3.85, s 3.82, s
9-OH 8.51, brs
8-OCH3 3.30, s 3.38, s
 
Figure 3. 1H-1H COSY and key HMBC correlations of 1 and 2. In order to assign the relative
configuration of 1, its NOESY experiment was carried out.
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Table 2. 13C NMR Data (δ) of 1–3 (125 MHz, CDCl3).
No. 1 2 3
2 75.0, C 132.7, C 135.2, C
3 200.6, C 104.8, C 105.7, C
3a 112.4, C 122.5, C 128.5, C
4 127.4, CH 118.9, CH 118.2, CH
5 110.8, CH 110.1, CH 120.7, CH
6 169.7, C 156.6, C 122.3, CH
7 94.9, CH 95.3, CH 111.3, CH
7a 165.4, C 137.1, C 135.9, C
8 73.9, CH 74.9, CH 76.8, CH
9 86.1, C 85.7, C 84.9, C
11 167.4, C 166.3, C 167.2, C
12 90.2, C 86.7, C 60.1, CH
13 35.1, CH2 36.5, CH2 29.8, CH2
14 21.3, CH2 19.2, CH2 22.3, CH2
15 45.3, CH2 45.4, CH2 46.0, CH2
17 166.0, C 165.9, C 166.0, C
18 55.7, CH 49.3, CH 49.2, CH
19 119.4, CH 122.8, CH 123.6, CH
20 142.4, C 138.2, C 138.2, C
21 26.1, CH3 18.4, CH3 26.2, CH3
22 18.8, CH3 26.1, CH3 18.4, CH3
6-OCH3 56.0, CH3 55.8, OCH3
8-OCH3 57.0, OCH3 56.8, OCH3
The NOESY correlations of 1 between H-7 and 8-OH, 8-OH and 9-OH, 9-OH and 12-OH, 12-OH
and H-18, and H-8 and H-19 (Figure 4) suggested that H-18, 8-OH, 9-OH, and 12-OH were located
on the same face of the molecule, and H-7 had a cis relationship with 8-OH/9-OH/12-OH/H-18. The
electronic circular dichroism (ECD) spectrum of 1 was tested and calculated to investigate the absolute
configuration of 1. Time-dependent density functional theory (TD-DFT) method was used for ECD
calculation of the molecule (2S,8S,9R,12R,18S)-1 at the B3LYP/6-311++G(2d,p)//B3LYP/6-311+G(d)
level. Boltzmann statistics with a standard deviation of σ 0.3 eV was used for the ECD simulation.
The calculated ECD spectrum of (2S,8S,9R,12R,18S)-1 was in good accordance with the experimental
ECD data of 1 (Figure 5), revealing that the absolute configuration of 1 should be 2S,8S,9R,12R,18S.
Additionally, the above conclusion was verified by the fact that the experimental ECD spectrum and the
specific optical rotation (OR) value of 1 were similar to those of 4 ([α]D20 = + 144.6 (c 1.00, MeOH) for 1
vs. [α]D20 = + 147.2 (c 0.1, CHCl3) for 4) [15]. Thus, compound 1 was defined as a 12-hydroxylation
derivative of 4.
 
Figure 4. The key NOESY correlations of 1.
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Figure 5. Experimental ECD of 1 and 4, and calculated ECD of (2S,8S,9R,12R,18S)-1.
Cyclotryprostatin F (2) was also obtained as a yellow amorphous powder, whose molecular
formula was deduced as C23H27N3O6 from HRESIMS. The NMR data of 2 (Table 1; Table 2) suggested
that it also possessed a diketopiperazine skeleton, which was considered similar to the known
compound 5 [16] through detailed NMR analyses of them. Combining the upfield shifted C-11 (δC
166.3 in 2; δC 167.0 in 5) and C-14 (δC 19.2 in 2; δC 22.1 in 5), and downfield shifted C-12 (δC 86.7 in 2;
δC 59.9 in 5) and C-13 (δC 36.5 in 2; δC 29.7 in 5) of 2 with the change of the molecular weight from 5 to
2 suggested that 2 was a 12-hydroxylation derivative of 5. This deduction could be confirmed by the
key HMBC correlations from H-13 and H-15 to C-12 in 2 (Figure 3). Similar 1H-1H coupling constants,
NOESY correlations and ECD Cotton effects (Figure 6) of 2 and 5 implied that 2 had the 8S,9S,12R,18S
absolute configuration, which was also confirmed by TD-DFT ECD calculation of (8S,9S,12R,18S)-2.
 
Figure 6. Experimental ECD of 2, 3 and 5, and calculated ECD of (8S,9S,12R,18S)-2.
Cyclotryprostatin G (3) was also isolated as an analog of 5, deduced from the similar NMR data of
them. Compound 3 was the demethylation derivative of 5 at C-6, which was verified by 1H-1H COSY
(H-4/H-5/H-6/H-7) and HMBC (H-6 and C-4, and H-6 and C-7a) experiments for 3. The stereochemistry
of 3 was suggested to be 8S,9S,12S,18S by comparing the NOESY and ECD spectra of 3 to those of 5
(Figure 6).
It is deduced that, the newborn OH-12 in 1 and 3 may be catalyzed by the multi-functional P450
ctpP450-3 (Figure 1). And the new formed OMe-8 in 23 may be introduced by the methyltransferase
encoded gene ctpOMT or other genes outside the reported boundary, or they were formed during our
isolation processes.
2.3. Biological Activities Screening
It has been reported that many indole-diketopiperazine derivatives displayed a wide range of
biological effects, such as cytotoxic [16,28] andantibacterial activities [29]. In the present study, all of
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the isolated compounds (1–8) were tested for their cytotoxic and antibacterial activities. Among them,
1 and 4 displayed selective cytotoxicities against HL-60 cell line with the IC50 values of 6.0 and 7.9 μM,
respectively. Whereas compounds 2, 3, and 5 exhibited activities against MCF-7 cell line with the IC50
values of 7.6, 10.8, and 5.1 μM, respectively. However, all of the metabolites appeared to be inactive in
antibacterial and antifungal assays (MIC > 25 μM).
3. Materials and Methods
3.1. Instrumentation
Optical rotations were measured on a JASCO P-1020 digital polarimeter (Jasco Corp., Tokyo,
Japan). UV spectra were recorded on a Thermo Scientific Multiskan GO microplate spectrophotometer
(Thermo Scientific Co., Waltham, MA, USA) in MeOH. ECD spectra were recorded on a JASCO J-815
circular dichroism spectrometer (JASCO Electric Co., Ltd., Tokyo, Japan). IR spectra were determined
on a Nicolet-Nexus-470 spectrometer (Thermo Electron Co., Madison, WI, USA) using KBr pellets. 1D
and 2D NMR spectroscopic data (TMS as an internal standard) were acquired on Agilent DD2-500
(JEOL, Tokyo, Japan) and Bruker AV-600 NMR spectrometer (Bruker BioSpin GmbH Co., Rheinstetten,
Germany). ESIMS and HRESIMS spectra were obtained from a Micromass Q-TOF spectrometer
(Waters Corp., Manchester, UK), and a Thermo Scientific LTQ Orbitrap XL spectrometer (Thermo
Fisher Scientific, Bremen, Germany). Semipreparative HPLC was performed on a Shimadzu LC-20 AT
system using a RP-C18 (Waters, 5 μm, 10 × 250 mm) column.
3.2. Genome Sequencing and Bioinformatics Analysis
The fungus Penicillium brasilianum HBU-136 was cultured in PDB medium for 30 h at 25 ◦C,
then high-quality genomic DNA was isolated from cultured cells using Fungal DNA Kit (OMEGA
Bio-Tek, E.Z.N.A.®, (Norcross, GA, USA). All the purified DNA was used to construct 350 bp DNA
library with DNA library preparation kit (Illumina, CA, USA), and was sequenced on HiSeq X10
instrument, employing paired-end 150 base reads (Mega genomics, CN). De novo assembling of the draft
genome was performed by using the software ABySS 2.15 (Vancouver, NA, Canada) and SPAdes 3.11
(St. Petersburg, EU, Russia), with multiple k-mers specified as “-k 33,55,77,99,117” and coverage fold of
160X PE clean reads. All the assemble scaffold sequences were tested by quality assessment tool QUAST
4.0, the last draft genome sequence was filtered by over 500 bp and was determined via the largest N50
number. Gene functions were proposed by the online BLAST program (http://blast.ncbi.nlm.nih.gov/)
and Conserved Domain Database (CDD) at the NCBI server (https://www.ncbi.nlm.nih.gov/). This
Whole Genome Shotgun project of the fungus HBU-136 has been deposited at DDBJ/ENA/GenBank
under the accession SSWP00000000. The version described in this paper is version SSWP01000000.
3.3. Fungal Material
The fungus Penicillium brasilianum HBU-136 was collected from the Bohai Sea (Huanghua, Hebei
Province, China, June 2016). The strain with the NCBI GenBank accession number MH377073 was
deposited in the College of Pharmaceutical Sciences, Hebei University, China.
3.4. Fermentation and Purification
The first fermentation was carried out for the fungus HBU-136 using rice medium (80 mL water
and 80 g rice in 1 L Erlenmeyer flasks, 40 flasks) at 28 ◦C for 45 days. After cultivation, the fermented
rice substrate was extracted with the mixture of CH2Cl2/MeOH (1:1, 500 mL for each flask) for five
times and EtOAc for two times successively. The two extract solvents were combined as their TLC
profiles were almost the same. The combined extract was concentrated to give a residue (30 g), which
was further subjected to silica gel column chromatography (CC), eluting with an EtOAc−petroleum
ether stepped gradient elution (0%, 20%, 40%, 60%, 80%, 100%), to offer six fractions Fr.1−Fr.6. Fr.5
was separated by twice Sephadex LH-20 CC [petroleum ether−MeOH−CHCl3 (v/v, 2:1:1)] to afford
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four subfractions Fr.5-1−Fr.5-4. Then, Fr.5-3 was fractionated by Sephadex LH-20 CC [MeOH−CHCl3
(v/v, 1:1)] and silica gel CC (stepped gradient, EtOAc−petroleum ether), and further purified by
semi-preparative HPLC (MeOH−H2O, 50:50, 2 mL/min) to afford 4 (3.1 mg) and 5 (6.7 mg).
The second large-scale fermentation (100 flasks) for the fungus HBU-136 was performed for 45 days
in a modified rice medium (including 80 mL water, 80 g rice, and 0.8 g MgCl2 in 1 L Erlenmeyer flask).
The extract was obtained and purified by the same approaches as first fermentation. Compounds 1
(1.8 mg), 4 (5.2 mg), 5 (4.8 mg), 7 (1.5 mg), and 8 (6.2 mg) were given from fraction Fr.5. Compounds 2
(4.0 mg), 3 (3.2 mg), and 6 (4.3 mg) were isolated from fraction Fr.6.
Spirotryprostatin G (1): Yellow amorphous powder; [α]20D = + 44.6 (c 1.00, MeOH); UV (MeOH) λmax
(log ε) 204 (4.05), 220 (4.02), 249 (3.96), 287 (3.77), 387 (3.17) nm; CD (0.75 mM, MeOH) λmax (Δε) 201
(+20.7), 219 (−4.3), 239 (−3.4), 252 (−10.9), 327 (+0.16) nm; IR (KBr) vmax 3447, 2360 and 1647 cm−1; 1H
and 13C NMR, see Table 1; Table 2; HRESIMS m/z 444.1757 [M + H]+ (calcd for C22H26N3O7, 444.1765
[M + Na]+), 466.1578 [M + Na]+ (calcd for C22H25N3O7Na, 466.1585 [M + Na]+).
Cyclotryprostatin F (2): Yellow amorphous powder; [α]20D = + 108 (c 1.00, MeOH); UV (MeOH) λmax
(log ε) 220 (4.30), 290 (3.70) nm; CD (0.75 mM, MeOH) λmax (Δε) 213 (+13.8), 230 (+8.6), 266 (+5.6),
319 (−0.01) nm; 1H and 13C NMR, see Table 1; Table 2; HRESIMS m/z 440.1837 [M − H]− (calcd for
C23H26N3O6, 440.1827 [M − H]−).
Cyclotryprostatin G (3): Yellow amorphous powder; [α]20D = + 101 (c 0.95, MeOH); UV (MeOH) λmax
(log ε) 223 (4.45), 272 (3.93) nm; CD (1.05 mM, MeOH) λmax (Δε) 195 (−8.1), 208 (+11.2), 228 (+5.7), 258
(+3.2), 298 (+0.2) nm; 1H and 13C NMR, see Table 1; Table 2; HRESIMS m/z 418.1737 [M + Na]+ (calcd
for C22H25N3O4Na, 418.1737 [M + Na]+).
3.5. Biological Assay
Cytotoxic Assay. The cytotoxic activity of compounds 1–8 were evaluated in vitro by the MTT
method [30], with the concentration of 10 μM. Three human tumor cell lines were used, including
human promyelocytic leukemia cell line (HL-60), human colorectal cancer cell line (HCT-116), and
human breast cancer cell line (MCF-7), with cisplatinum (DDP) as a positive control.
Antibacterial Assay. The antibacterial activity of the isolated compounds was determined
using the conventional broth dilution assay [31] with ciprofloxacin (CIP) as a positive
control. Sixteen pathogenic bacterial strains were used, including Bacillus megaterium,
Bacillus subtilis, Escherichia coli, Bacillus anthraci, Bacillus cereus, Bacterium paratyphosum B,
Enterobacter aerogenes, Micrococcus lysodeikticus, Micrococcus luteus, Proteusbacillm vulgaris,
Shigella dysenteriae, Psmdomonas aeruginosa, Staphylococcus aureus, Salmonella typhi, Vibrio anguillarum,
and Vibrio parahemolyticus. The concentration of compounds 1–8 was 25 μM.
3.6. ECD Spectrum Measurement and Calculation
The tested compounds 1–5 were dissolved in chromatographic methanol at the concentration of
0.5 mg/mL and transferred 300 μL to quartz cuvette (1 cm for width) for tested. First tested the ECD
spectrum of methanol as the blank control, then tested for compounds 1–5. The wavelength was set at
190–400 nm with the band width of 1 nm, and Nitrogen should be used throughout the experiment
at the flow rate of 3 mL/min. The ECD spectrum was calculated by the TDDFT methodology with a
larger basis set at the B3LYP/6-311++G(2d,p) level and simulated using SpecDis 1.62 [32] according to
Boltzmann distributions.
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4. Conclusions
In summary, three new indole-diketopiperazine derivatives (1–3) showed selective cytotoxicities
have been obtained from the marine-derived fungus P. brasilianum HBU-136 with the aid of genomic
analysis. ECD quantum chemistry calculations were carried out to assign the absolute configurations
of the new compounds 1–3. The present research indicated that it is a powerful approach to
discover new natural products from marine-derived fungi by the combination of chemical and
bioinformatics analyses.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/17/9/514/s1,
NMR and MS data of 1–8; Supplementary tables and figures for BGC analyses; tables for biological assay.
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Abstract: Two new spiro-heterocyclic γ-lactam derivatives, cephalimysins M (1) and N (2), were isolated
from the fermentation cultures of the marine-derived fungus Aspergillus fumigatus CUGBMF17018.
Two known analogues, pseurotin A (3) and FD-838 (4), as well as four previously reported helvolic
acid derivatives, 16-O-propionyl-16-O-deacetylhelvolic acid (5), 6-O-propionyl-6-O-deacetylhelvolic
acid (6), helvolic acid (7), and 1,2-dihydrohelvolic acid (8) were also identified. One-dimensional (1D),
two-dimensional (2D) NMR, HRMS, and circular dichroism spectral analysis characterized the structures
of the isolated compounds.
Keywords: marine-derived Aspergillus fumigatus; spiro-heterocyclic γ-lactam; cephalimysins
1. Introduction
Marine-derived fungi are important resources of structurally and biologically diverse secondary
metabolites in drug discovery [1–6]. A series of novel marine natural compounds have been isolated from
marine-derived fungi of Aspergillus fumigatus strains, such as E-β-trans-5,8,11-trihydroxybergamot-9-ene
and β-trans-2β,5,15-trihydroxybergamot-10-ene [7], diketopiperazines [8,9], indole alkaloids [10],
fumigaclavine C [11], fumiquinazoline K [12], and gliotoxin analogues [13]. During our ongoing
efforts to search for new bioactive metabolites from marine-derived fungi, an Aspergillus fumigatus
strain CUGBMF170049 was isolated from a sediment sample that was collected from the Bohai Sea,
China. Chemical investigations on an EtOAc-MeOH extracted fraction of its solid fermentation cultures
resulted in the characterization of two new spiro-heterocyclic γ-lactam derivatives, cephalimysins M
(1) and N (2), along with two known analogues, pseurotin A (3) [14], and FD-838 (4) [15], as well
as four previously reported helvolic acid derivatives, 16-O-propionyl-16-O-deacetylhelvolic acid (5),
6-O-propionyl-6-O-deacetylhelvolic acid (6) [16], helvolic acid (7), and 1,2-dihydrohelvolic acid (8) [17]
(Figure 1). Herein, we report the isolation and structural determination of the new compounds 1
and 2. The antibacterial activities of the compounds were also investigated against a panel of both
Gram-positive and Gram-negative bacteria, Mycobacterium bovis bacillus Calmette Guérin (BCG) and
Candida albicans. Compounds 5–7 showed significant antibacterial activities against both Staphylococcus
aureus and methicillin resistant S. aureus.
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Figure 1. Chemical structures of 1–8.
2. Results
2.1. Structure Elucidation
Compound 1 was obtained as pale yellow amorphous powder. Its molecular formula was
determined as C22H27NO7 by HRESIMS m/z 440.1684 [M +Na]+ (calcd. for C22H27NO7Na 440.1680,
Δmmu + 0.4) (Figure S1 in Supplementary Materials), which accounted for ten degrees of unsaturation.
The 1H, 13C, and HSQC NMR spectra (Figures S2–S4 in Supplementary Materials) of compound
1 showed signals of two ketone carbonyls at δC 196.7 (C-4) and 196.4 (C-17), one amide carbonyl
at δC 166.4 (C-6), a mono-substituted benzene ring (δC 133.4, δC 130.3/δH 8.25, δC 128.4/δH 7.53,
δC 133.9/δH 7.64, δC 128.4/δH 7.53, 130.3/δH 8.25), two sp2 quaternary carbons at δC 188.5 (C-2) and
109.6 (C-3), four sp3 methylenes (δC 34.4/δH 1.64, δC 31.1/δH 1.24, δC 24.1/δH 1.37, and δC 22.0/δH 1.24),
two sp3 oxygenated methines (δC 74.9/δH 4.38 and δC 67.0/δH 4.50), two sp3 oxygenated quaternary
carbons at δC 91.2 (C-5) and δC 92.5 (C-8), and three methyls (δC 13.9/δH 0.84, δC 5.4/δH 1.64, and
δC 51.7/δH 3.24) (Table 1). A comparison of 1H and 13C NMR data for compound 1 (Table 1) with those
of previously reported pseurotin A (3) [14] revealed many similarities in their chemical structures,
except for the oxygenated unsaturated side chain of 3 had been substituted with an oxygenated
saturated fatty chain in 1. Compound 1 had the same skeleton as that of pseurotin A, while the side
chain of 1 is an oxygenated saturated fatty chain. The COSY correlations (Figure 2, and Figure S5 in
Supplementary Materials) from H-19 (δH 8.25) to H-23 (δH 8.25), through H-20 (δH 7.53), H-21 (δH 7.64)
and H-22 (δH 7.53) identified the mono-substituted benzene ring. Likewise, the fatty acid side chain was
confirmed by COSY correlations from H-10 (δH 4.50) to H3-15 (δH 0.84), through H-11 (δH 1.64), H-12
(δH 1.37), H-13 (δH 1.24), and H-14 (δH 1.24). The lactam ring was evidenced by the HMBC correlations
(Figure 2, and Figure S6 in Supplementary Materials) from H-9-OH (δH 6.34) to C-5 (δC 91.2), C-8
(δC 92.5), and C-9 (δC 74.9), as well as from H-7-NH (δH 9.90) to C-5 (δC 91.2), C-6 (δC 166.4), C-8
(δC 92.5), and C-9 (δC 74.9). The phenylmethanone moiety was confirmed by the HMBC crossing peaks
from H-19 (δH 8.25) and H-23 (δH 8.25) to C-17 (δC 196.4), and the connection from C-8 (δC 92.5) to C-17
(δC 196.4) was revealed by the HMBC correlation from H-9 (δH 4.38) to C-17 (δC 196.4). The HMBC
correlation from H3-24 (δH 3.24) to C-8 (δC 92.5) confirmed the methoxy at C-8. The connection from
C-10 to C-4 through C-2 and C-3 was confirmed by the HMBC correlations from H-10-OH (δH 5.62) to
C-10 (δC 67.0) and C-2 (δC 188.5), from H-10 (δH 4.50) to C-2 (δC 188.5) and C-3 (δC 109.6), as well as
from H3-16 (δH 1.64) to C-2 (δC 188.5), C-3 (δC 109.6), and C-4 (δC 196.7). In addition, the spirobicyclic
moiety was suggested by the HMBC correlation from H-9 (δH 4.38) to C-4 (δC 196.7), the chemical
shift of C-5 (δC 91.2) and the molecular formula. The cis configurations of 8-OCH3 and 9-OH were
supported by the chemical shift of H-9 and the coupling constant (δH 4.38, J = 9.0 Hz) between H-9
and 9-OH [15,18]. The circular dichroism (CD) spectrum (Figure S7 in Supplementary Materials) of 1
showed negative Cotton effects at around 230, 280, and 345 nm, and positive Cotton effects at around
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250 and 310 nm, which were consistent with the reported CD data for pseurotin A [18]. Thus, the
structure of compound 1 was established, as shown in Figure 1, and was named cephalimysin M,
its absolute configurations for C-5, C-8, and C-9 being assigned the same as those of pseurotin A.
The absolute configuration of C-10 was not defined.
Table 1. NMR data for 1 and 2 (DMSO-d6).
Position
1 2
δC, Type δH, mult (J in Hz) δC, Type δH, mult (J in Hz)
2 188.5, C 172.2, C
3 109.6, C 111.6, C
4 196.7, C 193.4, C
5 91.2, C 92.1, C
6 166.4, C 166.4, C
8 92.5, C 92.6, C
9 74.9, CH 4.38, d (9.0) 75.0, CH 4.50, s
10 67.0, CH 4.50, td (7.2, 5.4) 141.8, C
11 34.4, CH2 1.64, m (overlap) 120.0, CH 7.40, d (3.6)
12 24.1, CH2 1.37, m 108.6, CH 6.52, d (3.6)
13 31.1, CH2 1.24, m 163.4, C
14 22.0, CH2 1.24, m 21.0, CH2 2.76, q (7.8)
15 13.9, CH3 0.84, t (7.2) 11.8, CH3 1.22, t (7.8)
16 5.4, CH3 1.64, s 50.2, CH2 4.25, s
17 196.4, C 196.4, C
18 133.4, C 133.4, C
19 130.3, CH 8.25, dd (8.4, 1.2) 130.4, CH 8.27, d (7.2)
20 128.4, CH 7.53, ddd (8.4, 8.4, 1.2) 128.4, CH 7.53, dd (7.2, 7.2)
21 133.9, CH 7.64, dddd (8.4, 8.4, 1.2, 1.2) 133.9, CH 7.67, dd (7.2, 7.2)
22 128.4, CH 7.53, ddd (8.4, 8.4, 1.2) 128.4, CH 7.53, dd (7.2, 7.2)
23 130.3, CH 8.25, dd (8.4, 1.2) 130.4, CH 8.27, d (7.2)
24 51.7, CH3 3.24, s 51.7, CH3 3.26, s
7-NH 9.90, s 9.98, s
9-OH 6.34, d (9.0)
10-OH 5.62, d (5.4)
Figure 2. Key two-dimensional (2D) NMR correlations for 1 and 2.
Compound 2 was obtained as pale yellow amorphous powder. Its molecular formula was
determined as C22H21NO8 by HRESIMS m/z 450.1159 [M +Na]+ (calcd. for C22H21NO8Na 450.1159,
Δmmu 0) (Figure S8 in Supplementary Materials), which accounted for thirteen degrees of unsaturation.
The 1H, 13C, and HSQC NMR spectra (Figures S9–S11 in Supplementary Materials) of compound 2
showed signals of two ketone carbonyls at δC 193.4 (C-4) and 196.4 (C-17), one amide carbonyl at δC 166.4
(C-6), a mono-substituted benzene ring (δC 133.4, δC 130.4/δH 8.27, δC 128.4/δH 7.53, δC 133.9/δH 7.67,
δC 128.4/δH 7.53, δC 130.4/δH 8.27), two sp2 methines (δC 120.1/δH 7.40, δC 108.6/δH 6.52), four sp2
quaternary carbons at δC 172.2 (C-2), 111.6 (C-3), 141.8 (C-10), and 163.4 (C-13), one sp3 methylene
(δC 21.0/δH 2.76), one sp3 oxygenated methylene (δC 50.2/δH 4.25), one sp3 oxygenated methine
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(δC 75.0/δH 4.50), two sp3 oxygenated quaternary carbons (δC 92.1 and δC 92.6), and two methyls
(δC 11.8/δH 1.22 and δC 51.7/δH 3.26) (Table 1). A comparison of 1H and 13C NMR data for compound 2
(Table 1) with that of the previously reported FD-838 (4) [15] revealed many similarities. Compound
2 had the same skeleton as that of FD-838, while methyl at C-3 of compound 4 was replaced by an
oxygenated methylene in compound 2. The mono-substituted benzene ring was identified by the
COSY correlations (Figure 2, and Figure S12 in Supplementary Materials) from H-19 (δH 8.27) to
H-23 (δH 8.27), through H-20 (δH 7.53), H-21 (δH 7.67), and H-22 (δH 7.53), and the furan side chain
was characterized by COSY correlations between H-11 (δH 7.40) and H-12 (δH 6.52), and between
H2-14 (δH 2.76) and H3-15 (δH 1.22), along with the HMBC correlations (Figure 2, and Figure S13 in
Supplementary Materials) from H3-15 to C-13, and from H2-14 to C-12 and C-13. The lactam ring
was suggested by the HMBC correlations from H-9 (δH 4.50) to C-5 (δC 92.1) and C-8 (δC 92.6), as
well as from H-7-NH (δH 9.98) to C-5 (δC 92.1), C-8 (δC 92.6) and C-9 (δC 75.0). HMBC crossing peaks
from H-19 (δH 8.27) and H-23 (δH 8.27) to C-17 (δC 196.4) confirmed the phenylmethanone moiety, and
the connection from C-8 (δC 92.6) to C-17 (δC 196.4) was revealed by the HMBC correlation from H-9
(δH 4.50) to C-17 (δC 196.4). The methoxy at C-8 was also confirmed by the HMBC correlation from
H3-24 (δH 3.26) to C-8 (δC 92.6). The spirobicyclic moiety was indicated by the HMBC correlation from
H-9 (δH 4.50) to C-4 (δC 193.4) and the chemical shift of C-5 (δC 92.1). The ROESY correlations (Figure 2,
and Figure S14 in Supplementary Materials) from H-9 (δH 4.50) to H-19 (δH 8.27) and H-23 (δH 8.27)
indicated the relative configurations of C-8 and C-9. The chemical shifts of C-5, C-8, and C-9 for 2 were
much closer to those of 1 and FD-838 [15], which defined the relative configurations of C-5, C-8, and
C-9. The circular dichroism (CD) spectrum (Figure S15 in Supplementary Materials) of 2 showed a
negative Cotton effect at around 318 nm and a positive Cotton effect at around 355 nm, which were
consistent with the reported CD data for FD-838 [15]. Therefore, the structure of compound 2 was
established, as shown in Figure 1, where absolute configurations were assigned the same as those of
FD-838 and named cephalimysin N.
In addition to compounds 1 and 2, known compounds were also identified in the fermentation
products, such as pseurotin A (3) [14], FD-838 (4) [15], as well as four known helvolic acid derivatives,
16-O-propionyl-16-O-deacetylhelvolic acid (5), 6-O-propionyl-6-O-deacetylhelvolic acid (6) [16],
helvolic acid (7), and 1,2-dihydrohelvolic acid (8) [17].
2.2. Biological Activity
Compounds 1–8 were tested against Gram positive bacteria S. aureus (ATCC 6538) and methicillin
resistant S. aureus (MRSA) (ATCC 29213), Gram negative bacteria Escherichia coli (ATCC 11775) and
Pseudomonas aeruginosa (ATCC 15692), BCG, and C. albicans. Compounds 5–7 showed antibacterial
activities against both S. aureus and MRSA. Comparing the antibacterial activities of compounds 5–7
with the inactive analogue 8 indicated that the α,β-unsaturated ketone appears to be a key functional
group for antibacterial activity (Table 2). None of the isolated compounds exhibited antimicrobial
activities against E. coli, P. aeruginosa, C. albicans (MIC > 100 μg/mL), nor BCG (MIC > 10 μg/mL).
Table 2. Antimicrobial activities of 1–8 (μg/mL).









a Vancomycin was used as positive control with MIC value of 0.78 μg/mL.
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3. Materials and Methods
3.1. General Experimental Procedures
The optical rotations ([α]D) were measured on Anton Paar MCP 200 Modular Circular Polarimeter
(Austria) in a 100× 2 mm cell at 22 ◦C. CD spectra were recorded on an Applied Photophysics Chirascan
spectropolarimeter (UK). NMR spectra were obtained on a Bruker Avance DRX600 spectrometer with
residual solvent peaks serving as references (DMSO-d6: δH 2.50, δC 39.52). High-resolution ESIMS
measurements were obtained on a Bruker micrOTOF mass spectrometer by direct infusion in MeCN
at 3 mL/min using sodium formate clusters as an internal calibrate. HPLC was performed using an
Agilent 1200 Series separation module that was equipped with Agilent 1200 Series diode array and
Agilent 1260 Series fraction collector, and Agilent SB-C18 column (250 × 9.4 mm, 5 μm).
3.2. Fungal Material
The Aspergillus fumigatus strain CUGBMF170049 was isolated from a sediment sample that was
collected from the Bohai Sea, China and grown on a potato dextrose agar plate at 28 ◦C. This strain was
identified as Aspergillus fumigatus based on DNA sequence analysis of its internal transcribed spacer
(ITS) region (Figure S16) (GenBank accession number MK453215) using a conventional primer pair of
ITS5 (5′-GGAAGTAAAAGTCGTAACAAGG-3′) and ITS4 (5′-TCCTCCGCTTATTGATATGC-3′).
3.3. Fermenttion and Extraction
A small spoonful of Aspergillus fumigatus (CUGBMF170049) spores growing on a potato dextrose
agar slant was inoculated into four 250 mL conical flasks, each containing 40 mL of liquid medium
consisting of potato infusion (20%), glucose (2.0%), artificial sea salt (3.5%), and distilled water.
The flasks were incubated at 28 ◦C for 3 d on a rotary shaker at 160 rpm. An aliquot (5 mL) of the
resultant seed culture was inoculated into teen 1 L conical flasks, with each containing solid medium
consisting of rice (120 g) and artificial seawater (3.5%; 80 mL), and the flasks were incubated stationary
for 30 days at 28 ◦C. The cultures were extracted three times by EtOAc:MeOH (80:20), and the combined
extracts were reduced to dryness in vacuo and the residue was partitioned between EtOAc and H2O.
Subsequently, the EtOAc layer was dried in vacuo to yield a dark residue (11.3 g).
3.4. Isolation and Purification
The EtOAc fraction was fractionated by a reduced pressure silica gel chromatography (50 × 80 mm
column, TLC H silica) using a stepwise gradient of 50–100% hexane/CH2Cl2 and then 0–100%
MeOH/CH2Cl2 to afford 15 fractions. Fraction C was fractionated on a Sephadex LH-20 column
(600 × 30 mm) while using an isocratic elution of hexane:CH2Cl2:MeOH (5:5:1) to give five subfractions
(F1–F5). Subfraction F3 (102.3 mg after drying in vacuo) was further fractionated by HPLC (Agilent
Zorbax SB-C18 250 × 9.4 mm, 5 μm column, 2.0 mL/min, isocratic 65% MeOH/H2O) to yield FD-838 (4;
tR 10.4 min, 3.3 mg). Fraction J was fractionated on a Sephadex LH-20 column (600 × 30 mm) using an
isocratic elution of CH2Cl2:MeOH (2:1), to give four subfractions (F1–F4). Subfraction F1 was further
fractionated by HPLC (Agilent Zorbax SB-C18 250 × 9.4 mm, 5 μm column, 2.0 mL/min, isocratic
65% MeOH/H2O) to yield helvolic acid (7, tR 10.8 min, 1.3 mg), 16-O-propionyl-16-O-deacetylhelvolic
acid (5, tR 11.9 min, 1.2 mg), and 6-O-propionyl-6-O-deacetylhelvolic acid (6, tR 12.4 min, 1.4 mg).
Fraction K was fractionated on a Sephadex LH-20 column (600 × 30 mm) using an isocratic elution of
CH2Cl2:MeOH (2:1) to give five subfractions (F1–F5). Subfraction F3 was further fractionated by HPLC
(Agilent Zorbax SB-C18 250 × 9.4 mm, 5 μm column, 2.0 mL/min, isocratic 65% MeOH/H2O) to yield
1,2-dihydrohelvolic acid (8, tR 13.9 min, 1.6 mg). Fraction L was fractionated on a Sephadex LH-20
column (600 × 30 mm) using an isocratic elution of CH2Cl2:MeOH (2:1) to give five subfractions (F1–F5).
Subfraction F4 was further fractionated by an ODS column, which was eluted by a stepwise gradient
(0–100% MeOH/H2O) to afford five subfractions (F1–F5). Subfraction F4 was further fractionated by
HPLC (Agilent Zorbax SB-C18 250 × 9.4 mm, 5 μm column, 2.0 mL/min, isocratic 65% MeOH/H2O) to
82
Mar. Drugs 2019, 17, 289
yield pseurotin A (3, tR 7.1 min, 3.2 mg), cephalimysins M (1, tR 12.0 min, 1.5 mg), and N (2, tR 8.9 min,
3.6 mg).
3.4.1. Cephalimysin M (1)
Pale yellow amorphous powder; [α]22D –21.3 (MeOH, 0.1); UV (MeOH) λmax (logε) 196 (4.43), 254
(4.14), 277(3.96) nm; (+)-ESIMS m/z 418.1 [M +H]+; (+)-HRESIMS m/z 440.1684 [M +Na]+ (calcd. for
C22H27NO7Na 440.1680); 1H and 13C NMR data: See Table 1.
3.4.2. Cephalimysin N (2)
Pale yellow amorphous powder; [α]22D –21.5 (MeOH, 0.1); UV (MeOH) 197 (4.43), 252 (4.12),
329(3.56) nm; (+)-ESIMS m/z 428.0 [M + H]+; (+)-HRESIMS m/z 450.1159 [M + Na]+ (calcd. for
C22H21NO8Na 450.1159); 1H and 13C NMR data: See Table 1.
3.5. Antimicrobial Assays
The antimicrobial assays were performed according to the Antimicrobial Susceptibility Testing
Standards that were outlined by the Clinical and Laboratory Standards Institute (CLSI) against S. aureus
ATCC 6538, MRSA ATCC 29213, E. coli ATCC 11775, P. aeruginosa ATCC 15692, and C. albicans ATCC
10231 based on a 96 well microplate format in liquid growth. Briefly, the bacteria from glycerol stocks
was inoculated on LB agar plate and cultured overnight at 37◦C. The glycerol stock of C. albicans was
prepared on Sabouraud dextrose agar at 28 ◦C for 24 h. Afterwards, single colonies were picked and
adjusted to approximately 104 CFU/mL with Mueller–Hinton Broth as bacterial suspension and with
RPMI 1640 media as fungal suspension. 2 μL of two-fold serial dilution of each compound (in DMSO)
were added to each row on 96-well microplate, containing 78 μL of bacterial or fungal suspension in
each well. (Vancomycin and Ciprofloxacin were used as positive controls; Amphotericin B was used as
positive for fungi; DMSO as negative control). The 96-well plate was aerobically incubated at 37 ◦C for
16 h. The 96-well plate of antifungal was aerobically incubated at 35 ◦C for 24 h. Here, MIC is defined
as the minimum concentration of compound at which no bacterial growth is observed.
3.6. Anti-Bacillus Calmette Guérin (BCG) Assay
The anti-BCG assay was carried out by using a constitutive GFP expression strain (pUV3583c-GFP),
according to previous published procedure (isoniazid was used as positive control with MIC value of
0.05 μg/mL) [19]. The concentrations for the tested compounds were from 0.156 to 10 μg/mL by using
two-fold diluted solutions.
4. Conclusions
As part of our ongoing research program to discover novel secondary metabolites from the marine
environment, eight compounds were isolated from the rice solid medium culture of the marine derived
fungus CUGBMF170049 isolated from a sediment sample that was collected from the Bohai Sea, China.
Two novel compounds (1 and 2) were isolated and characterized along with the previously reported
analogues pseurotin A (3) and FD-838 (4), as well as four known helvolic acid derivatives, namely
16-O-propionyl-16-O-deacetylhelvolic acid (5), 6-O-propionyl-6-O-deacetylhelvolic acid (6), helvolic
acid (7), and 1,2-dihydrohelvolic acid (8). All of the structures were confirmed by detailed analysis of
the spectroscopic data. Compounds 5–7 showed antibacterial activity against both S. aureus and MRSA.
Aanalogue 8 did not exhibit antibacterial activities that indicated that the α,β-unsaturated ketone of
5–7 is the key functional group for antibacterial activity. Structurally, cephalimysins M (1) and N (2)
belong to a family of rare natural products with diverse biological activities, which contain an unusual
spiro-heterocyclic γ-lactam core. To the best of our knowledge, 28 natural products of this family have
been reported, including pseurotin A [14], 8-O-demethylpseurotin A [20] pseurotins A1 and A2 [18,21],
pseurotins B – E [22], pseurotins F1 and F2 [23], 14-norpseurotin A [24] synerazol [25], azaspirene [26],
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azaspirofurans A and B [27], and FD-838 and cephalimysins A–L [15,28,29]. 2 is the first cephalimysin
analogue where the methyl of C-16 was oxidized to hydroxymethyl. The current research diversifies
the structures of this class of natural products.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/17/5/289/s1,
Figures S1–S15: The HRESIMS, UV, 1 D, 2D NMR, and CD spectra of compounds 1 and 2, Figure S16 the
phylogenetic tree of strain CUGBMF170049.
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Abstract: Three new thiodiketopiperazines, geospallins A–C (1–3), together with nine known
analogues (4–12), were isolated from the culture of the deep-sea sediment-derived fungus
Geosmithia pallida FS140. Among them, geospallins A and B (1 and 2) represent rare examples
of thiodiketopiperazines featuring an S-methyl group at C-10 and a tertiary hydroxyl group
at C-11. Their structures were determined by high-resolution electrospray mass spectrometry
(HRESIMS), spectroscopic analyses, and electronic circular dichroism (ECD) calculations.
Their angiotensin-converting enzyme (ACE) inhibitory activity was reported, and geospallins A–C
(1–3) showed inhibitory activity with IC50 values of 29–35 μM.
Keywords: thiodiketopiperazines; Geosmithia pallida; deep-sea-derived fungus
1. Introduction
2,5-Diketopiperazines are cyclodipeptides obtained by the condensation of two α-amino acids.
This subunit is often found alone or embedded in larger, more complex architectures in a variety
of natural products from fungi, bacteria, the plant kingdom, and mammals [1]. They are not only
a class of naturally occurring privileged structures that have the ability to bind to a wide range of
receptors, but they also have several characteristics that make them attractive scaffolds for drug
discovery [2,3]. Thiodiketopiperazines, such as gliotoxins, chetoseminudins, luteoalbusins, chetracins,
and apoaranotins, are common across the microbial world and have highly diverse organic structures
characterized by sulfur-containing functional groups. They also exhibit various pharmacological
activities, such as antifungal, antibacterial, and cytotoxic activities [4]. The angiotensin-converting
enzyme (ACE) is an important target and has broad effects in different systems, and ACE
inhibitors were originally developed for the treatment of congestive heart failure, diabetic kidney
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disease, and hypertension management [5]. ACE cleaves many peptides besides angiotensin I and
thereby affects diverse physiological functions, including renal development and male reproduction.
In addition, ACE has a role in both innate and adaptive responses by modulating macrophage and
neutrophil function—effects that are magnified when these cells overexpress ACE. Macrophages that
overexpress ACE are more effective against tumors and infections [5]. Sulfur-containing metabolites
are crucial for the inhibitory activity against ACE, which catalyzes the reaction from angiotensin I to
angiotensin II in the renin–angiotensin system and plays a major role in hypertension [6].
Recently, we initiated the investigation of microorganisms derived from deep-sea sediments,
aiming at discovering new metabolites with potent bioactivity [7–9]. As part of the program, the fungus
Geosmithia pallida FS140 was isolated from a sediment collected at a depth of 2403 m in the South
China Sea (19◦28.581′ N, 115◦27.251′ E). Chemical investigation of the fermentation broth led to
the isolation of a series of diketopiperazines including three new thiodiketopiperazines, named
geospallins A–C (1–3), as well as nine known analogues (4–12). Geospallins A and B (1 and 2) represent
rare examples of thiodiketopiperazines featuring an S-methyl group at C-10 and a tertiary hydroxyl
group at C-11. Biological tests verified that compounds 1−3 were responsible for the inhibition of ACE.
Details of the isolation, structure elucidation, and biological activities of diketopiperazines 1–12 are
presented below.
2. Results
The fermentation broth of the deep-sea-derived fungus G. pallida FS140 was extracted
with EtOAc and then concentrated under reduced pressure to give an extract. The EtOAc
extract was subjected to a series of solvent/solvent partitioning steps to afford compounds 1–12
(Figure 1). Three new structures were identified by the combination of spectroscopic analysis,
high-resolution electrospray mass spectrometry (HRESIMS), and electronic circular dichroism (ECD)
calculation, while twelve known analogues were identified as bisdethiobis (methylthio)gliotoxin
(4) [10,11], 6-acetylbis(methylthio)gliotoxin (5) [9,12], 6-deoxy-5a,6-didehydrogliotoxin (6) [13],
5a,6-didehydrogliotoxin (7) [14], 6-(phenylmethyl)-(3R,6R)-2,5-piperazinedione (8) [15],
3-(hydroxymethyl)-3,6-bis(methylthio)-6-(phenylmethyl)-(3R,6R)-2,5-piperazinedione (9) [15],
3-(hydroxymethyl)-6-(methoxyl)-6-(phenylmethyl)-(3R,6R)-2,5-piperazinedione (10) [16],
5a,6-anhydrobisdethiobis(methylthio)gliotoxin (11) [17], and bisdethiobis (methylthio)gliotoxin
(12) [12] by comparison of their spectroscopic data with those in the literature.
Figure 1. Structures of compounds 1–12 isolated from G. pallida FS140.
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2.1. Identification of New Compounds
Compound 1, a colorless oil, had the molecular formula of C18H26N2O7S2, as determined by
HRESIMS (m/z 469.1063 [M + Na]+, calcd for 469.1074), corresponding to seven degrees of unsaturation.
The 1H NMR spectrum revealed the presence of five methyl singlets (δH 3.15, 2.99, 2.26, 2.05, and 1.76),
a disubstituted double bond (δH 6.00 (2H, m)), and a series of aliphatic methylene or methine multiplets
(5.60 (1H, s), 5.52 (1H, s), 5.48 (1H, d, J = 5.6 Hz), 4.23 (1H, d, J = 1.8 Hz), 3.93 (1H, dd, J = 11.7, 6.7 Hz),
3.68 (1H, m), 3.66 (1H, m), 2.54 (1H, m), and 1.86 (1H, d, J = 14.2 Hz)). The 13C NMR, in combination
with HSQC experiments, resolved 18 carbon resonances attributed to three carbonyl groups (δC 169.4,
167.6, and 163.5), a disubstituted double bond (δC 137.2 and 127.4), three sp3 quaternary carbons
(δC 90.6, 81.0, and 76.8), three sp3 methines (δC 70.5, 65.2, and 51.8), two sp3 methylene (δC 62.8 and
42.3), a methoxyl group (δC 52.1), an N-methyl group (δC 28.6), and three methyl groups (δC 20.6, 16.1,
and 11.0) (Table 1). The 1D NMR data of 1 showed resonance characteristics of a thiodiketopiperazine
framework similar to that of 5, except for the absence of a double bond and presence of a methoxy
group. In comparison with 5, the 13C NMR spectroscopic data for 1 differed significantly from C-10
to C-13, with the distinctly upfield-shifted carbon at C-13 (δC 90.6 in 1 and δC 75.2 in 5) and the
downfield-shifted at C-10 and C-11 (δC 51.8 and 81.0 in 1 and δC 120.5 and 135.7 in 5, respectively).
Detailed 2D NMR analyses (1H–1H COSY, HSQC, and HMBC) allowed the establishment of the gross
structure of 1 as depicted in Figure 2. HMBC correlations from H-7 (δH 5.48) and H3-18 (δH 2.05) to C-17
(δC 169.4), from H3-19 (δH 2.26) to C-10 (δC 51.8), and from OH-11 (δH 5.60) to C-6/C-10/C-11/C-12
(δC 70.5, 51.8, 81.0, and 42.3, respectively), and 1H–1H COSY correlations of H-6/H-7/H-8/H-9/H-10
confirmed the presence of fragment A (Figure 2). Fragment B was very similar to 5, except for the
distinct downfield-shifted of the O-methyl group when compared with the S-methyl group (δC 52.1 in
1 and δC 15.1 in 5). The methyl group was assigned to C-13 by the HMBC correlations from the methyl
group (δH 3.15) to the severely downfield-shifted C-13 (90.6 ppm in 1 and 75.2 ppm in 5, respectively).
The relative configuration of 1 was established on the basis of the interpretation of the NOESY data
and 1H−1H coupling constants (Figure 2 and Table 1). The strong NOE interactions of H-10/OH-11,
OH-11/H-6, H-6/H-7, OH-11/H-12β, and H-12β/H3-20 indicated that H-10, OH-11, H-6, H-7,
and CH3-20 occupied the axial bonds of the cyclohexane-ring portion in a chair conformation and
were arbitrarily assigned β-orientations. Additionally, the axial orientation of both H-6 and H-7 were
in good accordance with their small coupling constant of 1.8 Hz.
Figure 2. Key COSY ( ), HMBC ( ), and NOESY ( ) correlations for compounds 1 and 2.
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Table 1. 1H (400 MHz) and 13C (100 MHz) NMR data for compounds 1–3 (in DMSO-d6)a.
No.
1 2 3
1H 13C 1H 13C 1H 13C
1 163.5 166.1 165.0
3 76.8 77.9 70.8
4 167.6 167.6 162.6
6 4.23, d (1.8) 70.5 4.32, d (1.8) 70.5 4.96, d (11.0) 69.8
7 5.48, d (5.6) 65.2 5.32, d (3.2) 66.4 5.80, d (11.0) 75.1
8 6.00, m 127.4 5.96, d (3.2) 127.4 191.6
9 6.00, m 137.2 5.96, d (3.2) 137.2 6.09, d (10.3) 125.4
10 3.66, m 51.8 3.65, s 51.3 6.98, d (10.3) 150.5
11 81.0 81.4 75.1
12 2.54, m1.86, d (14.2) 42.3
2.28, d (8.5)
2.12, d (14.2) 45.6
3.07, d (14.9)
2.95, d (14.9) 49.3
13 90.6 86.3 69.1
14 3.93, dd (11.7, 6.7)3.68, m 62.8
3.81, m
3.71, dd (10.9, 3.6) 62.2
4.18, dd (11.5, 6.0)
3.74, dd (11.5, 4.7) 62.6
N-Me 2.99, s 28.6 2.99, s 29.1 2.99, s 28.8
SMe-3 1.76, s 11.0 1.80, d (3.6) 10.6 2.16, s 13.0
OAc-7 169.4 169.4 168.9
2.05, s 20.6 2.05, s 20.6 2.07, s 20.4
SMe-10 2.26, s 16.1 2.26, s 16.1
OMe-13 3.15, s 52.1 2.18, s 14.6
11-OH 5.60, s 5.68, s 6.00, s
13-OH 6.04, brs
14-OH 5.52, s 6.64, brs 5.34, t (5.4)
a Chemical shifts are in ppm; coupling constant J is in Hz.
In order to define the absolute configuration of 1, the ECD spectrum of (3R, 6R, 7R, 10S, 11R, 13R)-1,
(3R, 6R, 7R, 10S, 11R, 13S)-1, (3S, 6S, 7S, 10R, 11S, 13R)-1, and (3S, 6S, 7S, 10R, 11S, 13S)-1 were
calculated by the time-dependent density functional theory (TDDFT) computational method and
compared with the experimental spectra of 1 (for details of calculations, see Supplementary Materials).
The experimental ECD spectrum of 1 showed an ECD curve with positive Cotton effects around 219 nm
(Figure 3a). The calculated ECD spectrum for (3S, 6S, 7S, 10R, 11S, 13S)-1 showed a similar ECD curve
with positive Cotton effects at 220 nm, indicating that 1 had an (3S, 6S, 7S, 10R, 11S, 13S)-configuration.
Compound 1 was given the trivial name geospallin A.
The HRESIMS data of 2 exhibited a sodium adduct ion at m/z 455.0907 [M + Na]+ (calcd 455.0917),
consistent with the molecular formula C17H24N2O7S2Na, showing 14 mass units less than that of 1.
The 1D NMR data of 2 were similar to those of 1, except for the absence of a methoxy group in 2,
indicating 2 was a demethylated derivative of 1. The additional hydroxy group was located at C-13
by HMBC correlation from the hydroxyl group (δH 6.04) to C-13 (δC 86.3) (Figure 2). The absolute
configuration of 2 was confirmed by using the same methods as described for 1. The experimental
ECD spectrum for 2 showed a similar ECD curve with positive Cotton effects at 220 nm (Figure S46 in
Supplementary Materials), indicating that compound 2 has a (3S, 6S, 7S, 10R, 11S, 13S)-configuration.
Compound 2 was given the trivial name geospallin B.
Compound 3, a colorless oil, had the molecular formula of C17H22N2O7S2, as determined by
HRESIMS (m/z 453.0764 [M + Na]+, C17H22N2O7S2Na, calcd for 453.0761), corresponding to eight
degrees of unsaturation. The 1H and 13C NMR spectra (Table 1) of 3 showed high similarity to those of
5, except for the presence of an α,β-unsaturated ketone moiety (δC 191.6, 125.4, and 150.5) in 3 instead
of two double bonds in 5, indicating that 3 was an oxidative derivative of 5. This was supported by
detailed 2D NMR spectra analyses (Figure 4). The location of the α,β-unsaturated ketone moiety was
assigned at C-11 by HMBC correlations from OH-11 (δH 6.00) to C-10, C-11, C-6, and C-12 (δC 150.5,
75.1, 69.8, and 49.3, respectively); from H-10 (δH 6.98) to C-6 and C-8 (δC 191.6); and from H-7 (δH 5.80)
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to the carbonyl group (δC 191.6, C-8) and acetyl group (δC 168.9). The relative configuration of 3 was
deduced by NOESY correlations of H-6/H-12β, H-7/H12α, and H-12α/SMe-13.
 
(a) (b) 
Figure 3. (a) Experimental electronic circular dichroism (ECD) spectra of geospallin A (1) in MeOH
and calculated ECD spectra of (3R, 6R, 7R, 10S, 11R, 13R)-1, (3R, 6R, 7R, 10S, 11R, 13S)-1, (3S, 6S, 7S,
10R, 11S, 13R)-1, and (3S, 6S, 7S, 10R, 11S, 13S)-1; (b) Experimental ECD spectra of geospallin C (3) in
MeOH and calculated ECD spectra of (3S, 6S, 7S, 11S, 13R)-3, (3S, 6S, 7S, 11S, 13S)-3, (3R, 6R, 7R, 11R,
13S)-3, and (3R, 6R, 7R, 11R, 13R)-3. The calculated ECD spectra were computed at the B3LYP/6-311G
(2d+p) level.
Figure 4. Key 1H-1H COSY ( ), HMBC ( ), and NOESY ( ) correlations for geospallin C (3).
The absolute structure of 3 was also deduced by comparison of the experimental and calculated
ECD spectra generated by TDDFT calculations in the Gaussian 16 program (Figure 3b). As illustrated in
Figure 3b, the experimentally acquired ECD spectrum for 3 agreed well with the ECD curve computed
for (3S, 6S, 7S, 11S, 13S)-3. Compound 3 was given the trivial name geospallin C.
2.2. Angiotensin-Converting Enzyme (ACE) Inhibitory Assay
The twelve thiodiketopiperazines (1−12) reported in this study were produced in sufficient
amounts to allow testing for the inhibition of angiotensin-converting enzyme (Table 2). IC50 values
above 100 μM were not determined, while compounds 1−3 showed inhibitory activity against ACE
with an IC50 value range of 29−35 μM.
Table 2. IC50 values of compounds 1–3 against angiotensin-converting enzyme (ACE).
Compounds IC50 (μM)
1 35 ± 5.2
2 31 ± 3.3
3 29 ± 3.3
Captopril 0.041 ± 0.005
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2.3. α-Glucosidase Inhibitory Activity Assay
All compounds were evaluated in vitro for α-glucosidase inhibitory activity. However, none of
the compounds showed inhibitory activity against α-glucosidase at a concentration of 100 μM.
3. Materials and Methods
3.1. General Experimental Procedures
IR spectra were carried out on a Shimadzu IR Affinity-1 spectrophotometer (Shimadzu
Corporation, Kyoto, Japan). UV data was acquired using a Shimadzu UV-2600 spectrophotometer
(Shimadzu Corporation, Kyoto, Japan). Optical rotations were obtained on an Anton Paar MCP-500
(Anton Paar, Graz, Austria). Circular dichroism (CD) spectra were recorded on a Jasco 820
spectropolarimeter (Jasco Corporation, Kyoto, Japan). NMR spectra were determined on a Bruker
Avance-400 spectrometer (Bruker Corporation, Fremont, CA, USA). ESI-MS spectra were measured
on an Agilent Technologies 1290-6430A Triple Quad LC/MS (Agilent Technologies Inc., Santa Clara,
CA, USA), and HRESIMS was measured on a Thermo MAT95XP high-resolution mass spectrometer
(Thermo Fisher Scientific, Bremen, Germany). A Shimadzu LC-20 AP (Shimadzu Corporation, Kyoto,
Japan) equipped with an SPD-M20A Photo-Diode Array (PDA) detector (Shimadzu Corporation,
Kyoto, Japan) was used for HPLC analysis. A YMC-pack ODS-A column (250 × 20 mm, 5 μm, 12 nm,
YMC CO., Ltd., Kyoto, Japan) was used for preparative HPLC separation. Column chromatography
was conducted using a commercial silica gel (SiO2; 200–300 mesh; Qingdao Haiyang Chemical Co. Ltd.,
Qingdao, China) and Sephadex LH-20 gel (Amersham Biosciences, Uppsala, Sweden). All solvents
were of analytical grade (Guangzhou Chemical Regents Company, Ltd., Guangzhou, China).
3.2. Fungal Material and Identification
The fungal strain FS140 was isolated from a deep-sea sludge in the South China Sea (19◦28.581′ N,
115◦27.251′ E, depth 2403 m) in September 2011. The isolate was identified as Geosmithia pallida FS140 by
sequence analysis of the internal transcribed spacer (ITS) region of the ribosomal DNA. The sequence
data have been submitted to GenBank (accession no. MK047400), and FS140 has 99% similarity with
Geosmithia pallida CCF4279 (accession no. KF808303). The strain was deposited in the Guangdong
Provincial Key Laboratory of Microbial Culture Collection and Application, Guangdong Institute
of Microbiology, Guangzhou, People’s Republic of China. Working stocks were prepared on potato
dextrose agar (PDA) slants and stored at 4 ◦C.
3.3. Fermentation, Extraction, and Isolation
Three pieces (0.5 × 0.5 cm2) of mycelial agar plugs of G. pallida FS140 were inoculated into 250 mL
of PD medium (potato 200 g/L, glucose 20 g/L, KH2PO4 3 g/L, MgSO4·7H2O 1.5 g/L, vitamin B1
10 mg/L, sea salt 15 g/L) in 500 mL Erlenmeyer flasks and incubated for 2 days in a rotary shaker
(200 r/m) at 28 ◦C. The seed cultures (10%) were then aseptically transferred into 500 mL of PD
medium in 1000 mL Erlenmeyer flasks and kept shaking (120 r/m) at 28 ◦C for 7 days. The whole
fermentation broth (80 L) was filtered through cheese cloth to separate the supernatant from the
mycelia. The supernatant was extracted with EtOAc (4 × 25 L) and evaporated under reduced pressure
to give a dark brown oily residue (31 g). The EtOAc-soluble fraction was separated over a column
of silica gel and eluted with petroleum ether/EtOAc in a linear gradient (30:1 → 1:1) and followed
by CHCl3/MeOH in linear gradient (10:1 → 0:1) to give 18 fractions (F1–F18). F7 was separated on
a preparative reversed-phase (RP) HPLC system equipped with a C-18 column (YMC*GEL ODS-A,
120A S-5 μm, 250 × 20 mm, MeOH/H2O, 0.1:0.9 → 1.0:0, 10 mL/min) to give 25 fractions (F7a–F7y).
F7c was chromatographed over a Sephadex LH-20 column eluted with CHCl3/MeOH (1:1, v/v),
then further separated by preparative RP HPLC on the ODS-A column (MeCN/H2O, 40:60, 10 mL/min)
to yield 2 (4.5 mg, tR = 16.0 min), 9 (23.0 mg, tR = 25.0 min), 10 (6.1 mg, tR = 31.0 min), and 8
(7.6 mg, tR = 34 min), sequentially. F7f was successfully separated by preparative RP HPLC on the
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ODS-A column (MeCN/H2O, 45:55, 10 mL/min) to afford 1 (5.9 mg, tR = 12.1 min) and 3 (6.8 mg,
tR = 13.4 min). F7k was separated on a preparative RP HPLC on the ODS-A column (MeCN/H2O, 50:50,
10 mL/min) to yield 4 (427 mg), and F7m was purified by column chromatography on a Sephadex
LH-20 (CHCl3/MeOH, 1:1, v/v) to afford 5 (312 mg). F9 was purified by preparative HPLC on the
ODS-A column (MeCN/H2O, 60:40, 10 mL/min) to give 7 (28 mg, tR = 14.2 min) and 12 (16.8 mg,
tR = 19.3 min), while F10 was subjected to a Sephadex LH-20 column elution with CHCl3/MeOH (1:1),
then further separated by preparative HPLC on the ODS-A column (MeCN/H2O, 65:35, 10 mL/min)
to obtain 6 (39 mg, tR = 9.6 min) and 11 (18.1 mg, tR = 11.8 min), successively.
Geospallin A (1): colorless oil; [α]25D +87.7 (c 0.1, MeOH); CD (MeOH, c 0.001 mg/mL) 219 nm
(Δε + 3.16); IR νmax 3443, 2924, 1739, 1662, 1372, 1237, 1095, 1022 cm−1; 1H and 13C NMR data,
see Table 1; HRESIMS m/z 469.1063 ([M + Na]+, calcd for 469.1074).
Geospallin B (2): colorless oil; [α]25D +84.9 (c 0.1, MeOH); CD (MeOH, c 0.001 mg/mL) 225 nm
(Δε + 3.21); IR νmax 3315, 3056, 2923, 1738, 1667, 1422, 1373, 1265, 1236 cm−1; 1H and 13C NMR data,
see Table 1; HRESIMS m/z 455.0907 ([M + Na]+, calcd for 455.0917).
Geospallin C (3): colorless oil; [α]25D −28.2 (c 0.1, MeOH); CD (MeOH, c 0.001 mg/mL) 202 (Δε − 3.52),
234 (Δε − 2.36) nm; UV (MeOH) λmax (log ε) 210 (4.26) nm; IR νmax 3407, 2925, 1749, 1703, 1654, 1415,
1376, 1222, 1085, 1038 cm−1; 1H and 13C NMR data, see Table 1; HRESIMS m/z 453.0764 ([M + Na]+,
calcd for 453.0761).
3.4. Quantum Chemical ECD Calculation
The quantum chemical ECD calculation methods were used to establish the absolute configurations
of compounds 1–3. The 3D structures were generated by Discover Studio 2.5. The conformational search
was performed by the Conformer Searching module of Open Babel 2.4.1 using a genetic algorithm
and the MMFF94 molecular mechanics force field. The geometry optimizations were then performed
by using density functional theory (DFT) at the b3lyp/6-311+g(2d,p) level. These stable conformers,
which had no imaginary frequency, were subsequently submitted to ECD calculations by TDDFT
calculations at the b3lyp/6-311+g(2d,p) level. The solvent effects were taken into account by the
integral equation formalism polarizable continuum model (IEFPCM, methanol). All calculations were
performed with the Gaussian 16 A.03 program [18]. The calculated spectra were drawn using SpecDis
software with a UV shift to the ECD spectra.
3.5. Angiotensin-Converting Enzyme (ACE) Inhibitory Assay
ACE inhibitory activity was determined by a previously reported method [19]. In brief, 20 μL
thiodiketopiperazines dissolved in DMSO with different concentrations were added to 120 μL
N-hippuryl–His–Leu substrates, then preheated in water for 3–5 min; next, 10 μL ACE enzymatic
solution was added and mixtures were incubated at 37 ◦C for 60 min, and 150 μL 1 M HCl was added to
stop the reaction. The mixture was loaded for HPLC with a flow rate of 0.5 mL/min by 60% methanol,
and the absorbance at 228 nm was detected. To serve as a blank, 10 μL pH 8.3 boric acid replaced the
thiodiketopiperazines. Hippuric acid solutions at 10, 20, 40, 60, 80, and 100 μg/mL were prepared
using 10 μL pH 8.3 boric acid. One enzymatic unit was defined as the amount giving the production
of 1 μM hippuric acid by the catalyzation of the substrate N-hippuryl–His–Leu at 37 ◦C in 1 min.
Captopril was used as a positive control. Physiological saline with a concentration of 0.9% (w/w) was
used as a negative control in our experiment, which exhibited no inhibitory activity towards ACE.
The IC50 values of thiodiketopiperazines were calculated after the ACE inhibitory experiments were
conducted, using different concentrations of thiodiketopiperazines.
3.6. α-Glucosidase Inhibitory Activity Assay
An assay of α-glucosidase inhibitory activity was performed as previously described [20].
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4. Conclusions
In this study, twelve diketopiperazines, including three new thiodiketopiperazines, were isolated
from the deep-sea-derived fungus Geosmithia pallida. All the stereochemical configurations of the new
compounds, including their absolute configurations, were established. Geospallins A and B (1 and 2)
represent rare examples of thiodiketopiperazines featuring an S-methyl group at C-10 and a tertiary
hydroxyl group at C-11, and their S-configuration at both C-7 and C-13 is the first report of such.
These thiodiketopiperazines were examined for their angiotensin-converting enzyme inhibitory assay,
and geospallins A–C (1–3) showed inhibitory activity, with IC50 values of 29–35 μM.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/16/12/464/s1,
The 1H- and 13C-NMR data of 1–12 and the HRESIMS and 2D-NMR spectra of compounds 1–3 (Figures S1–S47).
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Abstract: Five new sesterterpenes, 14,15-dehydro-6-epi-ophiobolin K (1), 14,15-dehydro-
ophiobolin K (2), 14,15-dehydro-6-epi-ophiobolin G (3), 14,15-dehydro-ophiobolin G (4) and
14,15-dehydro-(Z)-14-ophiobolin G (5), together with four known ophiobolins (6–9) were isolated
from the marine fungus Aspergillus flocculosus derived from the seaweed Padina sp. collected in
Vietnam. The five new ophiobolins were first isolated as ophiobolin derivatives consisting of a fully
unsaturated side chain. Their structures were elucidated via spectroscopic methods including 1D, 2D
NMR and HR-ESIMS. The absolute configurations were determined by the comparison of chemical
shifts and optical rotation values with those of known ophiobolins. All compounds (1–9) were then
evaluated for their cytotoxicity against six cancer cell lines, HCT-15, NUGC-3, NCI-H23, ACHN, PC-3
and MDA-MB-231. All the compounds showed potent cytotoxicity with GI50 values ranging from
0.14 to 2.01 μM.
Keywords: ophiobolins; marine fungus; Aspergillus flocculosus; anti-proliferation
1. Introduction
The marine environment is an enormous reservoir of novel sources of biologically active
metabolites, many of which display unique structural skeletons that can be used as lead structures
for the development of new drugs [1,2]. To adapt and live in an environment that is significantly
different from terrestrial organisms, marine organisms frequently produce structurally unique chemical
compounds [3,4]. Specifically, secondary metabolites from marine microorganisms are recognized
as a novel chemical source for drug discovery and development. Among marine-derived microbes,
marine fungi produce a wide range of promising biologically active compounds [5]. Numerous
novel compounds from marine fungi have displayed a wide range of bioactivities such as antiviral,
antibacterial, anticancer, antiplasmodial and anti-inflammatory [6–8]. In the marine context, Aspergillus
and Penicillium represent the best studied fungal genera as depicted in marine contexts [9,10]. The
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Mar. Drugs 2019, 17, 346
genus Aspergillus is known as a major contributor of pharmacologically bioactive compounds, including
anticancer asperazine, antibacterial varixanthone and antifungal amphotericin B [11,12].
Ophiobolins are a group of sesterpenoids with an unusual tricyclic 5-8-5 ring system. They show
a broad range of inhibitory activities against nematodes, fungi, bacteria and cytotoxic activity against
cancer cells [13,14]. They are produced by the fungal genus Bipolaris, Aspergillus, Sarocladium and
Drechslera [15]. The first ophiobolin, ophiobolin A, was isolated from Biolaris spp. and displays inhibitory
activity against calmodulin-activated cyclic nucleotide phosphodiesterase [16]. These findings made the
compound a useful calmodulin probe for research purposes and implied an application in anti–cancer
therapy [17]. Interestingly, more than half of the 49 ophiobolins identified between 1999 and 2016
exhibit cytotoxic activities against human cancer cell lines [18]. Although their biological properties
have been well exploited in recent years, their structure-activity relationship remains unestablished [18].
Consequently, this study focused on the discovery of bioactive natural products from marine fungi.
During our ongoing investigation for new bioactive compounds from marine microorganisms, the
fungal 168ST-16.1 strain was isolated from the seaweed Padina sp. collected at Da Nang, Vietnam,
and, based on its 28S rRNA gene sequence, it was identified as Aspergillus flocculosus. Subsequent
chemical investigations on an EtOAc extract of the fungal culture broth using reversed-phase HPLC
led to the isolation of the five new ophiobolins, named, 14,15-dehydro-6-epi-ophiobolins K and G
(1 and 3), 14,15-dehydro-ophiobolins K and G (2 and 4) and 14,15-dehydro-(Z)-14-ophiobolin G (5),
together with four known ophiobolins, 6-epi-ophiobolins C and N (6 and 8) and ophiobolins C and N
(7 and 9) [19–21] (Figure 1). Herein, details of the structure elucidation and biological activity of these
compounds are described.
Figure 1. Structures of 1–9 isolated from Aspergillus flocculosus.
2. Results and Discussion
Compound 1 was obtained as an amorphous powder. The molecular formula of 1 was determined
to be C25H34O3 based on HRESIMS. The 1H NMR spectroscopic data of 1 displayed resonances for an
aldehyde proton (δH 9.23), four olefinic protons (δH 6.84, 6.42, 6.38 and 5.93), five methylene protons
(δH 3.15, 2.47, δH 2.94, 2.22, δH 2.59, 2.25, δH 1.84, 1.63 and δH 1.63, 1.50), three methine protons (δH 3.33,
3.19 and 2.19) and five methyl groups (δH 1.83, 1.81, 1.79, 1.47 and 0.94) (Table 1). The combination
of 13C NMR and HSQC spectra revealed the presence of 25 carbon resonances, including one ketone
(δC 216.6), one aldehyde carbon (δC 194.0), four olefinic carbons, five methylene, three methine, five
methyl and six quaternary carbons (δC 146.8, 142.1, 134.9, 124.9, 76.6 and 43.6) (Table 2). Spin systems
and their partial structures were confirmed and assembled by combined analysis of COSY and HMBC
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correlations (Figure 2). Three spin systems, H2-1/H-2/H-6, H-8/H2-9/H-10 and H2-12/H2-13, and HMBC
correlations from H3-22 (δH 0.94) to C-1 (δC 41.4), C-10 (δC 47.8), C-11 (δC 43.6) and C-12 (δC 44.5),
and from H-21 (δH 9.23) to C-6 (δC 48.8), C-7 (δC 142.1) and C-8 (δC 158.4) confirmed the presence
of an eight-membered ring system with an aldehyde group. The five-membered ring with a ketone
was also determined by the HMBC correlations from H3-20 (δH 1.47) to C-2 (δC 49.6), C-3 (δC 76.6)
and C-4 (δC 55.0) and from H-6 (δH 3.33) to C-4 (δC 55.0), C-5 (δC 216.6), C-7 (δC 142.1) and C-21
(δC 194.0). Additionally, the HMBC correlations from H2-13 (δH 2.25, 2.59) to C-10 (δC 47.8), C-14
(δC 146.8) and C-15 (δC 124.9) suggested that one additional five-membered ring was connected to
the eight-membered ring, which generated a 5-8-5 tricyclic carbon skeleton. The partial structure
was closely related to ophiobolin analogs and the 1H and 13C NMR spectra of 1 resembled those of
6-epi-ophiobolin C (6) except for the presence of two olefinic protons (δH 6.38 and 6.42) and two sp2
quaternary carbons (δC 146.8 and 124.9). Finally, the COSY correlation of H-16/H-17/H-18 and the
HMBC correlations from H3-24 (δH 1.81) and H3-25 (δH 1.79) to C-18 (δC 125.9) and C-19 (δC 134.9) and
from H3-23 (δH 1.83) to C-14 (δC 146.8), C-15 (δC 124.9) and C-16 (δC 130.6) defined a conjugated side
chain connected to C-14 of the tricyclic ring. The planar structure of 1 was elucidated to possess a fully
unsaturated side chain. To the best of our knowledge, 1 is the first ophiobolin with three double bonds
at the side chain and is named 14,15-dehydro-6-epi- ophiobolin K.
Table 1. 1H and 13C NMR data for 1, 2 and 3 at 600 MHz (δ in ppm, J in Hz).
Position 1 a 2 b 3 b 4 b 5 b
1α 1.63, m 1.54, m 1.22 (t, 13.2) 1.44, m 1.42, m
1β 1.84, m 1.54, m 2.15 (dd, 13.2, 3.6) 2.13 (dd, 15.8, 4.5) 2.13 (dd, 15.8, 4.5)
2 2.19, m 2.57, m 2.72 (d, 12.9) 3.32, overlap 3.31, overlap
4 2.47 (d, 16.6) 2.57 (d, 18.9) 6.01, s 6.09, s 6.08, s
3.15 (d, 16.6) 2.70 (d, 18.9)
6 3.33 (d, 10.5) 3.47 (d, 11.8) 3.53 (d, 3.6) 4.29 (d, 7.2) 4.28 (d, 7.2)
8 6.84 (d, 6.7) 7.44 (t, 8.6) 6.91 (dd, 6.2, 2.3) 7.24 (d, 6.7) 7.21 (d, 6.8)
9α 2.94 (d, 20.8) 2.48, m 3.02 (d, 21.3) 2.37, m 2.30, m
9β 2.22, m 2.48, m 2.31, m 2.37, m 2.22, m
10 3.19 (d, 13.0) 2.28, m 3.37 (d, 13.1) 3.03 (d, 16.5) 3.06 (d, 16.5)
12α 1.50, m 1.43, m 1.45, m 1.46, m 1.44, m
12β 1.63, m 1.86, m 1.65, m 1.46, m 1.44, m
13α 2.25 (dd, 14.8, 6.3) 2.48, m 2.31, m 2.40, m 2.37, m
13β 2.59, m 2.95, m 2.58 (dd, 14.8, 6.4) 3.08, m 3.03, m
16 6.42 (d, 15.3) 6.37 (d, 15.1) 6.43 (d, 15.3) 6.31 (d, 15.3) 6.14 (d, 15.1)
17 6.38 (dd, 15.3, 9.7) 6.39 (dd, 15.1, 10.1) 6.40(dd, 15.3, 9.3) 6.34 (dd, 15.3, 10.3) 6.31 (dd, 15.1, 10.5)
18 5.93 (d, 9.7) 5.92 (d, 10.1) 5.90 (d, 9.3) 5.88 (d, 10.3) 5.94 (d, 10.5)
20 1.47, s 1.37, s 2.12, s 2.29, s 2.27, s
21 9.23, s 9.28, s 9.25, s 9.46, s 9.44, s
22 0.94, s 1.05, s 0.99, s 0.86, s 0.84, s
23 1.83, s 1.96, s 1.83, s 1.72, s 1.72, s
24 1.81, s 1.81, s 1.78, s 1.79, s 1.77, s
25 1.79, s 1.81, s 1.79, s 1.80, s 1.80, s
The assignments were aided by COSY, NOESY, HSQC, and HMBC NMR spectra. a Measured in CDCl3; b Measured
in methanol-d4.
Figure 2. Key COSY and HMBC correlations of 1 and 3.
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Table 2. 13C NMR data for 1–5 at 150 MHz (δ in ppm).
Position 1 a 2 b 3 b 4 b 5 b
1 41.4 41.5 45.3 34.9 34.9
2 49.6 50.6 49.5 49.8 49.9
3 76.7 76.6 179.9 180.2 180.2
4 55.0 53.9 129.4 130.1 130.1
5 216.6 216.2 209.4 209.2 209.4
6 48.8 48.8 49.7 48.0 48.0
7 142.1 141.8 140.6 138.7 138.6
8 158.4 160.7 156.7 159.7 160.0
9 34.1 29.3 34.0 28.8 29.9
10 47.8 56.2 47.2 41.9 40.7
11 43.6 44.2 44.0 45.1 45.3
12 44.5 34.9 43.4 40.4 40.4
13 27.2 26.9 26.8 31.4 33.1
14 146.8 143.3 146.6 143.2 142.7
15 124.9 126.5 125.0 127.1 126.6
16 130.6 131.1 130.6 130.0 129.6
17 123.6 122.7 123.2 122.9 123.9
18 125.9 126.0 126.0 126.0 126.1
19 134.9 133.7 133.5 133.6 133.8
20 25.8 24.4 15.7 17.2 17.1
21 194.0 195.1 193.2 195.1 195.2
22 21.3 18.0 19.8 24.6 24.7
23 13.6 14.1 13.8 14.2 15.5
24 18.4 16.9 16.9 16.9 16.9
25 26.1 24.8 24.8 24.8 24.8
a Measured in CDCl3; b Measured in methanol-d4.
The stereochemistry of 1 was determined by the analysis of proton-proton coupling constants
and NOESY data. The strong NOESY correlations of H-6/H-10 and H-2/H3-20/H3-22 suggested that
H-6 and H-10 were on the same face, and H-2, H3-20 and H3-22 were on opposite faces. Based on a
comprehensive literature review, ophiobolin analogs have A/B-cis or A/B-trans isomers at C-2 and
C-6 [18]. It has been reported that H-2 of the 6-epimer having H-6α is shielded by ca. 0.2-0.3 ppm in
comparison with the A/B-cis isomer having H-6β [13]. On the basis of this analysis, the H-2 protons
of 1 and 2 were observed at δH 2.19 and δH 2.57, respectively, indicating that 1 has an A/B-trans ring
structure. The lack of a NOESY correlation of H-2/H-6 and a comparison of the 1H NMR data of 1
with those of 6-epi-ophiobolin C (6) also supported the fact that the A/B ring junction is trans in 1
(Figure 3). The relative configuration of the side chain was confirmed by comprehensive NOESY and
1H NMR analyses. The NOESY correlations of H-9α/H3-23 and H-13β/H-16 indicated the relative
configuration of Δ14,15 was E conformation (Figure 3a). The geometry of the Δ16,17 was confirmed as E
by the large coupling constants of H-16 (d, J = 15.3 Hz) and H-17 (dd, J = 15.3, 9.7 Hz) and NOESY
correlations of H-13β/H-16, H-17/H3-23 and H-16/H-18. Moreover, a combination of literature review
and comparison of the NMR spectral data and spectral properties of 1 with those of 6, suggested that
14, 15-dehydro-6-epi-ophiobolin K (1) has the same absolute configuration of a 5-8-5 core structure in
6-epi-ophiobolin K [13,19,20].
Compound 2 had the same molecular formula C25H32O3 as 1. Its 1H and 13C NMR data were
similar to those of 1, differing only by slightly shifted proton and carbon signals. It has been reported
that H-2 of the 6-epi isomer having H-6α (A/B-trans) is upfield-shifted in comparison with the A/B-cis
ophiobolin [13] (Figure 3b). The H-2 proton (δH 2.57) of 2 is downfield-shifted than that (δH 2.19) of 1,
indicating that 2 has an A/B-cis ring structure. This study also revealed that the chemical shifts of the
geminal proton H2-4 are closer to each other when the A/B ring junction is cis than when it is trans
(Figure 3b). The key NOE correlations of H-2/H-6, H-2/H3-20 and H-2/H3-22 suggested that 2 has an
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A/B-cis ring structure and is a stereoisomer of 1 (Figure 3a). Based on these results, the structure of 2
was determined and named 14,15-dehydro-ophiobolin K.
 
Figure 3. (a) Key NOESY correlations of 1 and 2. (b) Comparison of chemical shifts of H2-4 and H-6 in
1 (H-6α), 2 (H-6β), 6 (H-6α) and 7 (H-6β).
Compound 3 was obtained as an amorphous powder with the molecular formula of C25H32O2
based on HRESIMS. The molecular formula of 3 has one less CH2 and one less oxygen compared to that
of 1. The 1H and 13C NMR data of 3 were quite similar to those of 1, displaying one additional singlet
olefin signal (δH 6.01) and a sp2 quaternary carbon at C-3 (δC 179.9), while lacking a methylene and sp3
quaternary carbon signal. The HMBC correlations from H3-20 (δH 2.12) to C-2 (δC 49.5), C-3 (δC 179.9)
and C-4 (δC 129.4) revealed that a double bond existed between C-3 and C-4 by the dehydroxylation of
the tertiary alcohol at C-3 in 1 (Figure 2). NOESY correlations from H-6/H-10 and H-2/H3-20/H3-22,
the lack of NOESY correlation of H-2/H-6 and, comparison of the NMR spectral data and spectral
properties of 3 with those of 6-epi-ophiobolin N (8), suggested that 3 has the same ring system as the
A/B-trans ophiobolin [13,19] (Figure 4). On the basis of detailed data analysis, the structure of 3 was
elucidated and named 14,15-dehydro-6-epi-ophiobolin G.
Compound 4 was isolated as an amorphous powder with the molecular formula of C25H32O2
as determined by HRESIMS. Its 1H NMR data were similar to those of 3, differing only by slightly
shifted signals. In contrast to the data for 3, the NOESY correlation of H-2/H-6 indicated that 4 has an
A/B-cis ring structure (Figure 4). Thus, compound 4 was identified as a stereoisomer of 3 and named
14,15-dehydro-ophiobolin G.
Compound 5 was isolated as an amorphous powder with the same molecular formula C25H32O2
as compound 4, as determined by HRESIMS. The 1H NMR data of 5 and 4 were nearly identical except
for the H-16 proton which was slightly downfield-shifted than that of 4. By comprehensive analysis of
its 1D and 2D NMR data, the planar structure of 5 was elucidated to be the same as that of 4, differing
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only in the orientation of H3-23. The NOESY correlations of H-16/H-10 and H-23/H2-13 suggested the
relative configuration of Δ14,15 in 5 was Z conformation, which is different from that of compound
4 (Figure 4). Therefore, the structure of 5 was elucidated to be as shown in Figure 1, and named 14,
15-dehydro-(Z)-14-ophiobolin G.
Figure 4. Key NOESY correlations of 3–5.
The structures of the four known compounds were determined as 6-epi-ophiobolin C (6), ophiobolin
C (7), 6-epi-ophiobolin N (8) and ophiobolin N (9) by comparing of their 1H, 13C NMR and MS data
with those reported in literature (Supplementary Materials).
The cytotoxicity of all the isolated compounds (1–9) against cancer cell lines, such as HCT-15,
NUGC-3, NCI-H23, ACHN, PC-3 and MDA-MB-231, was investigated using the sulforhodamine
B (SRB) assay, with adriamycin as a positive control. The results showed that all compounds were
strongly active against 6 cancer cell lines with GI50 values in the range of 0.14 to 2.01 μM (Table 3).
Compound 1 displayed the strongest cytotoxicity against the HCT-15, NUGC-3 and MDA-MB-231
cell lines with GI50 values of 0.21, 0.19 and 0.14 μM, respectively. Based on the cytotoxicity results,
the analogs with one double bond (6–9) in the side chain seemed to be slightly more active than
those with three double bonds (1–5). 5 was least active against all cell lines, even with GI50 values
ranging from 1.53 to2.01 μM, indicating that the geometry of C-14/C-15 might appear to have a slight
influence on their activities. In addition, results for all the strongly active compounds indicated that
the stereochemistry of C-6 and the hydroxyl group at C-3 might not noticeably affect the cytotoxicity.
Table 3. Growth Inhibition (GI50, μM) Values of 1–9 against Human Tumor Cell Lines.
Cell Lines a
GI50 (μM)
1 2 3 4 5 6 7 8 9 ADR b
HCT-15 0.21 0.44 0.96 1.24 1.67 0.24 0.21 0.30 0.22 0.13
NUGC-3 0.19 0.50 0.88 1.07 1.53 0.22 0.20 0.22 0.20 0.15
NCI-H23 0.18 0.61 1.40 1.50 1.84 0.24 0.16 0.22 0.22 0.15
ACHN 0.24 0.53 1.14 1.40 2.01 0.43 0.20 0.23 0.42 0.16
PC-3 0.24 0.47 1.00 1.38 1.60 0.27 0.36 0.20 0.20 0.14
MDA-MB-231 0.14 0.63 1.05 1.35 1.75 0.19 0.22 0.21 0.19 0.15
a HCT-15: Colon cancer, NUGC-3: Stomach cancer, NCI-H23: Lung cancer, ACHN: Renal cancer, PC-3: Prostate
cancer, MDA-MB-231: Breast cancer; GI50 values are the concentration corresponding to 50% growth inhibition.
b ADR: Adriamycin as standard.
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3. Materials and Methods
3.1. General Experimental Procedures
The 1D (1H and 13C) and 2D (COSY, HSQC, HMBC, and NOESY) NMR spectra were obtained
on a Bruker 600 MHz spectrometer. Specific optical rotations were obtained on a Rudolph Research
Analytical (Autopol III) polarimeter. UV-visible spectra were acquired on a Shimadzu UV-1650PC
spectrophotometer in 1 mm quartz cells. IR spectra were recorded on a JASCO FT/IR-4100
spectrophotometer. High-resolution ESIMS were recorded on a hybrid ion-trap time-of-flight mass
spectrometer (Shimadzu LC/MS-IT-TOF). HPLC was performed using a PrimeLine Binary pump
with RI-101(Shodex). RP-HPLC was performed using a semi-prep ODS column (YMC-Triart C18,
250 × 10 mm i.d, 5 μm) and an analytical ODS column (YMC-Triart C18, 250 × 4.6 mm i.d, 5 μm).
3.2. Fungal Material and Fermentation
The fungus 168ST-16.1 was isolated from the algae Padina sp., collected at a depth of 10 m in Son
Tra peninsular, Da Nang, Vietnam (16◦09′97.8” N, 108◦29′96.1” E), in August 2016. The fungal strain
was identified as Aspergillus flocculosus (GenBank accession number MG920345) by DNA amplification
and ITS region sequencing and named Aspergillus flocculosus 168ST-16.1.
The isolated fungi were cultured on rice media at 28 ◦C for three weeks in 100 Erlenmeyer flasks
(500 mL), each containing rice (20.0 g), yeast extract (20.0 mg), KH2PO4 (10 mg), and natural sea water
(40 mL).
3.3. Isolation of Compounds 1–9
The whole fermentation media were extracted with EtOAc and evaporated in vacuo to give
the crude extract (22 g), which was fractionated by flash column chromatography on ODS using a
gradient of MeOH/ H2O (1:4, 2:3, 3:2, 4:1 and 100% MeOH, each fraction 300× 3). The second fraction
eluted with 100% MeOH was separated into ten subfractions (Fr. A-J) by column chromatography
on ODS eluting with a step gradient of MeCN/H2O (70:30 to 100:0, v/v). Fr. E (200 mg) was further
purified by an analytical reversed-phase HPLC (YMC-Pack-ODS-A, 250 × 4.6 mm i.d, 5 μm, flow rate
2.5 mL/ min, isocratic elution with 55% MeCN in H2O, RI detector) to yield 1 (7.5 mg, tR = 18 min)
and 2 (1.5 mg, tR = 21 min). Compounds 3 (2.2 mg, tR = 30 min), 4 (3.1 mg, tR = 33 min), 5 (1.2 mg,
tR = 36 min), 6 (3.5 mg, tR = 50 min) and 7 (3.2 mg, tR = 53 min) were isolated from Fr. F (210 mg)
by a semi-preparative reversed-phase HPLC (YMC-Pack-ODS-A, 250 × 10 mm i.d, 5 μm, flow rate
6.0 mL/ min, isocratic elution with 60% MeCN in H2O, RI detector). Fr G (136 mg) was subjected
to a semi-preparative reversed-phase HPLC (YMC-Pack-ODS-A, 250 × 10 mm i.d, 5 μm, flow rate
5.5 mL/min, isocratic elution with 65% MeCN in H2O, RI detector) to obtain 8 (3.6 mg, tR = 40 min)
and 9 (2.9 mg, tR = 43 min).
14,15-dehydro-6-epi-ophiobolin K (1): amorphous powder; [α]23D +74.0(c 1.0, MeOH); IR νmax 3442, 2931,
2852, 1736, 1683, 1640, 1454, 1379 cm−1; UV(MeOH) λmax (log ε) 286 (3.62), 236 (3.04) nm; HRESIMS
m/z 405.2405 [M + Na]+ (calcd for 405.2406, C25H34O3Na); 1H NMR (CDCl3, 600 MHz) and 13C NMR
(CDCl3, 150 MHz) see Table 1.
14,15-dehydro-ophiobolin K (2): amorphous powder; [α]23D +94.0(c 1.0, MeOH); IR νmax 3451, 2967,
2897, 1734, 1688, 1448, 1377, 1233 cm−1; UV(MeOH) λmax (log ε) 289 (3.58), 238 (3.36) nm; HRESIMS
m/z 405.2404 [M + Na]+ (calcd for 405.2406, C25H34O3Na); 1H NMR (CD3OD, 600 MHz) and 13C NMR
(CD3OD, 150 MHz) see Table 1.
14,15-dehydro-6-epi-ophiobolin G (3): amorphous powder; [α]23D +87.0(c 1.0, MeOH); IR νmax 2922,
2858, 1683, 1625, 1455, 1377 cm−1; UV(MeOH) λmax (log ε) 286 (3.53), 227 (3.24) nm; HRESIMS m/z
387.2301 [M + Na]+ (calcd for 387.2300, C25H32O2Na); 1H NMR (CD3OD, 600 MHz) and 13C NMR
(CD3OD, 150 MHz) see Table 1.
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14,15-dehydro-ophiobolin G (4): amorphous powder; [α]23D +85.0(c 1.0, MeOH); IR νmax 2925, 2858,
1689, 1636, 1441, 1377 cm−1; UV(MeOH) λmax (log ε) 291 (3.59), 231 (3.37) nm; HRESIMS m/z 387.2299
[M + Na]+ (calcd for 387.2300, C25H32O2Na); 1H NMR (CD3OD, 600 MHz) and 13C NMR (CD3OD,
150 MHz) see Table 1.
14,15-dehydro-(Z)-14-ophiobolin G (5): amorphous powder; [α]23D +132.0(c 1.0, MeOH); IR νmax 2922,
2855, 1692, 1632, 1437, 1377 cm−1; UV(MeOH) λmax (log ε) 289 (3.61), 231 (3.54) nm; HRESIMS m/z
387.2299 [M + Na]+ (calcd for 387.2300, C25H32O2Na); 1H NMR (CD3OD, 600 MHz) and 13C NMR
(CD3OD, 150 MHz) see Table 1.
3.4. Cytotoxicity Test by SRB Assay
The human cancer cell lines, HCT-15 (colon), NUGC-3 (stomach), NCI-H23 (lung), ACHN (renal),
PC-3 (prostate) and MDA-MB-231 (breast), were purchased from American Type Culture Collection
(Manassas, VA, USA). They were then cultured in RPMI 1640 supplemented with 10% fetal bovine
serum (FBS). Cell cultures were maintained at 37 ◦C under a humidified atmosphere of 5% CO2.
The growth inhibition assay against human cancer cell lines was performed in accordance with the
sulforhodamine B (SRB) assay [22]. In brief, 8,000 cells/well were seeded onto a 96-well plate. On
the following, the cells were treated with compounds 1–9, vehicle control (0.1% DMSO) and positive
control (adriamycin). After incubation for 48 h, the cultures were fixed with 50% trichloroactetic acid
(50 μg/mL) and stained with 0.4% sulforhodamine B in 1% acetic acid. Unbound dye was removed
by washing with 1% acetic acid, and protein-bound dye was extracted with 10 mM Tris base (pH
10.5) for optical density determination. Absorbance at 540 nm was determined using a VersaMax
microplate reader from Molecular Devices (LLC, Sunnyvale, CA, USA). GI50 values were calculated
using GraphPad Prism 4.0 software from GraphPad Software, Inc. (San Diego, CA, USA).
4. Conclusions
Chemical investigation of the marine-derived fungus Aspergillus flocculosus 168ST-16.1 led to the
isolation and identification of five new (1–5) and four known (6–9) ophiobolin derivatives. The five
new ophiobolins possessed a fully unsaturated side chain, and 5 had a Z-conformation at C-14/C-15. To
the best of our knowledge, the new compounds 1–5 are the first ophiobolins with three double bonds at
the side chain. All compounds (1–9) exhibited potent growth inhibitory activities against the HCT-15,
NUGC-3, NCI-H23, ACHN, PC-3 and MDA-MB-231 cancer cell lines. The cytotoxicities of the new
ophiobolins 4 and 5 were slightly weaker or similar to those of the known compounds (6–9). These
results suggest that dehydration at C-14 and C-15 might not significantly affect the cytotoxicity against
cancer cell lines. This study is the first report to describe the effect of the side chain of ophiobolins by
evaluating the anticancer activity of five new and four known compounds together.
Supplementary Materials: The followings are available online at http://www.mdpi.com/1660-3397/17/6/346/s1,
Figures S1–S35: HRESI-MS data, 1H NMR, 13C NMR, COSY, HSQC, HMBC, NOESY and experimental spectra of
1–5, Figures S36–S43: LRMS data, 1H NMR, 13C NMR and experimental spectra of 6–9.
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Abstract: Carotenoids are natural pigments found in plants and microorganisms. These important
nutrients play significant roles in animal health. In contrast to plant production, the advantages of
microbial fermentation of carotenoids are the lower media costs, fast growth rate of microorganisms,
and the ease of culture condition control. In this study, a colony of red pigment-producing yeast,
Rhodotorula sp. RY1801, was isolated from the sediment of marine environment with the potential
to produce carotenoids. Optimization of carotenoid production in Rhodotorula sp. RY1801 was also
discussed. The optimum conditions found for carotenoid production were as follows: temperature,
28 ◦C; pH 5.0; carbon source, 10 g/L glucose, nitrogen source, 10 g/L yeast extract, maximum
concentration of 987 μg/L of total carotenoids was obtained. The results of this study show that
the isolated yeast strain Rhodotorula sp. RY1801 can potentially be used in future as a promising
microorganism for the commercial production of carotenoids.
Keywords: carotenoids; optimization; red yeast; Rhodotorula sp.
1. Introduction
Carotenoids are pigments that exist in a wide variety of plants and microorganisms. They are
characterized by yellow, orange, red or purple coloration [1]. Carotenoids have been proven to play
important roles in animal health as precursors of vitamin A, scavengers of active oxygen, and enhancers
of in vitro antibody production. Therefore, they are widely applied in animal feed additives as
nutrient supplements, food, pharmaceutical, and cosmetic industries as dyes/colorants and functional
ingredients [2]. Carotenoids are in high demand throughout the world, so a suitable method for
an industrial production of carotenoids producing is needed. Most of the carotenoids are extracted
from plants like annatto, tomato, grapes, carrot, paprika, etc. Carotenoids can also be produced from
microorganisms [3].
Carotenoids can be produced by numerous microorganisms. Filamentous fungi, yeasts,
bacteria and algae, such as Streptomyces chrestomyceticus, Blakeslea trispora, Phycomyces blakesleeanus,
Flavobacterium sp., Phaffia sp., and Rhodotorula sp., Actinomycetes have been described as
carotenoid-producing microorganisms [4,5]. The production of carotenoids from microorganisms
have advantages over plants, such as higher yields, less batch-to-batch variations, easily manipulated,
and no seasonal or geographic variations [6,7]. Carotenoid producing microorganisms, such as
bacteria and archaea, algae and fungi; are abundant in the natural environment. Microalgae are
currently the main sources of industrial carotenoid production [8], but other microorganisms could
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be valid alternatives [9]. With the rising demand of carotenoids, there has been renewed interest
in identifying novel carotenoid-producing microorganisms. Yeast is the most suitable candidate
for carotenoid production because of its fast growth rate, and the ease of cultivation. Yeast has the
potential to produce large amounts of carotenoids such as lycopene, β-carotene, astaxanthin, torulene
and torularhodin, etc. Carotenoid-producing yeasts are mainly represented by the genera Rhodotorula
sp., Rhodosporidium sp., Sporobolomyces sp., Xanthophylomyces sp. [10,11]. Microorganisms that inhabit
marine environments have been considered useful natural sources for new biomolecules production.
Marine microorganisms possess unique metabolic and physiological features. They have evolved
protective mechanisms compared to terrestrial microorganisms, which include the accumulation of
bioactive compounds. It is also considered that the production of these bioactive compounds may
be relatively easy by marine microorganisms [12,13]. The aim of the current study was carried out
to isolate, identify carotenoid-producing strains from the marine environment, and optimize the
nutritional and environmental parameters for their carotenoid production.
2. Results and Discussion
2.1. The Isolation and Identification of Carotenoids Producing Yeasts
A total of six morphologically distinct yeasts with red pigment were isolated from marine sediment
samples as pure cultures (designated as RY1801–RY1806). Among the isolates, only the strain RY1801
had rapid growth and high pigment producing abilities, which was subsequently used for further
study. The isolate RY1801 developed mucous, smooth surface and red-colored colonies on YPD agar
plate (Figure 1A), and the growth was frequently observed in the microscopic examination (Figure 1B).
Cells of the isolated strain RY1801 had an oval shape, the RY1801 cells size was 4–6.5 μm × 2–3.5 μm
and had a colony diameter of 1.5 mm after 24 h cultivation (Figure 1B). The liquid medium changed
to red after 24 h cultivation (Figure 1C). It has assimilated sugars such as glucose, galactose, sucrose,
maltose, melezitose, and raffinose. The nitrate assimilation was positive. Further biochemical tests
were carried out and are listed in Table 1. These biochemical results were not sufficient for classification
to the genus, so the Internal Transcribed Spacers (ITS) of the ribosomal DNA sequence was amplified.
Figure 1. (A), Pure culture of the potential marine yeast strain Rhodotorula sp. RY1801 on YPD agar. (B),
Micro-morphology of RY1801 observed under 40× with methylene blue staining. (C), Liquid culture
of RY1801.
The ITS sequence obtained from strain Rhodotorula sp. RY1801 (GeneBank MH760806) was
compared with the sequences in the GeneBank database and revealed that the strain RY1801 had 99%
homology to Rhodotorula babjevae. The nucleotide sequence of the ITS region from RY1801 strain was
identical to two other R. babjevae sequences included in the phylogenetic tree (Figure 2). Based on
morphological, physiological characteristics, and ITS sequence, the isolated red yeast RY1801was
tentatively named R. babjevae RY1801 and deposited at the China General Microbiological Culture
Collection Center (CGMCC, Beijing) as CGMCC No. 15980.
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Glucose + Ethanol - 2-keto-D-gluconate -
Galactose + Glycerol + Xylitol -
Sucrose + Erythritol - 50% glucose -
Maltose + Ribitol + 10% NaCl/5% Glucose -
Cellobiose - Galactitol + Starch formation -
Trehalose + D-Mannitol + Urease +
Lactose - D-Glucitol - Gelatin liquefaction -
Melibiose - α-Methyl
D-glucose + Growth at 19
◦C +
Raffinose + Salicin - Growth at 25 ◦C +
Melezitose + D-Gluconate + Growth at 37 ◦C +
Inulin - DL-Lactate + Growth at 40 ◦C -
Soluble starch + Succinate + Pellicle -
D-Xylose + Citrate + Sedimentation +
L-Arabinose + Inositol - True hyphae -
D–Glucosamine - Hexadecane + Acid production -
N-acetyl-D-glucosamine - Nitrate +
Methanol Vitamin-free
 Rhodotorula babjevae culture CBS:322 KY104720.1
 RY1801
 Rhodotorula babjevae strain YS3 KX774514.1
 Rhodotorula diobovata strain IGC 4364T AF387782.1
 Rhodotorula kratochvilovae strain IGC 4583T AF387783.1
 Rhodotorula mucilaginosa strain PMM08-3942L KP132585.1




Figure 2. Phylogenetic tree of RY1801 obtained by neighbor-joining analysis of ITS region of rDNA.
Several yeast species can synthesize carotenoids, in particular, the genera Xanthophyllomyces,
Rhodotorula, Sporobolomyces, and Phaffia have been used to produce carotenoids [14,15]. The production
of carotenoid pigments in numerous natural isolates of the genera Rhodotorula has been studied by
others, such as Rhodotorula glutinis, Rhodotorula minuta, Rhodotorula mucilaginosa, Rhodotorula acheniorum
and Rhodotorula graminis [16]. El-Banna et al. isolated 46 yeast isolates from natural environments,
all the strains belonged to Rhodotorula glutinis [17]. Muthezhilan et al. isolated a marine yeast
Rhodotorula Sp. (Amby109) which can produce carotenoid pigments [18]. In this study, we isolated and
identified the marine yeast which can produce red pigment, based on morphological, physiological
characteristics and ITS sequence, and our results showed that the isolated red yeast RY1801 belonged
to Rhodotorula sp.
The carotenoid pigments extracted from Rhodotorula sp. RY1801 have shown no inhibitory activity
against all the detected strains. Muthezhilan et al. results showed that the pigment derived from
marine yeast Rhodotorula Sp. (Amby109) have strong antimicrobial activity [18].
2.2. Effects of Various Parameters on Biomass Growth and Carotenoids Production
2.2.1. The Incubation Temperature
Incubation temperature ranging from 20 to 37 ◦C were checked for the biomass and carotenoids
production in Rhodotorula sp. RY1801. As shown in Figure 3, the optimal temperature for biomass
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and carotenoids production was 28 ◦C, although reduced biomass and carotenoid production was
seen and tested at other temperatures. Our results were similar to the results provided by others.
Other studies revealed the optimal temperature for maximum Rhodotorula glutinis growth and
carotenoids production was 29 and 30 ◦C, respectively [19] in monoculture and 30 ◦C in co-culture
with lactic acid bacteria [20]. The temperature also has an effect on the regulation of enzymes involved




































Figure 3. Effect of temperature on biomass and carotenoids production by Rhodotorula sp. RY1801.
2.2.2. Culture Medium pH
The influence of culture medium pH on biomass growth and carotenoids production in Rhodotorula
sp. RY1801 was evaluated in YPD medium at 28 ◦C. As seen in Figure 4, the optimal initial pH under
our culture conditions was pH 5 and similar biomass and carotenoids concentrations were seen at pH
6.0 and 7.0. Our results were similar to those by other workers. A study by Latha et al. indicated that
the R. glutinis biomass increased as the initial culture pH increased from 5.5 to 7.5, although optimal
carotenoids production was pH 5.5 [22]. A similar optimal pH 5.5 was observed for β-Carotene







































Figure 4. Effect of initial pHs on production of biomass and carotenoids by Rhodotorula sp. RY1801.
2.2.3. Carbon Sources
Carbon has been considered an important source for the energy supply and growth of
microorganisms and is widely studied in the context of microbial fermentations. We investigated the
influence of several carbon sources on biomass, and carotenoid production under culture conditions
with initial pH 5.0 at 28 ◦C. Among the several carbon sources tested, glucose proved to be the most
suitable carbon source for carotenoid production, with 962 μg/L of carotenoid (Figure 5). This may
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be due to the fact that glucose can easily be assimilated in the metabolic pathway for biosynthesis of
carotenoids. The type of carbon source has a significant influence on carotenoids production, and their





































Figure 5. Effect of different carbon sources on production of biomass and carotenoids by Rhodotorula
sp. RY1801.
2.2.4. Inorganic Nitrogen and Organic Nitrogen Sources
The influence of different nitrogen sources on biomass and carotenoids production was
investigated with culture media containing 2% (w/v) glucose, initial pH 5.0, at 28 ◦C. Among the tested
nitrogen sources, yeast extract was proved to be the most suitable nitrogen source for carotenoids
production, with 987 μg/L of carotenoid (Figure 6). The influence of nitrogen sources on carotenoids






































Figure 6. Effect of nitrogen sources on production of biomass and carotenoids by Rhodotorula
sp. RY1801.
Optimization of cultural conditions is necessary in microbial fermentations for carotenoids to
fully exploit the potential of selected microbial strain. The fermentation conditions for the production
of carotenoids by the new isolated Rhodotorula sp. strain was optimized in shake flasks. With different
culture conditions, the amount of biomass varied widely from 3.21 to 5.63 g/L and the total carotenoids
content varied from 589 to 987 μg/L. The biomass yield in our study is lower than others, which could
be attributed to the short time of culture (3 days). El-Banna et al. found that Rhodotorula glutinis strain
NO. 0 produced 7 g/L dry biomass and 266 μg/g cellular carotenoids, 1.6 μg/L volumetric carotenoids
after growing at 30 ◦C for 4 days [16]. Hamidid et al. have also reported that the production biomass
was ranged from 0.04 to 0.84 g/L and the total carotenoid from 0.15 to 10.78 mg/L when optimizing
culture conditions for Halorubrum sp. [25].
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3. Materials and Methods
3.1. Sample Collection and Yeast Isolation
Different sediment samples were collected from the exposed intertidal zone along the South
Yellow Sea in Dongtai City, Jiangsu Province, China. Each sediment sample (approximately 100 g) was
placed in a sterile plastic bag with an ice bag and transported to the laboratory within 10 h and then
processed immediately to isolate yeast. Ten grams of each sample (wet mass) were homogenized in
90 mL sterile 0.9% saline solution then individual yeast colonies were obtained by serial dilution and
plating on yeast extract–peptone–dextrose (YPD) agar plates. All the plates were incubated at 28 ◦C
for 24–48 h to determine the morphology of the colony.
3.2. Identification of the Red Yeast RY1801 Strain
The pure culture of strain RY1801 was used to investigate its physiological and morphological
characteristics according to the methods described by Kurtzman et al. [26]. Genomic DNA of RY1801
was extracted using QIAamp DNA Mini Kit (QIAGEN) following the manufacturer’s instructions.
DNA amounts and purity contained in each extract were evaluated by measuring the absorbances at
230, 260 and 280 nm (Nanodrop 2000, Thermo Scientific, Waltham, MA, USA) and calculating the ratio
A260/A280 and A260/A230. DNAs were stored at −20 ◦C prior to use for amplification studies [27].
The ITS region was sequenced using the forward primer ITS1 (5′-TCCGTAGGTGAACCTGCGG-3′)
and the reverse primer ITS4 (5′-TCCTCCGCTTATTGATATGC-3′) [28]. The PCR conditions were as
follows: 94 ◦C for 10 min, followed by 30 cycles, 92 ◦C for 1 min, 52 ◦C for 1 min, 72 ◦C for 1 min, and
final synthesis at 72 ◦C for 5 min. The PCR products were separated by agarose gel electrophoresis
and purified for sequencing. The sequences obtained were compared to rDNA sequences from
the GeneBank (http://www.ncbi.nlm.nih.gov/BLAST/). ITS fragments obtained from GeneBank
database were aligned with ClustalW (http://www.ebi.ac.uk/Tools/clustalw2/index.html) and the
phylogenetic tree was computed with Jalview 2.4.0.b2 using the neighbor-joining method.
3.3. Determination of Biomass and Total Carotenoids
The cells were harvested by centrifugation 8000 rpm and 4 ◦C for 10 min, later washed with
distilled water and centrifuged. The biomass of RY1801 was quantified through drying at 60 ◦C until a
constant mass was obtained.
The carotenoids were extracted using techniques as described by Lopes et al. [29] with slight
modification. The 0.1 g dry weight biomass was mixed with 2 mL DMSO and 5 mL acetone in a 10 mL
tube. The mixture was subjected to 5 ultrasonic cycles at 40 kHz (Ningbo Scientz Biotechnology Co.,
Ltd., Ningbo, China) for 10 min, with 5 ml acetone added. The tube was vortexed vigorously and kept
standing for 10 min. Centrifugation was performed (5000 × g for 10 min) to remove the biomass from
the extracted carotenoids. The biomass was then resuspended in DMSO and acetone for additional
extractions. The carotenoids-containing supernatant was pooled and analyzed by spectrophotometry.
Initial spectrophotometry scan between 300 and 600 nm revealed the maximum absorption to occur at
490 nm. Carotenoids concentration was determined using the following equation [30–32].
Total carotenoids (μg/g of yeast) = Amax × D × V/(E × W)
Amax: the absorbencies of total extract carotenoid at 490 nm
D: sample dilution ratio
V: volume of extraction solvent (mL)
E: extinction coefficient of total carotenoid (0.16)
W: dry weight of yeast (g)
109
Mar. Drugs 2019, 17, 161
3.4. Antimicrobial Activity of Carotenoid Pigments
The carotenoid pigments were extracted and dissolved in methanol. The antimicrobial activity was
obtained using an agar well diffusion method [33]. Escherichia coli ATCC 29522, Staphylococcus aureus
ATCC 25923 and Pseudomonas aeruginosa ATCC27853 were used as indicator strains. After incubation
at 37 ◦C for 24 h, the antimicrobial activity of carotenoid pigments was determined by measuring the
diameter of the zone of inhibition.
3.5. Optimization of Carotenoid Production in Shake-Flasks Experiments
In order to determine the initial pH values, incubation temperature, carbon source and nitrogen
sources on carotenoids production and biomass growth, the experiment was conducted using a series
of 250-mL flasks. Each flask contained 100 ml YPD media with 5% inoculum of Rhodotorula sp. RY1801.
The initial media pH values, incubated temperatures, different carbon sources, and nitrogen sources
were adjusted according to the experimental design. The flasks were shaken at 120 rpm for 72 h.
The yeast biomass was harvested using refrigerated centrifugation (8000 rpm, 10 min). After washing
the cellular pellet with distilled water twice, the biomass was used for further carotenoids extraction
and carotenoids production analysis.
4. Statistical Analysis
All data were analyzed using One-way Analysis of Variance (ANOVA), and multiple comparison
tests (Duncan’s and Tukey’s-tests) were performed using SPSS Statistic 2.0 software. Data were
presented as Mean ± Standard. p < 0.05 was considered statistically significant.
5. Conclusions
Red yeast strain Rhodotorula sp. RY1801 was isolated from the exposed intertidal zone along
the South Yellow Sea in Dongtai City, Jiangsu Province, China. The optimum conditions found for
carotenoids production for Rhodotorula sp. RY1801 were as follows: temperature, 28 ◦C; pH 5.0; carbon
source, 10 g/L glucose; and nitrogen source, 10 g/L yeast extract, maximum concentration of 987 μg/L
of total carotenoids was obtained. The results of this study showed that the isolated yeast strain
Rhodotorula sp. RY1801 potentially can be used in the future as promising microorganism for the
commercial production of carotenoids.
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Abstract: The democratization of sequencing technologies fostered a leap in our knowledge of the
diversity of marine phytoplanktonic microalgae, revealing many previously unknown species and
lineages. The evolutionary history of the diversification of microalgae can be inferred from the
analysis of their genome sequences. However, the link between the DNA sequence and the associated
phenotype is notoriously difficult to assess, all the more so for marine phytoplanktonic microalgae
for which the lab culture and, thus, biological experimentation is very tedious. Here, we explore the
potential of a high-throughput untargeted metabolomic approach to explore the phenotypic–genotypic
gap in 12 marine microalgae encompassing 1.2 billion years of evolution. We identified species-
and lineage-specific metabolites. We also provide evidence of a very good correlation between the
molecular divergence, inferred from the DNA sequences, and the metabolomic divergence, inferred
from the complete metabolomic profiles. These results provide novel insights into the potential
of chemotaxonomy in marine phytoplankton and support the hypothesis of a metabolomic clock,
suggesting that DNA and metabolomic profiles co-evolve.
Keywords: chemotaxonomy; phylogeny; mamiellales; galactolipids; betaine lipids; xanthophylls
1. Introduction
Phytoplanktonic eukaryotes are phylogenetically highly diverse, as they have many representatives
in most super-groups of the eukaryotic tree of life [1,2]. The Archaeplastida super-group, or green
lineage [3], includes all of the species that have descended from a primary endosymbiosis event,
when an ancestral eukaryotic cell engulfed a photosynthetic prokaryote, that eventually evolved into
an organelle, the chloroplast [4]. Our knowledge on the diversity of phytoplanktonic green microalgae
has greatly increased with the democratization of DNA sequencing and genomics, but it is likely to
stay behind that of their terrestrial relatives, including land plants, whose estimated species number
exceeds 400,000 [5]. This is not surprising since unicellular organisms are generally less studied than
multicellular organisms, and because bona fide species identification relies on tedious sampling and
isolation steps which have yet to be performed for many marine microalgae. Recently, DNA sequencing
of numerous environmental marine water sample extracts collected worldwide during the Ocean
Sampling Day initiative provided evidence that many of the sequences detected belong to species
from the green lineage that have no representative strains in culture [6]. This study also demonstrated
the very broad geographic distribution of species from the class Mamiellophyceae, that dominates
the picoeukaryotic fraction (cell diameter <3 μm) [7] in many coastal areas and thus plays a key
ecological role in marine food webs. These picoalgae exemplify the ecological success of miniaturized
eukaryotic cells [8] displaying a simple cellular organization (one mitochondrion and one chloroplast)
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and high surface–volume ratio, which is likely to confer advantages in nutrient-poor environments [9].
The Mamiellophyceae lineage is ancient, probably over 350 million years old [10], and currently
comprises 22 described species [11]. Species from the three genera Bathycoccus, Micromonas, and
Ostreococcus are particularly prevalent in the marine environment [6].
Historically, analysis of pigment composition has been used to assist the classification of microalgae.
Indeed, Bathycoccus, Micromonas, and Ostreococcus species were found to contain characteristic pigments
of many marine green microalgae, prasinoxanthin [12], but also specific pigments such as uriolide,
micromonal, and dihydrolutein [13], which were not detected in other species outside the Mamiellales.
The advent of metabolomics now enables the metabolic signatures of microalgae to be explored at
an unprecedented level of resolution [14]. These novel approaches have led to the discovery of new
metabolites, fostered by the search for natural bioactive compounds with applications in agronomic,
medical, or biofuel research. Indeed, polyunsaturated fatty acids (PUFA) are lipids with high nutritional
value [15] and may have applications in the prevention of several pathologies, such as cancers or
cardiovascular diseases [16,17]. Furthermore, the anti-inflammatory and antiviral properties of polar
lipids have also been highlighted recently [18,19].
Here, we explored the potential of an untargeted metabolomic approach including pigments, lipids,
and other uncharacterized metabolites to investigate chemotaxonomic markers in 12 marine microalgal
strains from 11 species, including 9 microalgae from the green lineage; the Mamiellales Ostreococcus
tauri [20], O. mediterraneus [21], Bathycoccus prasinos [22], Micromonas commoda [23], and Mantoniella
sp., the Chlorellales Picochlorum costavermella [24], and strains from basal groups Nephroselmis sp. and
Pyramimonas sp. To broaden the phylogenetic diversity of the dataset, two additional marine microalgae
outside the green lineage were included: Phaeodactylum tricornutum (Stramenopile lineage) and Pavlova
lutheri (Haptophyta lineage). We assess whether total metabolomic profiling enables us to delineate
well-defined species, and we characterize the 10 major compounds of each species. Last but not least,
we assess whether distances between metabolomic profiles, integrating both the composition and the
frequency of each compound, reflect phylogenetic distances between species. This leads us to discuss
the hypothesis of a metabolomic corollary of the molecular clock, a central tenet of molecular evolution.
2. Results
2.1. An Untargeted Holistic Analysis of Metabolomic Profiles
To investigate metabolome diversity in 12 divergent algae, an untargeted holistic approach was
chosen to cover a broad range of metabolites, such as lipids or pigments known as algal biomarkers.
Algal ethyl acetate extracts were analyzed by UHPLC-ESI+-HRMS2, and acquired ion chromatograms
were processed through an untargeted metabolomic workflow in Compound Discoverer 2.1 software
(Thermo Scientific) to generate extracted ion chromatograms across samples, detect and quantify
corresponding metabolites, and generate the observations/variables matrix used for further statistical
analyses. As a first observation, 2565 ions were detected across all samples, and 1143 ions were unique
features detected in only one species. Moreover, detected features ranged from 867 ions in O. tauri
sp. 1 to 241 ions in Pyramimonas sp. 1422 ions are shared between at least two species (Figure S1).
These observations suggest high variation in the diversity of produced metabolites. To display this
variation, an initial principal component analysis (PCA) was conducted on the observations/variables
matrix to compare metabolomic profiles between strains at the global metabolome scale (Figure 1).
Principal Components (PCs) 1 and 2 describe 34.8% of the variation, and the first PC separates
Mamiellales from the two microalgae P. lutheri (Haptophyta lineage) and P. tricornutum (Stramenopile
lineage), hereafter considered outlier microalgae as they are not part of the green lineage. The second
PC separates Ostreococcus species from other Chlorophytes (Nephroselmis, Pyramimonas). Interestingly,
intraspecific metabolome diversity seems minimal as compared to within-replicate variation, as the
two O. tauri strains’ PCA confidence ellipses overlap.
114
Mar. Drugs 2020, 18, 78
Figure 1. Principal Component Analysis of the whole metabolome of 12 marine microalgae. For each
species and strain, confidence ellipses cover 95% of group position estimation.
2.2. Identification of the Major Metabolites and Detection of Chemotaxonomic Markers
In order to go further into the comparative metabolic profiling of the 12 strains, the 10 major
metabolites of each strain, defined as the 10 highest peak areas of the extracted ion chromatograms
(XIC), were identified (Figure 2). Identification was carried out by comparing compound raw formulas
(calculated on the basis of high-resolution mass spectrometry) to databases (Dictionary of Marine
Natural Products and SciFinder) to retrieve candidate compounds, then MS2 spectra were submitted
to databases for comparison (Global Natural Products Social Molecular Networking—GNPS [25])
or elucidated to infer putative structures. Compounds were classified into 10 different groups of
polar lipids and pigments. Among the polar galactolipids, eight were monogalactosyl diacylglycerols
(MGDGs) (Figure S2), two were monogalactosyl monoacylglycerols (MGMGs or Lyso-MGDGs),
and one was a sulfoquinovosyl diacylglycerol (SQDG) (Figures S4 and S5).
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Figure 2. Matrix of the top 10 (blue), detected (green), and not detected (yellow) metabolites, and structure
examples of the 59 most abundant compounds over the 12 microalgal strains. For all compounds,
identifications are based on (1) molecular formulas, (2) automatic assignment via Global Natural Products
Social Molecular Networking (GNPS), (3) interpretation of MS2 spectra and comparison with published
data, and (4) phylogeny.
For MGDGs and SQDGs, the regiochemical assignment (sn-1 and sn-2 positions) of both fatty acid
(FA) chains was done by comparing the MS2 fragmentation patterns. The fragment resulting from sn-1
FA loss ([M+X-R1CO2H]+) exhibits a higher peak intensity than the one resulting from sn-2 FA loss
([M+X-R2CO2H]+) for the protonated adduct (X = H) of SQDGs [26] and sodiated adduct (X = Na) of
MGDGs [27]. Besides this, it has been established in the literature that the sugar moiety is a galactose
for glycolipids and a sulfoquinovose for SQDG [28]. The betaine lipids are the most represented
and diversified group with twenty 1,2-diacylglyceryl-3-O-4′-(N,N,N-trimethyl)-homoserines (DGTSs)
(Figures S6 and S7), seven 1,2-diacylglyceryl-3-O-2′-(hydroxymethyl)-(N,N,N-trimethyl)-ß-alanines
(DGTAs), two 1-acylglyceryl-3-O-4′-(N,N,N-trimethyl)-homoserines (lyso-DGTSs), and one
1,2-diacylglyceryl-3-O-carboxy-(hydroxymethyl)-choline (DGCC) (Figure S8). Regiochemical
assignment of FAs was done as for galactolipids on the basis of MS2 spectra. Here, the collision-induced
[M +Na-R2CO2H]+ fragment of sodiated adducts produced a higher peak than the [M+Na-R1CO2H]+
fragment [29]. Distinction of the isomeric DGTA and DGTS betaine lipids was performed on the
basis of strain phylogeny in case of coelution. The fragmentation pattern commonly described for
these lipids includes the characteristic 59 Da neutral loss corresponding to the loss of trimethyl amine
(NMe3) and the 87 Da neutral loss (CH3-CH--N+Me3) for DGTSs as a consequence of fragmentation
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after transposition of the carboxyl group [30]. Unfortunately, this fragmentation reaction was not
observed in our analyses. According to the literature, DGTAs are specific to brown algae (P. lutheri
and P. tricornutum) while DGTSs are produced by microalgae from the green lineage [28]. On the
pigment side, 11 chlorophylls (Figures S9–S23) and 6 xanthophylls (Figures S24–S30) appeared to
be largely shared among strains. In the xanthophyll series, one compound was identified as either
prasinoxanthin or its isomer violaxanthin. The uncertainty was eventually disentangled thanks to
the typical dehydration fragmentation pattern of prasinoxanthin (Figure S28), while an 80 Da neutral
loss was observed for the epoxycarotenoid violaxanthin (Figure S29) [31]. Fucoxanthin (Figure S30)
was unambiguously identified from specific fragments at m/z 109.1014, 581.3975, and 641.4207 in
MS2 [32]. Apart from the polar lipids and pigments, a ceramide non-hydroxy fatty acid sphingosine
(Cer) (Figure S31) was also identified.
The most abundant and diversified metabolites identified over the 12 strains were polar lipids
and pigments. These observations are consistent with an increasing number of studies concerning the
analysis of algal lipidomes [28,33] and provide new lipidome information for the strains Mantoniella
sp., Nephroselmis sp., and Pyramimonas sp. recently isolated from environmental samples. Further
phylogenetic signals of metabolites are given and discussed in the following section.
The 10 major metabolites of each microalga shown above were chosen to construct a new matrix
of compound abundance to perform a second PCA (Figure 3A). Remarkably, the variability explained
by the two PCs remained similar (38.8%), and so did the pattern of clustering of the different strains
as compared to the first PCA conducted on the whole metabolome analysis. The first PC again
discriminated the outlier microalgae P. lutheri and P. tricornutum from the Mamiellales, while PC2
separated P. costavermella from the brown algae, and the green microalgae fanned out along this axis.
The contribution of each major metabolite to a strain or group of algae can be inferred from the
biplot projection of the PCA (Figure 3B–D). The first PC separates the green microalgae from the
outlier brown ones, and as expected, this distinction is primarily due to the betaine lipids DGTAs and
DGTSs. The high chemical diversity of DGTSs is due to a greater variability in the acyl chain length
and number of unsaturations, while DGTAs hold only long (C20–C22) and highly unsaturated acyl
chains (Figure 2). MGDGs are represented in every species. MGDGs 18:3/16:4, 18:4/16:4, and 18:5/16:4
are only found in green microalgae. They predominate in the Mamiellales as previously described
by Degraeve-Guilbault et al. [34]. Major galactolipids of the brown algae P. tricornutum contain 16:0,
16:1, 16:3, and 20:5 fatty acid chains, which is also consistent with previous analyses, reinforcing the
reproducibility of these observations [29]. Interestingly, MGMGs are only detected in P. tricornutum
and P. costavermella. Usually, these lipids are not extensively studied in the literature and may be
associated with lipid remodeling or environmental plasticity [35]. Some strains can exhibit metabolites
exclusive to their group. DGCCs are present in P. lutheri but absent in P. tricornutum and may be a
biomarker of haptophytes [28,36]. This is largely described in the literature, but we also show here
that fucoxanthin occurs in the lineage containing P. lutheri and P. tricornutum. On the other hand, C14
esterified siphonaxanthin (Figures S25–S27) and siphonein (Figure S29) are specific to the Chlorophytes
Nephroselmis and Pyramimonas. In fact, these pigments are widely found in green algae, especially in
deep-water or shade species, as they improve the efficiency of light-harvesting complexes [37] or protect
the cells from high light damage. Moreover, prasinoxanthin (Figure S31) is the major xanthophyll that
identifies Mamiellales amongst other green algae [12].
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Figure 3. (A) Principal component analysis (PCA) constructed from the 59 most abundant metabolites
matrix over the 12 microalgal strains, and the corresponding biplots of the (B) betaine lipids, (C) galacto-,
sulfolipids, and ceramide, and (D) pigments (each arrow corresponds to a metabolite). Confidence
ellipses cover 95% of group position estimation. Arrow coordinates correspond to the contributions of
metabolites to the PC and color to the metabolite class. Arrows point toward the strains where they are
the most represented.
Beyond a simple identification of metabolite classes within microalgal species or lineages,
our results demonstrate that some specific metabolites within classes may serve as phylogenetic
markers, pending analysis of additional species identified in each group. Our analysis confirms that
prasinoxanthin is specific to the Mamiellales, but also that DGTS 22:6/16:4 is specific to microalgae from
this group. The number and diversity of DGTSs we found between Pyramimonas sp. and Mamiellales
is an outstanding observation, since these betaine lipids were not detected in Nephroselmis sp. or even
in B. prasinos or O. mediterraneus. Within the Mamiellales, the Ostreococcus genus differs by the presence
of two MGDGs (20:5/16:3 and 16:1/16:1). The species O. tauri has six DGTSs which are not found in O.
mediterraneus. Interestingly, the presence/absence matrix does not differentiate both O. tauri strains.
More data will be necessary to confirm these observations, but the “major metabolites approach” does
indeed appear to be interesting for differentiating between these microalgae at the species level.
The choice of taxonomic chemical biomarkers is always challenging as the diversity and abundance
of metabolites should reflect species divergence rather than intrinsic variability due to environmental
factors. To get around this, chemical classification of plants has been preferentially achieved by
comparison of secondary metabolites since these are remarkably diverse [38], include numerous classes
of compounds (glycosides, phenolics, or alkaloids) [39], and are relevant for species classification, as
they are restricted to taxonomically related groups of species [40,41]. Comparison of algae has so far
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relied on pigment analysis using 44 pigment types spanning 27 classes of photosynthetic algae [42],
and these pigments are consistent with the endosymbiotic evolutionary history of eukaryotes [43].
More recently, many efforts in algal compound screening have enabled the description of hundreds
of new metabolites each year [44], which provide the opportunity to identify species from a broader
spectrum of compounds. Algal lipids have been extensively described in model species such as
Chlamydomonas reinhardtii, Chlorella sp., Nannochloropsis sp., or P. tricornutum [29,45–47], while complete
lipidome profiles have yet to be acquired for most algae. Nonetheless, lipids, especially FAs [48–50],
sterols [50], alkenones [51], or polar lipids [52,53], are widely used as species tracers. It is important
to keep in mind that lipid profiles may be impacted by environmental, biotic, or abiotic factors [54],
as demonstrated in many studies on nutrient availability, irradiance, and growth stage [29,34,55,56].
However, even though taxonomic signals may be diminished by external factors, it has been shown
that taxonomy accounts for 3 to 4 times more variance in the lipid profiles of phytoplankton than
abiotic factors [49]. Besides this, polar lipids, especially betaine lipids (DGTA/S, DGCC), constitute the
least impacted metabolite class by growth stage as demonstrated by Cañavate and colleagues, and they
are therefore considered reliable lipidic taxonomic markers [57]. The abundancy profiles of “major
metabolites” are consistent across experiments from available studies performed at the molecular
level [29,34,58], suggesting that they are relevant chemotaxonomic marker candidates.
2.3. Phylogenetic Analysis and Metabolome-Based Taxonomy
The phylogeny based on the partial analysis of the 18S rDNA subunit was consistent with previous
findings based on a larger set of sequence data [1,59] retracing the molecular divergence between
species and the different microalgal families (Figure 4A) and was therefore used as a reference for
comparison with the information from the metabolome of each microalga.
Figure 4. (A) Partial 18S ribosomal gene phylogeny based on 429 base pairs; scale indicates substitution
per site. (B) A hierarchical clustering dendrogram based on 3138 metabolites; the scale represents the
Spearman correlation coefficient between strains. (C) A hierarchical clustering dendrogram based on the
59 most abundant metabolites; the scale represents the Spearman correlation coefficient between strains.
First, hierarchical clustering analysis (HCA) was performed to determine the metabolomic
proximity between strains. The HCA dendrogram (Figure 4B) was generated by calculating the
distance matrix between strains based on the Spearman correlation coefficient and aggregated by
“complete linkage”. A clear clustering of Mamiellales species emerged from HCA, except for Mantoniella
sp., which exhibited a metabolomic profile more closely related to Pyramimonas sp. This peculiarity
disappears when the metabolome is reduced to the 10 major metabolites to build the chemotaxonomy
(Figure 4C). This suggests that major compounds tend to be reliable species biomarkers when comparing
divergent as well as closely related organisms. Microalgal cultures are very rarely axenic, since a
bacterial community often co-exists with microalgae [60]. Estimation of the proportion of bacteria by
cytometry revealed that most cultures contained less than 5% bacteria, while it turned out that both
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Mantoniella sp. and Pyramimonas sp. could not be cleansed of bacterial partners (microalgae/bacteria
~1:1). This may be a consequence of their mixotrophic regime [61,62]. The clustering of these strains
may thus be due to the metabolomic contribution of bacteria, either because of identical metabolites of
bacterial origin or through a similar microalgae–bacteria interaction process that may dramatically
influence the metabolome of the microalgal partner. However, we demonstrate here that algal
metabolites predominate in the total extract, so bacterial participation disappears when considering
the major metabolites only. Besides this, statistical comparison of genetic distances with metabolomic
distances based on whole-metabolome analysis amongst algae confirms a strong correlation between
both approaches (Mantel test: r = 0.77, p-value = 0.001). Thus, there is a good overlap of phylogenetic
and chemotaxonomic signals, as metabolomic distances reflect genetic distances between species.
This correlation is even stronger when estimated from the most abundant metabolites (Mantel test:
r = 0.90, p-value = 0.001), confirming the robustness and potential of the metabolomic approach to
discriminate and retrace the evolutionary history of divergent species.
Establishing the full lipidome profile of algae at the molecular level within and between species is
relevant for several reasons. First, it provides a fundamental description of the species at the metabolite
level and helps to estimate the chemical divergence between strains or species. Secondly, it can lead
to the identification of algal species producing interesting bioactive compounds, such as high-value
carotenoids and lipids, with agronomical and pharmaceutical applications. The present study
highlights the abundance of long-chain polyunsaturated FA, such as octadecapentaenoic acid (18:5n-3),
eicosapentaenoic acid (20:5n-3), or docosahexaenoic acid (22:6n-3), the health benefits of which have
been previously recognized [63], for example, in preventing cardiovascular or mental disorders [64–66].
Moreover, particularly abundant in Mamiellophyceae, polar lipids and especially MGDG 18:3/16:4
and MGDG 18:4/16:4 of Tetraselmis sp. have effective anti-inflammatory properties [67,68]. P. lutheri’s
major galactolipid MGDG 20:5/18:4 has also been shown to have anti-inflammatory activity [69],
inhibiting both human melanoma cell growth [70] and bacterial development [71]. Last but not
least, SQDGs are probably among the most promising compounds in the medical field as lipids
from this class are known to act on HIV infection [72], but also exhibit anti-HSV-1 and anti-HSV-2
activities [73] and anti-inflammatory [74] and antitumor properties [75]. The aforementioned bioactive
molecules are far from exhaustive but highlight the biotechnological potential of algae as producers of
bioactive molecules.
In conclusion, we investigated the metabolomes of 12 microalgal strains from 11 species and
characterized the major carotenoids and lipids. The approach of using major metabolites allows
microalgal species and lineages to be distinguished. Evolutionary divergence between species can be
inferred, in good congruence with the phylogenies obtained from sequence data obtained through
a classical molecular approach. Therefore, these results support the hypothesis of a metabolomics
equivalent to the “molecular clock” based on the analysis of sequence data. The resulting “metabolomics
clock” metaphor is also constrained by the technical challenges raised by the “molecular clock” inferred
from DNA sequence analysis: What are the mode and tempo of metabolome evolution? Are some
metabolites changing faster than others? What is the distribution of fitness effects of metabolite
changes? To answer these questions, statistical developments are needed to develop metabolomic
distances and larger datasets including additional species should be obtained to include a broader
variation in evolutionary distances.
3. Materials and Methods
3.1. Culture Conditions and Growth Measurement
Cultures were grown in modified Keller Artificial Seawater medium [76] (K-ASWO) containing
420 mM NaCl, 10 mM KCl, 20 mM MgCl2, 10 mM CaCl2, 25 mM MgSO4, 2.5 mM NaHCO3, 0.88 mM
NaNO3, 5.0 × 10−5 M NH4Cl, 1.0 × 10−5 M β-glycerophosphate, 1.0 × 10−8 M H2SeO3, 1 mL of 1 M
Tris-HCl (pH 7.2) per liter of medium, 3.7× 10−10 M cyanocobalamin, 2.0× 10−9 M biotin, and 3.0 × 10−7
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thiamine in addition to Keller trace metal solution [77]. Algal strains were cultured in T75 cell culture
flasks with ventilated caps (Sarstedt, Germany) containing 100 mL of K-ASWO medium. Each flask
was inoculated to a cell density of 1 × 106 cells.mL-1 for O. tauri 1 (RCC 6850) and 2 (RCC 4221),
O. mediterraneus (RCC 2590), B. prasinos (RCC 4222), M. commoda (RCC 827), Mantoniella (RCC 6849),
P. costavermella (RCC 4223), P. tricornutum (RCC 6851), and P. lutheri (RCC 6852); 2.4 × 105 cells.mL−1
for Nephroselmis sp. A (RCC 6846); 3.3 × 105 cells.mL−1 for Nephroselmis sp. B (RCC 6847); and 7.8 × 104
cells.mL−1 for Pyramimonas sp. (RCC 6848). Cultures were maintained at a temperature of 20 ◦C under
continuous light of 100 μE.m-2.s-1 and were agitated manually once a day; cell density was measured
every day by flow cytometry.
3.2. Microalgal Culture Axenization
All cultures were treated with antibiotics to lower the bacterial concentration. Quantities of
50 μg.mL−1 ampicillin (A9518, Sigma-Aldrich), 50 μg.mL−1 gentamycin (G1914, Sigma-Aldrich),
20 μg.mL−1 kanamycin (60615, Sigma-Aldrich), and 100 μg.mL−1 neomycin (N6386, Sigma-Aldrich)
were added to K-ASWO, and after two subculturing stages, the bacterial content was low enough
to perform metabolomic analysis in most strains. A single antibiotic treatment reduced the bacterial
contamination in Ostreococcus and P. lutheri cultures but was unable to remove bacteria completely
in others.
3.3. Flow Cytometry
Cells were fixed using glutaraldehyde (0.25% final concentration, G6257, Sigma-Aldrich) with the
addition of Pluronic F-68 (0.1% final concentration, P-7061, Sigma-Aldrich) for 15 min in the dark and
stained with SYBR Green I (LON50512, Ozyme) for another 15 min in the dark. Cell counting was
performed using a Beckman Coulter Cytoflex flow cytometer (laser excitation wavelength 488 nm) by
chlorophyll autofluorescence for microalgae (detection filter>620 nm) and by SYBR Green I fluorescence
for bacteria (detection bandwidth 525–540 nm, corresponding to the FITC (fluorescein isothiocyanate)
channel). Data were analyzed with CytExpert 2.2 software (Beckman Coulter).
3.4. Metabolite Extraction
Microalgal cells were collected three to four days post inoculation (Supplemental Figure S1)
by filtration of 100 mL of culture through a Whatman GF/F filter (Z242519, Sigma-Aldrich) under
reduced pressure (600 mbar). Then, filters were placed in disposable glass culture tubes with 7 mL
of ethyl acetate (16371, Sigma-Aldrich) to solubilize algae cells overnight in a C25 incubator shaker
(New Brunswick Scientific, 100 rpm, 19 ◦C).
3.5. UHPLC-HRMS Analyses
Microalgal extracts were analyzed on an Ultimate 3000 UHPLC Dionex system coupled to an
Orbitrap MS/MS FT Q-Exactive Focus Thermo Scientific mass spectrometer. Samples were solubilized
in MeOH (1 mg.mL−1) and 1 μL was injected onto the column. The column was a Phenomenex Luna
Omega Polar C18 (150 × 2.1 mm, 1.6 μm, 100 Å) conditioned at 42 ◦C. The mobile phase was a mixture
of water (solvent A) with increasing proportion of acetonitrile (solvent B, 012041, Biosolve), both
solvents modified with 0.1% of formic acid. The gradient was as follows: 50% B from 3 min before
injection to 1 min after; between 1 and 3 min, a linear increase of B up to 85%, followed by 85% B
for 2 min; 89% B from 5.1 to 7 min; 93% B from 7.1 to 10 min; 97% B from 10.1 to 13 min; and finally,
100% B from 13.1 to 18 min. The flow was set to 0.5 mL.min−1 and injected into the mass spectrometer
1 min after injection (diverted before). Mass spectrometry analyses were performed in the positive
electrospray ionization mode in the 133.4–2000 Da range, and mass spectra were recorded in the
centroid mode. The mass spectrometer method was set to FullMS data-dependent MS2. In fullMS,
the resolution was set to 70,000 and the AGC target to 3 × 106 for a chromatogram peak width (FWHM)
of 6 s. In MS2, the resolution was 17,500, the AGC target 1 × 105, the isolation window 0.4 Da, and
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the stepped normalized collision energy 15/30/45 with 10 s of dynamic exclusion. The lock mass was
calibrated on the Cu(CH3CN)2+ ion at m/z 144.9821 Da.
3.6. LC-MS Data Preprocessing
Total ion chromatograms were processed through the untargeted metabolomic workflow of
Compound Discoverer (CD) 2.1 (Thermo Scientific). A Quality Control mix (QC) composed of the
12 algal extracts was analyzed together with algal extracts and K-ASWO medium used as a blank
to remove nonalgal compounds. The CD workflow performs retention time correction, detection
of unknown compounds, and grouping across samples; fills gaps when features are absent; hides
chemical background (using blank samples); and finally predicts compound elemental composition.
The retention time window was set to 2–18 min. The maximum time shift for compound alignment
was 0.1 min, the maximum mass tolerance for compound grouping and elemental composition
calculation was 3 ppm, and the minimum peak intensity was 2 × 106. This workflow provided an
observation/variable matrix used for further statistical analysis.
3.7. Confirmation of Algae Identities and Reconstruction of Phylogenies
Algae identification was performed on the basis of partial 18S rDNA sequence analysis. Total DNA
was extracted with hexadecyltrimethylammonium bromide (CTAB) as described by Winnepenninckx
et al. [78]. The 18S rDNA gene region was amplified by PCR using the unique nondegenerate universal
eukaryotic forward primer F-566 (5’ CAG CAG CCG CGG TAA TTC C 3’) and the reverse primer
R-1200 (3’ CCC GTG TTG AGT CAA ATT AAG C 5’) [79] before sequencing by the GATC company.
Then, partial 18S rDNA sequences were aligned using MUSCLE 3.8 [80], and gaps were manually
removed to get 429 base pairs sequences. Best substitution model selection and phylogenetic tree
reconstruction was performed using IQ-TREE 1.6.12. The best selected model was TIM2e+G4
with the Bayesian Inference Criterion, and 1000 bootstraps were used to construct the consensus
phylogenetic tree.
3.8. Figure Plotting and Statistical Analysis
All figures were plotted using R 3.6.1. Principal Component Analysis and corresponding biplots
were calculated and constructed using the FactoMineR v1.42 package and PCA function with the
scaled data option and 95% confidence ellipse lines. The phylogenetic tree was plotted using the
phytool v0.6-99 package, and the patristic matrix was calculated using the ape v5.3 package, while the
metabolite distance correlation matrix was calculated using the R base stats functions. The Mantel test
was performed using the ade4 v1.7-4 package.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/18/2/78/s1,
Figure S1: Histogram of detected compounds (A) and occurrence in algal strains (B), Figure S2: Microalgal
concentration growth curves over time, Table S1: Algal and bacterial concentration (cells.mL−1) at sampling day
for the 12 algae species, Figures S3–S31: Analytical data on microalgal metabolites.
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Abstract: Four new isocoumarin derivatives, botryospyrones A (1), B (2), C (3), and D (4), and a
new natural tryptamine, (3aS, 8aS)-1-acetyl-1, 2, 3, 3a, 8, 8a-hexahydropyrrolo [2,3b] indol-3a-ol
(5), were isolated from a marine mangrove endophytic fungus Botryosphaeria ramosa L29, obtained
from the leaf of Myoporum bontioides. Their structures were elucidated using spectroscopic analysis.
The absolute configurations of compounds 3, 4, and 5 were determined by comparison of their
circular dichroism (CD) spectra with the calculated data. The inhibitory activities of compound
1 on Fusarium oxysporum, of compounds 2 and 3 on F. oxysporum and Fusarium graminearum, and
of compound 5 on F. oxysporum, Penicillium italicum, and F. graminearum were higher than those of
triadimefon, widely used as an agricultural fungicide. Compound 5 was produced after using the
strategy we called “using inhibitory stress from components of the host” (UISCH), wherein (2R, 3R)-3,
5, 7-trihydroxyflavanone 3-acetate, a component of M. bontioides with weak growth inhibitory activity
towards B. ramosa L29, was introduced into the culture medium.
Keywords: isocoumarin; tryptamine; Botryosphaeria ramose; antifungal activity
1. Introduction
Since the 1990s, marine-derived fungi including mangrove fungi have attracted considerable
interest as a target source of bioactive natural products with chemodiversity [1–3]. Myoporum bontioides
(Siebold and Zucc.) A. Gray (Scrophulariaceae) is one of the mangrove plants distributed along
the coasts of Asian countries [4]. Our chemical investigations into this species have led to the
discovery of various flavonoids, sesquiterpenoids, and phenylethanoids, among others [5]. Through
our ongoing search for novel bioactive metabolites from the endophytic fungi of this plant [6–9], we
have investigated the secondary metabolites of the fungus Botryosphaeria ramosa L29, the ethanolic
extract of which was found to possess antifungal activity. Four new isocoumarin derivatives, named
botryospyrones A (1), B (2), C (3), and D (4) (Figure 1) were isolated. However, under such a common
cultural condition, the fungal strain faced no living stress from the environment. A plausible question
is whether inhibitory stressors from components of the host under natural conditions might change
the metabolites of the fungal strain. To provide an answer to this question, a strategy which we called
“using inhibitory stress from components of the host” (UISCH) was used and prompted the endophyte
Mar. Drugs 2019, 17, 88; doi:10.3390/md17020088 www.mdpi.com/journal/marinedrugs128
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to produce the novel natural product (3aS, 8aS)-1-acetyl-1, 2, 3, 3a, 8, 8a-hexahydropyrrolo [2,3b]
indol-3a-ol (5) belonging to the tryptamine class.
 
Figure 1. Chemical structures of the isolated compounds 1–5.
Herein, we report the details of the isolation, structure elucidation, and antifungal activity of
these compounds.
2. Results and Discussion
Compounds 1–4 were obtained from the fungus Botryosphaeria ramosa L29 grown in common
autoclaved rice medium. Compound 5 was produced when using the UISCH strategy. The flavonoid
(2R, 3R)-3, 5, 7-trihydroxyflavanone 3-acetate, a component of M. bontioides [10] which had been found
by us to have 18.56% growth inhibition rate (0.25 mM) to the mycelium of the fungus Botryosphaeria
ramosa L29, was added to the autoclaved rice medium. Under these conditions, compound 5 was
generated and purified.
Compound 1 was isolated as a yellow powder. The high resolution electron spray ionization mass
spectroscopy (HRESIMS) spectrum of 1 showed an ion peak at m/z 223.0608 ([M + H]+, calcd. for
C11H11O5 223.0606), corresponding to the molecular formula C11H10O5. The infrared radiation (IR)
bands of 1 at 3244, 1682, 1622, and 1615 cm−1 represented the hydroxyl, ester carbonyl, and aromatic
ring groups, respectively. The 13C NMR (Table 1) and heteronuclear singular quantum correlation
(HSQC) spectrum of 1 showed 11 carbon signals consisting of two methyl groups, one sp2 methine
group, seven olefinic quaternary carbons, and one ester carbonyl carbon. The 1H NMR (Table 1)
and HSQC spectra, along with the molecular formula of 1 indicated signals for one hydrogen-bond
hydroxyl group (δH 11.18), two aromatic hydroxyl groups (δH 5.38 and 6.42), one olefinic proton (δH
6.38), and two methyl groups (δH 2.18 and 2.29). These characteristics suggested that compound 1
might be an isocoumarin [11] substituted with three hydroxyl and two methyl groups.
Table 1. 1H (600MHz) and 13C NMR (150MHz) data for compounds 1 and 2.
Position
1 a 2 a
δH, multi (J/Hz) δc (ppm) δH, multi (J/Hz) δc (ppm)
1 166.7 166.4
3 153.7 153.9












9 2.29,s 19.6 2.27,d(1.0) 19.6
10 2.18,s 9.8
a Measured in CDCl3.
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The heteronuclear multiple bond correlation (HMBC) correlations (Figure 2) from 8-OH to C-7,
C-8 and C-8a, from 7-OH to C-6, C-7, and C-8, from 6-OH to C-5, C-6 and C-7, and from H-10 to
C-5, C-6 and C-4a indicated the positions of 6-OH, 7-OH, 8-OH, and CH3-10. In addition, the HMBC
correlations from H-9 to C-3 and C-4, and from H-4 to C-5 suggested that CH3-9 was located at C-3.
Therefore, the structure of compound 1 was determined as 6, 7, 8-trihydroxy-3, 5-dimethylisocoumarin,
as shown in Figure 1.
 
Figure 2. Key HMBC and NOESY correlations for compounds 1–5.
Compound 2 was obtained as a colorless powder, with the molecular formula C12H12O5
determined by the HRESIMS at m/z 237.0765 ([M + H]+, calcd. C12H13O5 237.0763). The NMR
data (Table 1) and HSQC spectrum revealed that compound 2 shared the same isocoumarin skeleton
as 1. However, the CH3 at C-5 in 1 was replaced by a methoxy group in 2, which was revealed by the
HMBC correlations (Figure 2) from the proton of 5-OCH3 to C-5 and from H-4 to C-5. Moreover, the
hydroxyl at C-7 in 1 was absent in 2, and the hydroxyl at C-6 in 1 was changed to a methoxyl in 2,
which was supported by the HMBC correlations from H-7 to C-5, C-6, and C-8a, and from the proton of
6-OCH3 to C-6. Thus, compound 2 was elucidated as 8-hydroxy-5, 6-dimethoxy-3-methylisocoumarin
(Figure 1).
The HRESIMS data of compound 3 at m/z 225.0757 ([M + H]+, calcd. C11H13O5 225.0757)
established the molecular formula C11H12O5. Its 1H NMR spectrum displayed a singlet for an
aromatic methyl group (δH 2.09, s), a doublet for another methyl group (δH 1.18 s) attached to a
methine, two phenolic hydroxyl groups (δH 11.27, s and 9.42, s), and a singlet for an aromatic proton
(δH 6.68, s). The 13C NMR spectrum (Table 2) exhibited the existences of a benzene ring moiety
(δc 162.7, 155.0, 146.5, 110.7, 101.3, 104.1), an ester carbonyl group (δc 171.5), two methyl (δc 17.8, 6.9)
groups, and two oxygenated methine (δc 84.2, 67.2) groups. These data indicated compound 3 was
a dihydroisocoumarin derivative with great similarity to 4, 6-dihydroxymellein [12]. In view of the
downfield chemical shift and the peak shape, the hydroxyl group at δH 11.27 must be attached to
C-8 to form an intramolecular hydrogen bond with the carbonyl (C-1). Hence, the only difference
between 3 and 4 is that 6-dihydroxymellein might be an additional methyl at C-7 in 3. This conclusion
was confirmed by the HMBC correlations from CH3-10 to C-6, C-7, and C-8, from 8-OH to C-7, C-8 and
C-8a, and from H-5 to C-6, C-7, and C-8a. The deduction that CH3-9 and 4-OH facing trans direction
was revealed by the strong nuclear Overhauser effect (NOE) correlation between H-4 and CH3-9. The
absolute configuration of 3 was concluded to be 3S, 4R, in that the calculated ECD curve of (3S, 4R)-3
had a good agreement with the experimental data (Figure 3).
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Table 2. 1H (600MHz) and 13C NMR (150MHz) data for compounds 3 and 4.
Position
3 a 4 a
δH, multi (J/Hz) δc δH, multi (J/Hz) δc
1 171.5 166.5
3 5.33,d(4.8) 84.2 5.30,d(3.0) 82.5
4 4.17,m 67.2 4.29,m 67.2
4a 146.5 149.8









9 1.18,d(4.8) 17.8 1.22,d(6.6) 18.1
10 2.09,s 6.9 2.11,s 7.8
a Measured in (CD3)2CO.
Figure 3. Calculated and experimental ECD spectra for compounds 3, 4 and 5.
The NMR features (Table 2) suggested that compound 4 was quite similar to 3, except for two
aromatic hydroxyl groups in 3 being replaced by two methoxy groups (δH 3.96, δc 55.8, 6-OCH3; δH
3.99, δc 61.2, 8-OCH3) in 4, supported by the HMBC correlations from 6-OCH3 to C-6 and from 8-OCH3
to C-8, and by the molecular formula C13H16O5 according to HRESIMS at m/z 253.1078 ([M + H]+,
calcd. C13H17O5 253.1076). The positions of 6-OCH3 and 8-OCH3 were further confirmed by HMBC
correlations from CH3-10 to C-6, C-7, and C-8, and from H-5 to C-6, C-7, and C-8a. The NOE correlation
between H-4 and CH3-9, together with the similar experimental and calculated ECD curves shown in
Figure 3, suggested that compound 4 had the same absolute configuration as 3. Hence, compound 4
was elucidated as (3S, 4R)-4-hydroxy-6, 8-dimethoxy-3, 7-dimethyldihydroisocoumarin.
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Compound 5 was obtained as a yellow solid. The molecular formula C12H14N2O2 (seven degrees
of unsaturation) was established from HRESIMS at m/z 219.1127 ([M + H]+, calcd. C12H15N2O2
219.1128). The IR spectrum showed an absorption band at 3366 cm−1, corresponding to an
amino-group. In addition, the bands at 1615, 1457, and 1413 cm−1 were indicative of the amido
carbonyl group and aromatic ring system. The 13C NMR (Table 3) and HSQC spectra of compound 5
revealed the presence of an acetyl methyl carbon (δC 22.0), one carbonyl carbon (δC 170.5), two sp3
hybridized methene carbons (δC 36.4, 47.0), four aromatic methine carbons (δC 130.7, 123.4, 119.5,
110.2), one heteroatom substituted methine carbon (δC 81.6), one heteroatom attached quaternary
carbon (δC 86.6), and two phenolic quaternary carbons (δC 149.6, 129.2). These data were almost
identical to those of the known compound (3aR, 8aS)-1-acetyl-1, 2, 3, 3a, 8, 8a-hexahydropyrrolo
[2,3b] indol-3a-ol isolated from Streptomyces staurosporeus fermentation with tryptamine [13], which
suggested that compound 5 had the same planar structure as the known compound.
Table 3. 1H (600MHz) and 13C NMR (150MHz) data for compound 5.
Position
5 a

















a Measured in CDCl3.
The deduction was further confirmed by detailed analysis of the HMBC correlations of 5 (Figure 2).
Most chemical shifts of the 1H NMR data of 5 were also consistent with those of the known compound
with differences ≤ 0.03 ppm in deuterated chloroform. However, the chemical shift of one of the
H-3 protons at δH 2.70 in the latter was shifted upfield by 0.16 ppm to 2.54 ppm in the former
(compound 5), suggesting that the absolute configuration at C-3a in compound 5 might be different
from that of the known compound. Moreover, the specific rotations of the two compounds greatly
differed in value (5, [α]25D 23.06; the known compound, [α]
25
D 72.00; in MeOH), suggesting that they
were a pair of diastereoisomers. Furthermore, NOE correlations between one of the protons of H-3 at
δH 2.54 and the proton at δH 5.28, together with no NOE correlations between H-8a (δH 5.32) and the
proton at δH 5.28, suggested that the proton at δH 5.28 should be 3a-OH, which was opposite to H-8a.
Thus, the relative configuration of 5 was different from that of the known compound. On the basis
of this deduction, the theoretical ECDs were calculated. From Figure 3, the experimental curve of
compound 5 matched well with that of the calculative (3aS, 8aS)-5 and greatly diverged from those of
(3aR, 8aR)-5, (3aR, 8aS)-5, and (3aS, 8aR)-5, suggesting that the absolute configuration of 5 was 3aS,
8aS. Since 1-acetyl-1, 2, 3, 3a, 8, 8a-hexahydropyrrolo [2,3b] indol-3a-ol had been synthesized as a
racemic mixture without specifying the relative configuration [14], it is impossible to judge whether
compound 5 was a new compound or not. However, it can be concluded that this is the first report of
5 as a new natural product. Notably, as shown in the HPLC profiles (Figure S34), this new metabolite
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was produced after adding the ingredient (2R, 3R)-3, 5, 7-trihydroxyflavanone 3-acetate of the host [10],
which exhibits weak antifungal activity against the research fungus L29, suggesting that the pressure
to inhibit growth from the antifungal agent of the host changed the metabolic pathway of the fungus.
To the best of our knowledge, this is the first example of a new natural product from plant endophytic
fungus generated according to such a strategy.
Compounds 1–3 and 5 were evaluated in vitro for antifungal activity towards three
phytopathogenic fungi: Fusarium oxysporum (F. oxysporum), Penicillium italicum (P. italicum), and
Fusarium graminearum (F. graminearum) (Table 4). Compared to the positive control triadimefon, all of
the compounds exhibited higher inhibitory activities against F. oxysporum and F. graminearum except
for compound 1. This compound displayed good activity against F. oxysporum (minimum inhibitory
concentration (MIC) value = 112.6 μM) and very weak activity towards F. graminearum (MIC value =
900.0 μM). The activities towards P. italicum for all compounds except compound 3 (inactive, MIC value
> 900.0 μM), appeared to range between modest and high values (MIC values from 450.4 μM to 57.3
μM). It should be noted that compound 5 exhibited approximately twelve-, three-, and eighteen-fold
stronger activities against F. oxysporum, P. italicum, and F. graminearum than triadimefon, respectively.
Moreover, the activities on F. oxysporum for compounds 1 and 2, and on F. graminearum for compounds 2
and 3, were approximately three and two point five times higher than those of triadimefon, respectively.
The activities of compound 4 were not assessed because the amount produced was too small.
Table 4. Antifungal activity of compounds 1, 2, 3, and 5 measured as minimum inhibitory concentration
(MIC) values.
Compounds
F. oxysporum P. italicm F. graminearum
MIC, μM
1 112.6 450.4 900.0
2 105.8 211.7 211.7
3 223.0 >900.0 223.0
5 28.6 57.3 28.6
Triadimefon a 340.4 170.2 510.7
a Positive control towards the test fungi.
3. Materials and Methods
3.1. General Experimental Procedures
Optical rotations were recorded using a P-1020 digital polarimeter (Jasco International Co., Ltd.,
Tokyo, Japan). Ultraviolet (UV) and IR spectra were obtained using a UV-2550 spectrophotometer
(Shimadzu Corporation, Tokyo, Japan) and Nicolet iS10 Fourier transform infrared spectrophotometer
(Thermo Electron Corporation, Madison, WI, USA), respectively. CD spectra were collected
on Chirascan CD spectrometer (Applied Photophysics Ltd., London, UK). 1H and 13C NMR
data were collected on an AVIII 600 MHz NMR spectrometer (Bruker BioSpin GmbH Company,
Rheinstetten, Germany). The positive ion mode on a quadrupole-time of flight (Q-TOF) mass
spectrometer (Thermo Fisher Scientific Inc., Frankfurt, Germany) was used for the measurement
of HRESIMS. Semi-preparative HPLC was performed on a 1260 Infinity Series high performance liquid
chromatography system (Agilent Corporation, Santa Clara, CA, USA). Common column and thin
layer chromatography (TLC) was performed using a 200−300 mesh and G60, F-254 silica gel (Qingdao
Haiyang Chemicals Co., Ltd., Qingdao, China), respectively. For gel filtration chromatography, a
Sephadex LH-20 (GE Healthcare, Chicago, IL, USA) was used.
3.2. Fungal and Plant Material
M. bontioides was collected from a mangrove in Leizhou Peninsula, China, in May 2014. The strain
L29 was obtained from its leaf and was identified as Botryosphaeria ramosa on the basis of molecular
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analysis methods [15]. These cultures are deposited in the College of Materials and Energy, South
China Agricultural University. A BLAST research by NCBI showed that the internal transcribed spacer
(ITS) sequence (No. MK370738 in GenBank) of the fungal strain was identical to that of Botryosphaeria
ramosa CMW26167 (No. NR151841.1).
3.3. Cultivation, Extraction, and Isolation
The strain maintained on potato dextrose agar (PDA) medium at 28 ◦C for 3 days was put into
the liquid medium (2% glucose, 2% peptone) and incubated at 28 ◦C for about 4 days. After that, the
culture (6 mL) was transferred to an Erlenmeyer flask with the rice medium (70 mL H2O, 50 g rice,
0.25 g crude sea salt) treated either with (2R, 3R)-3, 5, 7-trihydroxyflavanone 3-acetate (0.25 mM) or
without this compound (control), and was incubated for 28 days at room temperature. The flavanone
was isolated from M. bontioides, the host of the fungus B. ramosa L29. It was shown to cause an 18.56%
growth inhibition rate at the concentration of 0.25 mM to the mycelium of B. ramosa L29 by a petri
plate mycelia growth rate method [16]. The media (20 bottles) were continuously extracted three
times using 95% ethanol. The solvent was evaporated in vacuo and was extracted three times with
ethyl acetate to obtain a dark brown crude extract (25.0 g). The EtOAc extracts of different conditions
were analyzed by reversed-phase HPLC (Hypersil BDS C18 column, 150 × 4.6 mm, 5 μm) using a
gradient of MeOH/H2O (20:80–80:20, 0–30 min; 80:20–100: 0, 30–45 min; 100: 0, 45–60 min) at a flow
rate of 1.0 mL/min, and recorded at 254 nm. Then, the EtOAc extract was subjected to silica gel
column chromatography eluted with a gradient of petroleum ether/EtOAc (90:10, 85:15, 75:25, 50:50,
25: 75, 15:80, v/v) to afford six fractions (Fraction 1–6). Fraction 1 was chromatographed on a silica gel
column, eluted with a gradient system of petroleum ether/EtOAc (95:5, 90:10, 85:15, v/v) to provide
Fraction 1.1–1.5; Fraction 1.2 was separated through a Sephadex LH-20 chromatograph (MeOH as
eluent) to give Fraction 1.1.1–1.1.2, and Fraction 1.1.1 was purified through semi-preparative HPLC
(MeOH/H2O,90:10, v/v; 2.0 mL/min) to yield compound 2 (3 mg, tR = 33.5 min). Fraction 2 was eluted
with a gradient system of petroleum ether/EtOAc (90:10, 85:15, 80:20, 75:25, v/v) on a silica gel column
to give Fraction 2.1–2.4; Fraction 2.2 was applied on semi-preparative HPLC (MeOH/H2O, 79:21, v/v;
2.0 mL/min) to provide compound 4 (1.5 mg, tR = 29.3 min). Then, Fraction 3 was fractioned by silica
gel column chromatography using petroleum ether/ EtOAc (80:20, 75:25, 70:30, 60:40, 50:50, 40:60,
30:70,20:80, v/v) as eluents to afford Fraction 3.1–3.8; Fraction 3.4 was subjected to semi-preparative
HPLC (MeOH/H2O, 68:32, v/v; 2.0 mL/min) to yield compounds 3 (2.8 mg, tR = 22.1 min) and 1
(2.5 mg, tR = 25.2 min). Further separation of Fraction 3.7 by semi-preparative HPLC (MeOH/H2O,
65:35, v/v; 2.0 mL/min) led to the isolation of compound 5 (2 mg, tR = 20.4 min).
Compound 1. Yellow powder; IR (KBr) νmax 3244, 2940, 1682, 1622, 1153, 1164, 1615, 834 cm−1;
HRESIMS m/z 223.0608 ([M + H]+, calcd. for C11H11O5 223.0606); 13C NMR and 1H NMR (Table 1).
Compound 2. Colorless powder; HRESIMS m/z 237.0765 ([M + H]+, calcd. for C12H13O5
237.0763); 13C NMR and 1H NMR (Table 1).
Compound 3. Colorless powder; UV (CH3CN) λmax (log ε) 217 (1.97), 261 (0.68), 298 (0.22) nm;
[α]25D 16.80 (c 0.30, MeOH); HRESIMS m/z 225.0757 ([M + H]
+, calcd. for C11H13O5 225.0757); 13C
NMR and 1H NMR (Table 2).
Compound 4. Colorless powder; UV (CH3CN) λmax (log ε) 217 (0.90), 260 (0.31) nm; [α]
25
D 16.00
(c 0.25, MeOH); HRESIMS m/z 253.1078 ([M + H]+, calcd. for C13H17O5 253.1076); 13C NMR and 1H
NMR (Table 2).
Compound 5. Yellow solid; UV (CH3CN) λmax (log ε) 204 (2.26), 234 (0.97), 297 (0.17) nm; IR (KBr)
νmax 3366, 2922, 1615, 1457, 1413, 1313, 1188, 1061, 752 cm−1; [α]25D 23.06 (c 0.19, MeOH); HRESIMS
m/z 219.1127 ([M + H]+, calcd. for C12H15O2N2 219.1128); 13C NMR and 1H NMR (Table 3).
3.4. ECD Calculations
Conformational analysis of the enantiomers of compounds 3–5 established by NOESY
analyses were carried out via searching with the MMFF94s molecular mechanics force field using
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Spartan’10 software (Wavefunction Inc., Irvine, CA, USA) within 10 kcal/mol. The Gaussian
09 program (Gaussian Inc., Wallingford, CT, USA) was used to optimize by density functional theory
(DFT) at the 6-31G (d, p) level (methanol as the solvent), and to calculate ECD on 6-311 + G(d, p)
level by time-dependent density functional theory (TDDFT). Boltzmann statistics were performed
for ECD simulations with a standard deviation of 0.3 eV. The softwares SpecDis 1.64 (University of
Wurzburg, Wurzburg, Germany) and OriginPro 8.5 (OriginLab, Ltd., Northampton, MA, USA) were
used to generate the ECD curves.
3.5. Antifungal Activity Assay
Three fungi including F. oxysporum, P. italicum, and F. graminearum used for bioassay were acquired
from the College of Agriculture, South China Agricultural University. The antifungal effects were
examined by the two-fold broth dilution method, as previously reported [17].
4. Conclusions
In this study, four new isocoumarin derivatives, which we named botryospyrones A, B, C, and D,
along with a new natural tryptamine derivative, (3aS, 8aS)-1-acetyl-1, 2, 3, 3a, 8, 8a-hexahydropyrrolo
[2,3b] indol-3a-ol, were isolated from an endophytic fungus B. ramosa L29, obtained from the leaf of
M. bontioides. Compound 1 remarkably inhibited F. oxysporum, compounds 2 and 3 highly inhibited
F. oxysporum and F. graminearum, and compound 5 significantly inhibited F. oxysporum, P. italicum,
and F. graminearum. The compounds were more potent than triadimefon, revealing their potential to
be used as new antifungal leads. Compound 5 was produced when using the “UISCH” strategy by
adding (2R, 3R)-3, 5, 7-trihydroxyflavanone 3-acetate, a component of M. bontioides with weak growth
inhibitory activity towards B. ramosa L29, into the medium, suggesting that this strategy could be
applied to induce an endophyte to produce new bioactive molecules.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/17/2/88/s1,
Figures S1–S34: the NMR and HRESIMS spectra for all the isolated compounds, UV spectra for compounds 3–5,
IR spectra for compounds 1 and 5, HPLC profiles for B. ramosa L29 EtOAc extract cultured in autoclaved rice
medium with/without 0.25 mM (2R, 3R)-3, 5, 7-trihydroxyflavanone 3-acetate.
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